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ABSTRACT OF THE DISSERTATION
The Roles of MIST1 and RAB26 in
Zymogenic (Chief) Cell Differentiation
and Subcellular Organization
by
Ramon Jin
Doctor of Philosophy in Biology and Biomedical Sciences
(Molecular Cell Biology)
Washington University in St. Louis, 2015
Professor Jason C. Mills, Chair
Professor Paul H. Taghert, Co-Chair
Little is known about how differentiating cells reorganize their cellular structure to
perform specialized physiological functions. Specifically, exocrine cells like pancreatic acinar
and zymogenic chief cells have a highly developed secretory architecture that is rapidly
established upon differentiation.

What is known in these cells is that the evolutionarily

conserved transcription factor MIST1 is required for final maturation. We hypothesized that
MIST1 directly regulates specific subcellular components that facilitate functional maturation of
secretory cells.
We show that MIST1 binds to conserved CATATG E-boxes to activate transcription of 6
genes, including the small GTPases RAB26 and RAB3D. We next demonstrate that RAB26 and
RAB3D expression is significantly downregulated in Mist1-/- ZCs and upregulated in gastric
cancer cell lines stably expressing MIST1 and induced to form secretory granules. Moreover,
granule formation in these MIST1-expressing cells requires Rab activity because treatment with
a Rab prenylation inhibitor or transfection of dominant negative RAB26 abrogates granule
formation.

xii

We next sought to elucidate how a scaling factor like MIST1 rearranges cellular
architecture through transcriptional targets, specifically RAB26.

We confirm that RAB26

expression was tissue specific and confined to acinar secretory cells. Functional studies in
gastric cell lines showed RAB26 association with lysosomes but not with secretory granules. In
addition, increasing RAB26 expression caused lysosomes to coalesce in a central, perinuclear
region, causing redistribution of other organelles including mitochondria into distinct subcellular
neighborhoods.
In mouse exocrine cells that are null for Mist1 and lack RAB26, we found lysosomes to
be similarly abnormally distributed. Normally, lysosomes cluster centrally and basally away
from secretory granules, whereas in Mist1−/− cells, they rapidly accumulate apically and degrade
secretory vesicles.

We confirmed active granule degradation when much of the vesicle

phenotype in Mist1−/− mice was rescued upon crossing with mice deficient in the lysosome acid
hydrolase processing enzyme, GlcNAc-1-phosphotransferase, alpha and beta subunits
(Gntpab−/−).
Taken together, we propose that MIST1 promotes normal maturation of secretory
granules through blocking their targeting by the cellular degradation/recycling machinery. These
results illustrate how a transcription factor can regulate cell architecture and have implications
for disease processes like acute pancreatitis where MIST1 is lost, and secretory vesicles are
targeted to lysosomes.

xiii

CHAPTER 1: Preface

1

Introduction
As a whole, this work will examine the cell biology of two functionally interconnected
molecules. In this Preface, I will give the context and background for the studies I will describe.
Specifically, I will introduce the concepts of vesicular trafficking, Rab proteins, and
transcriptional control of cellular architecture. Then, in Chapter 1, I will focus on applying this
molecular knowledge towards an understudied organ, the stomach. I will strive to convince the
reader of the continued need for translational cell biological discoveries with a clinical
perspective. By exploring the congenital and acquired diseases of the stomach, I will show that
our known understanding, be it molecular mechanistic or pathophysiologic, is still far exceeded
by what is unknown. Bench to bedside translation has slowed, and far too often the treatment is
found on the surgical table. Each major cell type of the gastric epithelium will be introduced and
examined pathophysiologically with a focus on the specific importance of gastric zymogenic
chief cells.

Chapter 2 will describe the importance of the transcription factor MIST1, an

exocrine secretory tissue specific functional maturation factor. Experiments will elucidate novel
direct transcriptional targets and assay their function in secretory cell maturation. In Chapter 3, I
will elucidate the novel lysosomal localization and function of RAB26, one of the novel direct
MIST1 targets. From these experiments, I will return to an in vivo gastric system in Chapter 4 to
apply these novel findings of lysosome vesicle organization to MIST1 function and zymogenic
cell development. Finally, in Chapter 5, I will interpret these results and give my suggestions to
future experimental considerations. This will be highlighted by novel findings that suggest
MIST1, RAB26, and lysosomal dysfunction may play important complementary roles during the
pathologic transition and dedifferentiation steps that occur during gastric carcinogenesis.

2

Secretory Vesicle and Lysosome Trafficking
The subject of vesicle trafficking involves answering the simple question of how cells
develop compartmentalization as a response to ever increasing complex physiological functions.
Specifically, I will focus on two common pathways that all cells share; which, at first glance,
appear to be antitheses of each other. Lysosomes are responsible for the undertaking of cellular
degradation, and secretory vesicles are charged with delivering and releasing the major synthetic
products.

But both vesicular compartments begin life at the endoplasmic reticulum (ER)

(Cooper, 2000). From this organelle, the unsorted proteins that have been properly folded and
glycosylated progress via COPII coated vesicles to the Golgi apparatus where they begin the
process of vesicular differentiation (Benham, 2012).
Secretion can occurs through a baseline constitutive pathway and an enhanced regulated
version. In fact, giving a regulated secretory load to a cell with only constitutive pathway
capabilities will induce neither accumulation of vesicles filled with that cargo nor secretion of
those proteins; indicating that regulated secretory components are uniquely expressed and
regulated (Molinete et al., 2000). In cells using both routes, the two pathways must be sorted
and maintained separately because they simultaneously shuttle different secretory contents
(Burgess and Kelly, 1987). It is thought that this division of secretory contents occurs at the
trans-Golgi, where regulated secretory proteins are processed through protein aggregation, lipid
raft formation, and organized budding (Tooze et al., 2001). From the Golgi, these immature
secretory granules are processed by prohormone convertases as they mature (Taylor et al., 2003).
In addition to sorting-for-entry into maturing secretory vesicles, a sorting-for-retention process
(Arvan and Castle, 1998) also must occur for secretory granule maturation. Active events ensure
proper vesicular identity by removal of constitutive secretory and lysosomal proteins and vesicle
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membrane constituents through clathrin-coated vesicles (Brodsky et al., 2001).

SNARE

mediated vesicle fusion events form and enlarge the maturing secretory vesicles (Waters and
Hughson, 2000). Once mature, secretory vesicles are maintained as reserve and ready-to-release
pools that tether, dock, fuse, and release their contents upon secretagogue signaling in a complex
process that is ATP-dependent and involves actin remodeling and calcium signaling (Burgoyne
and Morgan, 2003).
The constitutive secretory pathway of trafficking from the trans-Golgi to the plasma
membrane may actually involve a combination of several pathways (Ponnambalam and Baldwin,
2003) that are all distinct from one another and from the regulated secretory vesicle route (Tooze
and Huttner, 1990).

Thus, there may be direct sorting events at the Golgi or subsequent

separation of constitutive secretory components from forming regulated secretory vesicles
(Arvan and Castle, 1998).

These continuously secreted vesicles may enter an endosomal

intermediate compartment or directly progress to the cell surface (Arvan and Castle, 1998).
The itinerary for lysosomes also begins at the ER with subsequent Golgi processing and
sorting. In formation, lysosomes require membrane proteins and acid hydrolases. The best
understood pathway involves sorting of acid hydrolases by the Mannose-6-Phosphate Receptor
(M6PR) (Kornfeld and Mellman, 1989). These hydrolases are bound by M6PR at the transGolgi and mediate adapter protein and subsequent clathrin coat protein binding and budding
(Ghosh et al., 2003). As these mature and acidify, M6PR releases its cargo and is recycled back
to the Golgi by interaction with the TIP47 protein (Diaz and Pfeffer, 1998).

These late

endosomes continue to mature and fuse with other similar endosomal vesicles to eventually
become functional lysosomes. Lysosomal membrane protein trafficking is less well understood.
They are surmised to reach mature lysosomes either by an indirect plasma membrane recycling
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endocytic route or the more direct route taken by acid hydrolases through recognition of their
sorting motifs (Saftig and Klumperman, 2009). Once formed, lysosomes are able to fuse with
other trafficked membrane compartments including endosomes, vacuoles, and autophagosomes
to regulate subcellular degradation (Luzio et al., 2000).
The diverse destination of lysosomes and the secretory pathway in light of the intimacy
of their formation highlights the important task of ordered and organized vesicle trafficking.
However, to confuse matters somewhat, a combined secretory lysosome organelle also exists in
some cells. These hybrid vesicles share features of both lysosomes and regulated secretory
vesicles, and have unique properties that enable cell specific physiologic function (Marks et al.,
2013). They are expressed only in a particular subset of cells (Blott and Griffiths, 2002),
highlighting the ability of cells to adapt their subcellular structure and components for
specialized function. This concept of differential organization of subcellular compartments to
suit differing cell physiological needs is a key theme of this dissertation and will be revisited
many times.

Rab Proteins as Membrane Organizers
The Rab small protein GTPases are important intracellular regulators of vesicle
positioning and trafficking. Of the more than 70 members identified (Schwartz et al., 2007),
they all define and organize specific subcellular membrane domains. By guanine nucleotide
cycling and binding membrane specific effector proteins, these small GTPases function as
mechanical switches that mediate vesicle trafficking events (Grosshans et al., 2006). They
become associated with cell membranes by enzymatic attachment of hydrophobic geranylgeranyl
groups to carboxy-terminal cysteine residues (Seabra et al., 1992). The sequence of bound GTP
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and GDP is facilitated and determined by membrane specific guanine nucleotide exchange
factors (GEFs) and GTPase-activating proteins (GAPs) (Stenmark, 2009). In its GTP bound
form, Rab proteins are considered “active”; they can bind many unique effectors to coordinate
membrane trafficking and transport (Zerial and McBride, 2001). Upon performing its cell
biological task, Rabs hydrolyze to GTP to GDP and bind to GDP-dissociation inhibitor (GDI),
which initiates retrieval back to the membrane of origin (Stenmark, 2009). Specifically, we will
focus on the ones important in the secretory and lysosomal membrane trafficking pathways (Fig.
1).
Both routes begin in all cells with vesicle progression from the ER through the Golgi;
many ubiquitously expressed Rab proteins mediate this traffic. Among the most extensively
studied is RAB6, which has been found to regulate intra-Golgi and retrograde ER trafficking
(Martinez et al., 1994; White et al., 1999). RAB33B complements the function of RAB6 in all
cells by co-coordinating Golgi homeostasis and ER trafficking (Starr et al., 2010). Anterograde
trafficking from ER to Golgi and through the Golgi cisternae is facilitated by RAB1 and RAB2
(Plutner et al., 1991; Tisdale and Balch, 1996). Additional ER and Golgi characterized Rabs
include RAB43 and RAB18 (Liu and Storrie, 2012). The number of Rab proteins that all cells
must dedicate to this initial pathway clearly indicates the complexity and importance of early
protein sorting and processing.
The best characterized secretory Rabs are the RAB3 and RAB27 families, both playing
important roles in regulated secretion (Fukuda, 2008). As discussed, this pathway is found only
in certain cells; thus, RAB3 and RAB27 expression is limited. RAB27 functions in the transport
and docking of mature vesicles (Fukuda, 2013) in highly secretory cells including cytotoxic T
lymphocytes (Menasche et al., 2000), melanocytes (Hume et al., 2001), and exocrine secretory

6

cells (Gomi et al., 2007). RAB3 has four isoforms: RAB3A, B, C, and D; the first three isoforms
are predominantly neuronal involved in neurotransmitter and neuroendocrine hormone release
(Johannes et al., 1994; Schluter et al., 2004; Weber et al., 1994), while RAB3D is expressed in a
variety of extraneuronal cells including exocrine secretory cells (Millar et al., 2002; Ohnishi et
al., 1996). Functionally, RAB3 isoforms all share a similar role in mature secretory vesicle
docking (Fukuda 2008). Constitutive secretion has been found to be coordinated by the widely
expressed RAB8 (Chen et al., 1993). In particular, RAB8 facilitates basolateral transport from
the trans-Golgi to the plasma membrane (Huber et al., 1993)
The endolysosomal trafficking pathway is found in all cells, and contains likewise more
ubiquitously expressed Rab proteins (Gurkan et al., 2005). RAB4, 5, and 11 localize to the
endocytic pathway where RAB5 controls early endosome fusion, and RAB4 and RAB11 mediate
endosomal recycling events back to the cell surface (Mohrmann and van der Sluijs, 1999).
Maturation of early to late endosome has been found to be mediated by a RAB5-RAB7
conversion (Rink et al., 2005). RAB7 further coordinates delivery to lysosomes, while RAB9
traffics M6PR in a retrograde fashion back to the Golgi (Stenmark, 2009)
Rab protein constitution reflects the diverse physiological functions of that cell (Zerial
and McBride, 2001). Differential expression and control of Rab proteins may represent a yet
unappreciated method for cells to adapt and change subcellular vesicle compartments to suite
developing physiological needs.

Developmental Regulation of Vesicle Compartments
It has long been recognized that upon maturation, secretory cells change
morphologically, characterized by increase stores of secretory vesicles (Boquist, 1970; Caro and
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Palade, 1964). However, the direct relationship between developmental signals and cellular
architecture has only recently been appreciated, and with the advent of modern molecular
techniques we have begun to unmask the developmental regulators that govern these changes in
subcellular organelles (Mills and Taghert, 2012).

For example, as lymphocytic B cells

differentiate into antibody secreting plasma cells, expression of XBP1, a b-ZIP transcription
factor is increased and maintained at high levels. Induced XBP1 expression directly “scales-up”
ER components to accommodate secretory capacity (Shaffer et al., 2004).

In fact, this

developmentally regulated transcription factor is a feature of many diverse mature secretory cells
(Acosta-Alvear et al., 2007) including exocrine secretory cells (Huh et al., 2010; Lee et al.,
2005). Remarkably, its function in these different tissues remains conserved in expanding ER to
adjust to increasing secretory demands. XBP1 mediated ER expansion is accompanied by Golgi
expansion during secretory cell differentiation (Clermont et al., 1993; Kirk et al., 2010). In fact,
the same transcriptional signals may be involved in amplifying both compartments (Travers et
al., 2000).
Concomitant with enlarging the ER and Golgi, XBP1 also functions to enhance secretory
vesicles by direct induction of the transcription factor, MIST1 (Acosta-Alvear et al., 2007; Huh
et al., 2010). This bHLH transcription factor is again highly expressed in mature secretory cells
(Johnson et al., 2004; Lemercier et al., 1997; Pin et al., 2001), but it functions to control direct
components of secretory vesicle maturation (Capoccia et al., 2013; Garside et al., 2010;
Rukstalis et al., 2003; Tian et al., 2010). Analogously, in Drosophila, the expression of the
bHLH transcription factor and MIST1 ortholog, DIMM are developmentally restricted to mature
neurosecretory neurons and endocrine cells (Hewes et al., 2003; Park and Taghert, 2009). DIMM
also controls a subset of direct effectors important for secretion (Park et al., 2011; Park et al.,
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2008).

Other secretory vesicle developmental transcription factor effectors include: REST

control of neurosecretion (D'Alessandro et al., 2008), FOXQ1 mediated mucus granule
formation in the stomach (Verzi et al., 2008), and FOXA2 regulation of β cell insulin secretion
(Gao et al., 2007). In sum, these transcriptional control networks function in developing cells to
enhance secretion logically and stepwise through the major organelles of the secretory pathway.
Lysosomes and degradative function have similarly been shown to be induced during
development/differentiation. In epidermis development, keratinocytes terminally differentiate
into keratinized corneocytes (Sotiropoulou and Blanpain, 2012); a process which involves a
dramatic cell architectural change. Critical for this process is the upregulation of lysosomes, in
particular the need for cathepsin D mediated terminal differentiation (Egberts et al., 2004). The
autophagy pathway, a lysosome degradative and recycling process for organelles and
intracellular proteins, is activated upon and required for differentiation in many cells including
erythrocytes, adipocytes, and certain hematopoietic cell lineages to mediate subcellular
reorganization (Mizushima and Levine, 2010). Maintained lysosome function is crucial for the
sustained health of long lived terminally differentiated cells (Nixon, 2013).
Analogous to secretory vesicles, many transcriptional controllers of lysosomes have also
been recently revealed. The best characterized of these is the bHLH transcription factor, TFEB
(Sardiello et al., 2009). Through direct activation of a gene network, TFEB has also been found
to be a master enhancer of lysosome function and autophagy (Settembre et al., 2011), and linked
to important developmental growth signals (Settembre et al., 2012). Conversely, the zinc finger
family transcription factor, ZKSCAN3, has been show to repress lysosomes and associated
degradative and autophagocytic function (Chauhan et al., 2013). In addition, at least one factor
critical for early tissue development/specification have also been found to have dual roles as
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factors that scale lysosomal activity in terminal differentiation of cells. CDX2, a homeobox
transcription factor required for intestinal specification, has been found to activate an endosomelysosome trafficking gene network in enterocytes (Gao and Kaestner, 2010). Interestingly, the
importance of developmental regulation of cell function is even seen in hybrid secretory
lysosomes. Melanocyte differentiation is dependent on the bHLH transcription factor, MITF
(Bertolotto et al., 1998), and upon expression in these cells, it activates secretory lysosome
components and granule trafficking effectors (Chiaverini et al., 2008; Levy et al., 2006).
Clearly, the dramatic morphologic changes that occur rapidly and are maintained for the
lifetime of differentiated cells depend on transcriptional regulation.

In essence, these

transcription factors and the network of genes they control, allow the cell to quickly and
efficiently adjust physiological function. In disease states in which physiological function is
decreased, manipulation of these factors may represent novel therapeutic targets (Decressac et
al., 2013; Settembre et al., 2013).

Summary
The belief of all cells having the same unregulated baseline functions is changing into the
realization that cells have precisely controlled, highly adaptable, and fully integrated networks
that can be scaled up and down along different cell lineages and over time in the adult in
response to changing environmental conditions.

Elucidating the control points and the

components of these networks will further advance our knowledge of how cells change upon
physiological and pathological cues. In summary, this dissertation is founded on the following
cell biological tenets (Fig. 2):

10

1. Vesicular compartments of cells are complex, dynamic, and reflect the specific function
of the cell.
2. As function changes during cellular differentiation or changing environmental conditions,
so must these vesicular compartments.
3. Developmental transcription factors have direct control over a network of subcellular
components and are responsible, in part, for regulating vesicular compartments.

11

References
Acosta-Alvear, D., Zhou, Y., Blais, A., Tsikitis, M., Lents, N. H., Arias, C., Lennon, C. J.,
Kluger, Y. and Dynlacht, B. D. (2007). XBP1 controls diverse cell type- and condition-specific
transcriptional regulatory networks. Mol Cell 27, 53-66.
Arvan, P. and Castle, D. (1998). Sorting and storage during secretory granule biogenesis:
looking backward and looking forward. Biochem J 332 ( Pt 3), 593-610.
Benham, A. M. (2012). Protein secretion and the endoplasmic reticulum. Cold Spring Harb
Perspect Biol 4, a012872.
Bertolotto, C., Abbe, P., Hemesath, T. J., Bille, K., Fisher, D. E., Ortonne, J. P. and Ballotti,
R. (1998). Microphthalmia gene product as a signal transducer in cAMP-induced differentiation
of melanocytes. J Cell Biol 142, 827-35.
Blott, E. J. and Griffiths, G. M. (2002). Secretory lysosomes. Nat Rev Mol Cell Biol 3, 122-31.
Boquist, L. (1970). Cilia and vesicular particles in the endocrine pancreas of the Mongolian
gerbil. J Cell Biol 45, 532-41.
Brodsky, F. M., Chen, C. Y., Knuehl, C., Towler, M. C. and Wakeham, D. E. (2001).
Biological basket weaving: formation and function of clathrin-coated vesicles. Annu Rev Cell
Dev Biol 17, 517-68.
Burgess, T. L. and Kelly, R. B. (1987). Constitutive and regulated secretion of proteins. Annu
Rev Cell Biol 3, 243-93.
Burgoyne, R. D. and Morgan, A. (2003). Secretory granule exocytosis. Physiol Rev 83, 581632.
Capoccia, B. J., Jin, R. U., Kong, Y. Y., Peek, R. M., Jr., Fassan, M., Rugge, M. and Mills,
J. C. (2013). The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell
maturation. J Clin Invest 123, 1475-91.
Caro, L. G. and Palade, G. E. (1964). Protein Synthesis, Storage, and Discharge in the
Pancreatic Exocrine Cell. An Autoradiographic Study. J Cell Biol 20, 473-95.
Chauhan, S., Goodwin, J. G., Chauhan, S., Manyam, G., Wang, J., Kamat, A. M. and
Boyd, D. D. (2013). ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell 50,
16-28.
Chen, Y. T., Holcomb, C. and Moore, H. P. (1993). Expression and localization of two low
molecular weight GTP-binding proteins, Rab8 and Rab10, by epitope tag. Proc Natl Acad Sci U
S A 90, 6508-12.
Chiaverini, C., Beuret, L., Flori, E., Busca, R., Abbe, P., Bille, K., Bahadoran, P., Ortonne,
J. P., Bertolotto, C. and Ballotti, R. (2008). Microphthalmia-associated transcription factor
regulates RAB27A gene expression and controls melanosome transport. J Biol Chem 283,
12635-42.
Clermont, Y., Xia, L., Rambourg, A., Turner, J. D. and Hermo, L. (1993). Structure of the
Golgi apparatus in stimulated and nonstimulated acinar cells of mammary glands of the rat. Anat
Rec 237, 308-17.
Cooper, G. M. (2000). The Endoplasmic Reticulum. In The Cell: A Molecular Approach. 2nd
edition. , (ed. S. (MA)): Sinauer Associates.
D'Alessandro, R., Klajn, A., Stucchi, L., Podini, P., Malosio, M. L. and Meldolesi, J. (2008).
Expression of the neurosecretory process in PC12 cells is governed by REST. J Neurochem 105,
1369-83.

12

Decressac, M., Mattsson, B., Weikop, P., Lundblad, M., Jakobsson, J. and Bjorklund, A.
(2013). TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein
toxicity. Proc Natl Acad Sci U S A 110, E1817-26.
Diaz, E. and Pfeffer, S. R. (1998). TIP47: a cargo selection device for mannose 6-phosphate
receptor trafficking. Cell 93, 433-43.
Egberts, F., Heinrich, M., Jensen, J. M., Winoto-Morbach, S., Pfeiffer, S., Wickel, M.,
Schunck, M., Steude, J., Saftig, P., Proksch, E. et al. (2004). Cathepsin D is involved in the
regulation of transglutaminase 1 and epidermal differentiation. J Cell Sci 117, 2295-307.
Fukuda, M. (2008). Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life
Sci 65, 2801-13.
Fukuda, M. (2013). Rab27 Effectors, Pleiotropic Regulators in Secretory Pathways. Traffic.
Gao, N. and Kaestner, K. H. (2010). Cdx2 regulates endo-lysosomal function and epithelial
cell polarity. Genes Dev 24, 1295-305.
Gao, N., White, P., Doliba, N., Golson, M. L., Matschinsky, F. M. and Kaestner, K. H.
(2007). Foxa2 controls vesicle docking and insulin secretion in mature Beta cells. Cell Metab 6,
267-79.
Garside, V. C., Kowalik, A. S., Johnson, C. L., DiRenzo, D., Konieczny, S. F. and Pin, C. L.
(2010). MIST1 regulates the pancreatic acinar cell expression of Atp2c2, the gene encoding
secretory pathway calcium ATPase 2. Exp Cell Res 316, 2859-70.
Ghosh, P., Dahms, N. M. and Kornfeld, S. (2003). Mannose 6-phosphate receptors: new twists
in the tale. Nat Rev Mol Cell Biol 4, 202-12.
Gomi, H., Mori, K., Itohara, S. and Izumi, T. (2007). Rab27b is expressed in a wide range of
exocytic cells and involved in the delivery of secretory granules near the plasma membrane. Mol
Biol Cell 18, 4377-86.
Grosshans, B. L., Ortiz, D. and Novick, P. (2006). Rabs and their effectors: achieving
specificity in membrane traffic. Proc Natl Acad Sci U S A 103, 11821-7.
Gurkan, C., Lapp, H., Alory, C., Su, A. I., Hogenesch, J. B. and Balch, W. E. (2005). Largescale profiling of Rab GTPase trafficking networks: the membrome. Mol Biol Cell 16, 3847-64.
Hewes, R. S., Park, D., Gauthier, S. A., Schaefer, A. M. and Taghert, P. H. (2003). The
bHLH protein Dimmed controls neuroendocrine cell differentiation in Drosophila. Development
130, 1771-81.
Huber, L. A., Pimplikar, S., Parton, R. G., Virta, H., Zerial, M. and Simons, K. (1993).
Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma
membrane. J Cell Biol 123, 35-45.
Huh, W. J., Esen, E., Geahlen, J. H., Bredemeyer, A. J., Lee, A. H., Shi, G., Konieczny, S.
F., Glimcher, L. H. and Mills, J. C. (2010). XBP1 controls maturation of gastric zymogenic
cells by induction of MIST1 and expansion of the rough endoplasmic reticulum.
Gastroenterology 139, 2038-49.
Hume, A. N., Collinson, L. M., Rapak, A., Gomes, A. Q., Hopkins, C. R. and Seabra, M. C.
(2001). Rab27a regulates the peripheral distribution of melanosomes in melanocytes. J Cell Biol
152, 795-808.
Johannes, L., Lledo, P. M., Roa, M., Vincent, J. D., Henry, J. P. and Darchen, F. (1994).
The GTPase Rab3a negatively controls calcium-dependent exocytosis in neuroendocrine cells.
EMBO J 13, 2029-37.

13

Johnson, C. L., Kowalik, A. S., Rajakumar, N. and Pin, C. L. (2004). Mist1 is necessary for
the establishment of granule organization in serous exocrine cells of the gastrointestinal tract.
Mech Dev 121, 261-72.
Kirk, S. J., Cliff, J. M., Thomas, J. A. and Ward, T. H. (2010). Biogenesis of secretory
organelles during B cell differentiation. J Leukoc Biol 87, 245-55.
Kornfeld, S. and Mellman, I. (1989). The biogenesis of lysosomes. Annu Rev Cell Biol 5, 483525.
Lee, A. H., Chu, G. C., Iwakoshi, N. N. and Glimcher, L. H. (2005). XBP-1 is required for
biogenesis of cellular secretory machinery of exocrine glands. EMBO J 24, 4368-80.
Lemercier, C., To, R. Q., Swanson, B. J., Lyons, G. E. and Konieczny, S. F. (1997). Mist1: a
novel basic helix-loop-helix transcription factor exhibits a developmentally regulated expression
pattern. Dev Biol 182, 101-13.
Levy, C., Khaled, M. and Fisher, D. E. (2006). MITF: master regulator of melanocyte
development and melanoma oncogene. Trends Mol Med 12, 406-14.
Liu, S. and Storrie, B. (2012). Are Rab proteins the link between Golgi organization and
membrane trafficking? Cell Mol Life Sci 69, 4093-106.
Luzio, J. P., Rous, B. A., Bright, N. A., Pryor, P. R., Mullock, B. M. and Piper, R. C. (2000).
Lysosome-endosome fusion and lysosome biogenesis. J Cell Sci 113 ( Pt 9), 1515-24.
Marks, M. S., Heijnen, H. F. and Raposo, G. (2013). Lysosome-related organelles: unusual
compartments become mainstream. Curr Opin Cell Biol 25, 495-505.
Martinez, O., Schmidt, A., Salamero, J., Hoflack, B., Roa, M. and Goud, B. (1994). The
small GTP-binding protein rab6 functions in intra-Golgi transport. J Cell Biol 127, 1575-88.
Menasche, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F., Dupuis, S., Wulffraat, N.,
Bianchi, D., Fischer, A., Le Deist, F. et al. (2000). Mutations in RAB27A cause Griscelli
syndrome associated with haemophagocytic syndrome. Nat Genet 25, 173-6.
Millar, A. L., Pavios, N. J., Xu, J. and Zheng, M. H. (2002). Rab3D: a regulator of exocytosis
in non-neuronal cells. Histol Histopathol 17, 929-36.
Mills, J. C. and Taghert, P. H. (2012). Scaling factors: transcription factors regulating
subcellular domains. Bioessays 34, 10-6.
Mizushima, N. and Levine, B. (2010). Autophagy in mammalian development and
differentiation. Nat Cell Biol 12, 823-30.
Mohrmann, K. and van der Sluijs, P. (1999). Regulation of membrane transport through the
endocytic pathway by rabGTPases. Mol Membr Biol 16, 81-7.
Molinete, M., Irminger, J. C., Tooze, S. A. and Halban, P. A. (2000). Trafficking/sorting and
granule biogenesis in the beta-cell. Semin Cell Dev Biol 11, 243-51.
Nixon, R. A. (2013). The role of autophagy in neurodegenerative disease. Nat Med 19, 983-97.
Ohnishi, H., Ernst, S. A., Wys, N., McNiven, M. and Williams, J. A. (1996). Rab3D localizes
to zymogen granules in rat pancreatic acini and other exocrine glands. Am J Physiol 271, G5318.
Park, D., Hadzic, T., Yin, P., Rusch, J., Abruzzi, K., Rosbash, M., Skeath, J. B., Panda, S.,
Sweedler, J. V. and Taghert, P. H. (2011). Molecular organization of Drosophila
neuroendocrine cells by Dimmed. Curr Biol 21, 1515-24.
Park, D., Shafer, O. T., Shepherd, S. P., Suh, H., Trigg, J. S. and Taghert, P. H. (2008). The
Drosophila basic helix-loop-helix protein DIMMED directly activates PHM, a gene encoding a
neuropeptide-amidating enzyme. Mol Cell Biol 28, 410-21.

14

Park, D. and Taghert, P. H. (2009). Peptidergic neurosecretory cells in insects: organization
and control by the bHLH protein DIMMED. Gen Comp Endocrinol 162, 2-7.
Pin, C. L., Rukstalis, J. M., Johnson, C. and Konieczny, S. F. (2001). The bHLH transcription
factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J
Cell Biol 155, 519-30.
Plutner, H., Cox, A. D., Pind, S., Khosravi-Far, R., Bourne, J. R., Schwaninger, R., Der, C.
J. and Balch, W. E. (1991). Rab1b regulates vesicular transport between the endoplasmic
reticulum and successive Golgi compartments. J Cell Biol 115, 31-43.
Ponnambalam, S. and Baldwin, S. A. (2003). Constitutive protein secretion from the transGolgi network to the plasma membrane. Mol Membr Biol 20, 129-39.
Rink, J., Ghigo, E., Kalaidzidis, Y. and Zerial, M. (2005). Rab conversion as a mechanism of
progression from early to late endosomes. Cell 122, 735-49.
Rukstalis, J. M., Kowalik, A., Zhu, L., Lidington, D., Pin, C. L. and Konieczny, S. F. (2003).
Exocrine specific expression of Connexin32 is dependent on the basic helix-loop-helix
transcription factor Mist1. J Cell Sci 116, 3315-25.
Saftig, P. and Klumperman, J. (2009). Lysosome biogenesis and lysosomal membrane
proteins: trafficking meets function. Nat Rev Mol Cell Biol 10, 623-35.
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di
Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S. et al. (2009). A gene network
regulating lysosomal biogenesis and function. Science 325, 473-7.
Schluter, O. M., Schmitz, F., Jahn, R., Rosenmund, C. and Sudhof, T. C. (2004). A complete
genetic analysis of neuronal Rab3 function. J Neurosci 24, 6629-37.
Schwartz, S. L., Cao, C., Pylypenko, O., Rak, A. and Wandinger-Ness, A. (2007). Rab
GTPases at a glance. J Cell Sci 120, 3905-10.
Seabra, M. C., Goldstein, J. L., Sudhof, T. C. and Brown, M. S. (1992). Rab geranylgeranyl
transferase. A multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-XCys or Cys-Cys. J Biol Chem 267, 14497-503.
Settembre, C., Di Malta, C., Polito, V. A., Garcia Arencibia, M., Vetrini, F., Erdin, S.,
Erdin, S. U., Huynh, T., Medina, D., Colella, P. et al. (2011). TFEB links autophagy to
lysosomal biogenesis. Science 332, 1429-33.
Settembre, C., Fraldi, A., Medina, D. L. and Ballabio, A. (2013). Signals from the lysosome:
a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 14, 283-96.
Settembre, C., Zoncu, R., Medina, D. L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T.,
Ferron, M., Karsenty, G., Vellard, M. C. et al. (2012). A lysosome-to-nucleus signalling
mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31, 1095-108.
Shaffer, A. L., Shapiro-Shelef, M., Iwakoshi, N. N., Lee, A. H., Qian, S. B., Zhao, H., Yu,
X., Yang, L., Tan, B. K., Rosenwald, A. et al. (2004). XBP1, downstream of Blimp-1, expands
the secretory apparatus and other organelles, and increases protein synthesis in plasma cell
differentiation. Immunity 21, 81-93.
Sotiropoulou, P. A. and Blanpain, C. (2012). Development and homeostasis of the skin
epidermis. Cold Spring Harb Perspect Biol 4, a008383.
Starr, T., Sun, Y., Wilkins, N. and Storrie, B. (2010). Rab33b and Rab6 are functionally
overlapping regulators of Golgi homeostasis and trafficking. Traffic 11, 626-36.
Stenmark, H. (2009). Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10,
513-25.

15

Taylor, N. A., Van De Ven, W. J. and Creemers, J. W. (2003). Curbing activation: proprotein
convertases in homeostasis and pathology. FASEB J 17, 1215-27.
Tian, X., Jin, R. U., Bredemeyer, A. J., Oates, E. J., Blazewska, K. M., McKenna, C. E. and
Mills, J. C. (2010). RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate
exocrine granule maturation. Mol Cell Biol 30, 1269-84.
Tisdale, E. J. and Balch, W. E. (1996). Rab2 is essential for the maturation of pre-Golgi
intermediates. J Biol Chem 271, 29372-9.
Tooze, S. A. and Huttner, W. B. (1990). Cell-free protein sorting to the regulated and
constitutive secretory pathways. Cell 60, 837-47.
Tooze, S. A., Martens, G. J. and Huttner, W. B. (2001). Secretory granule biogenesis: rafting
to the SNARE. Trends Cell Biol 11, 116-22.
Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S. and Walter, P.
(2000). Functional and genomic analyses reveal an essential coordination between the unfolded
protein response and ER-associated degradation. Cell 101, 249-58.
Verzi, M. P., Khan, A. H., Ito, S. and Shivdasani, R. A. (2008). Transcription factor foxq1
controls mucin gene expression and granule content in mouse stomach surface mucous cells.
Gastroenterology 135, 591-600.
Waters, M. G. and Hughson, F. M. (2000). Membrane tethering and fusion in the secretory and
endocytic pathways. Traffic 1, 588-97.
Weber, E., Berta, G., Tousson, A., St John, P., Green, M. W., Gopalokrishnan, U., Jilling,
T., Sorscher, E. J., Elton, T. S., Abrahamson, D. R. et al. (1994). Expression and polarized
targeting of a rab3 isoform in epithelial cells. J Cell Biol 125, 583-94.
White, J., Johannes, L., Mallard, F., Girod, A., Grill, S., Reinsch, S., Keller, P.,
Tzschaschel, B., Echard, A., Goud, B. et al. (1999). Rab6 coordinates a novel Golgi to ER
retrograde transport pathway in live cells. J Cell Biol 147, 743-60.
Zerial, M. and McBride, H. (2001). Rab proteins as membrane organizers. Nat Rev Mol Cell
Biol 2, 107-17.

16

Figure Legends

Figure 1.

Rab proteins coordinate trafficking of secretory vesicles and lysosomes.

Important Rab proteins are highlighted with arrows indicating their canonical routes of effector
mediated trafficking.

Pertinent organelle and vesicular compartments are shown: the

endoplasmic reticulum in blue, the Golgi in orange, secretory vesicles in red, and the endolysosomal pathway in green.

Figure 2.

Transcriptionally controlled network of subcellular effectors.

Schematic

depicting the differentiation of a cell through augmentation of particular organellar and vesicular
structures to meet new physiological functional needs.

Known developmentally regulated

transcription factors are shown with the particular subcellular compartment that they control.
Black arrows signify gene network activation, and red arrows denote gene network repression.
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CHAPTER 2: Congenital and Acquired Diseases of the Stomach

This chapter is adapted from the published work:

Jin R. U. and Mills J. C. (2014). Chapter 5: Congenital and Acquired Diseases
of the Stomach. In Translational Gastroenterology, from Development to
Disease, edited by Deborah L. Gumucio, Linda C. Samuelson, Jason R.
Spence, 57-72.
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Introduction
The basic function of the stomach is to facilitate initial digestion of food contents arriving
from the esophagus and modulate their transport to the intestines. Interestingly, the basic tenets
of stomach function have been known for more than 5,000 years, as traditional Chinese medicine
has always taught that the qi (energy) of the stomach needs to be in balance for proper downward
flow. In short, it has been believed that insufficient secretory function or “dryness” disturbs the
function of the stomach, in effect causing upward movement (“reflux”) and dyspepsia. In this
chapter, I will focus on the clinical disorders of the stomach, using lessons learned from modern
science to help elucidate the mechanisms and gaps in traditional wisdom.
Conceptually, I will approach this task by examining first the congenital or
developmental stomach disorders and then subsequently discuss the acquired or adult
pathologies. Throughout, I will examine the mechanisms behind the pathology and discuss
associated diagnostics and therapeutics. The focus of this chapter is to situate and justify our cell
biological study of the stomach.

Accordingly, I will adopt a human-centric perspective

throughout.

I. Developmental/Congenital Clinical Disorders
A. Anatomic Development of the Stomach
The gross anatomic development of the stomach can be said to begin with the embryonic
folding of the endodermal germ layer into the gut tube.

Functional and developmental

specification of this tube occurs next with formation of the foregut, midgut, and hindgut. During
the fourth week of embryonic growth, endodermal foregut gives rise to a bulge that will form the
primitive stomach. As the bulge grows, its dorsal region outpaces its ventral such that by the
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sixth week of development, this asymmetric growth establishes the greater and lesser stomach
curvatures and, subsequently, a complex, two-step reorientation. The stomach initially rotates 90
degrees clockwise about its longitudinal axis. Then it turns about its anterior-posterior axis such
that the pylorus and cardiac regions tip upwards and downwards, respectively.

These spatial

movements end around the 8th week of development with the greater curvature of the stomach
facing the left side of the body, and the lesser curvature facing right (Fig. 1) (Carlson, 1999;
Sadler, 2012).
The histologic cell types that constitute the epithelium of the stomach arise around the
time the stomach settles into its final position. Mucus secreting cells are the first to emerge, as
the single cell epithelial lining invaginates from the surface of the gastric lumen towards the
submucosal layers. These early invaginations are the gastric pits, lined by mucinous pit (aka
foveolar cells). During the next couple of weeks, the other major cells of the gastric mucosa
begin to develop with narrower gastric glands elongating downward from the pit region until
birth (Angioi et al., 2001; Kataoka et al., 1984; Menard et al., 1993; Nomura et al., 1998). Once
established, the glands and the differentiated cells that constitute them are continually renewed
throughout adult life. Hence, I will discuss each specific lineage and associated diseases in the
Adult/Acquired disorders section. As for the early developmental disorders, I will show that
many of them are due to gut tube formation defects or problems occurring during stomach
rotation. In addition, because of the shared foregut embryonic origins of the stomach with the
esophagus and the duodenum, many of the disorders are shared with those organs. Congenital
clinical disorders are summarized in Table 1.

B. Disorders
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1. Motility
Gastric ENS primer
Motility of the stomach is dictated by the enteric nervous system. This autonomic gut
“brain” is divided into the submucosal (Meissner’s) plexus and the myenteric
(Auerbach’s) plexus. Developmentally, the ENS forms via migration of vagal, truncal
and sacral enteric neural crest-derived cells (ENCCs) that colonize and innervate the
developing gut (Heanue and Pachnis, 2007). This ENS development is complete by 13
weeks of embryonic development (Gariepy, 2004).

The proximal stomach and

esophagus is colonized by truncal ENCCs while the vagal ENCCs populate the rest of the
stomach and distal GI tract (Heanue and Pachnis, 2007).

a. Cardiac Achalasia
Primary achalasia is characterized by diminished esophageal peristalsis with impaired
LES relaxation and presents clinically as difficulty swallowing (Francis and Katzka, 2010). As
mentioned above, the ENS that populates the esophagus also innervates the proximal or cardiac
portion of the stomach. Accordingly, the cardiac region of the stomach has been shown to have
similar impaired relaxation in patients with esophageal achalasia (Mearin et al., 1995). Thus, the
disease causing mechanism will likely be shared between the esophagus and proximal stomach.
In fact, loss of nitric oxide producing ganglion cells (De Giorgio et al., 1999) and diminished
Interstitial Cells of Cajal (Vanderwinden and Rumessen, 1999) have both been found in the
gastric cardia of patients with primary achalasia. Genetically, some insight has been gained from
patients with mutations in the Triple A Syndrome (AAAS) gene. These patients present clinically
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with a congenital autosomal recessive disorder characterized by the three A’s of achalasia along
with ACTH resistance and alacrima (Handschug et al., 2001; Tullio-Pelet et al., 2000).

b. Infantile Hypertrophic Pyloric Stenosis (IHPS)
IHPS is a common condition (2 per 1000 live births) that presents during the first weeks
of life as gastric outlet obstruction that causes projectile vomiting (Gariepy, 2004; Peeters et al.,
2012). Hypertrophy of the muscularis encircling the distal or pylorus region of the stomach
prevents the stomach from emptying. The hypertrophy can be anatomical (i.e. actually increased
muscle density) and/or functional (decreased ability of that muscle to relax normally). The
underlying cause of this disease may be similar to that described for achalasia as ENS defects,
nitric oxide deficiency, and loss of Interstitial Cells of Cajal have also been observed in IHPS
patients (Guarino et al., 2000; Vanderwinden et al., 1992; Vanderwinden and Rumessen, 1999).
In rodent models in which the enzyme responsible for nitric oxide generation, one of the nitric
oxide synthases (NOS), is disturbed either genetically (Huang et al., 1993) or pharmacologically
(Voelker et al., 1995) a similar anatomic defect is detected. Over-exuberant muscularis growth
has also been suggested as a possible cause (Shima et al., 2000; Shima and Puri, 1999).
Extensive genetic linkage, association, and candidate gene approach studies have elucidated a
complex network of genes and loci with associated syndromes and environmental factors
(Peeters et al., 2012). Briefly, the diagnosis of this condition is still made clinically through
imaging modalities including barium studies and ultrasonography (Poon et al., 1996; Taylor et
al., 2013) and the standard treatment for IHPS is still surgical pyloromyotomy (St Peter et al.,
2006) while other interventions have been tried including endoscopic balloon dilatation (Ogawa
et al., 1996).
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2. Gastric Atresia
Gastric atresia is a rare condition seen only in 1 out of 100,000 live births. Clinically, the
symptoms are similar to those seen in other gastric outlet obstructions comprising postprandial
vomiting and abdominal distension presenting in early infancy. Anatomically, this obstruction
occurs in the distal stomach and is likely due to aberrant outpouchings of the stomach wall
termed membranes or fibrous cords.

It has been theorized that gastric atresias arise from

aberrant endodermal fusion or fetal ischemic events (Berrocal et al., 1999; Semrin, 2010).
Understanding the molecular basis of this disease has benefited from the clinical association of
pyloric atresias with epidermolysis bullosa (EB) (Hayashi et al., 1991; Pfendner et al., 2007).
Several genes have been linked to this autosomal recessive disorder including α6 integrin
(ITGA6) (Ruzzi et al., 1997), β6 integrin (ITGB6) (Niessen et al., 1996; Vidal et al., 1995), and
plectin (PLEC1) (Nakamura et al., 2011; Pfendner and Uitto, 2005). These genes all encode
components of the hemidesmosome, a cellular anchor that allows tight attachment of cells to the
basement membrane.

Generation of rodent models of this syndrome (Jiang and Uitto, 2005)

should lead to continued understanding of the basic mechanisms of these adhesional complexes
(Sterk et al., 2000). Diagnosis of gastric atresias is typically made using imaging modalities
including contrast radiography and ultrasonography, and treatment is still largely by excision
(Al-Salem, 2007; Ilce et al., 2003). Excitingly, chorionic villus biopsies or amniotic fluid
samples are being used in novel genetic diagnostic techniques for the subset of gastric atresias
that are associated with epidermolysis bullosa and genetically based on hemidesmosome defects
(Pfendner et al., 2003). In addition, these same patients might benefit from new gene, protein,
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and cell based therapies aimed at restoring the structural defects being developed for EB (Tamai
et al., 2009).

3. Gastric Volvulus
Gastric Mesentery Primer
During embryonic development, the tubular foregut is attached to the front and back of
the body wall by the ventral and dorsal mesogastria. As the stomach rotates and enlarges,
the ventral mesogastrium moves to the right connecting the lesser curvature and the
superior duodenum with the developing liver. The dorsal mesogastrium moves to the
left, enlarges to become the greater omentum, and encompasses the developing pancreas
and spleen (Carlson). These mesenteries mature to form the four major ligaments that
anchor the stomach intraperitoneally. The gastrophrenic, gastrosplenic, and gastrocolic
form from the dorsal mesogastrium or greater omentum, while the gastrichepatic
ligament develops from the ventral mesogastrium or lesser omentum (Gray, 2008).

Gastric volvulus is a rare medical emergency defined as an abnormal 180-degree twisting
of the stomach that can ultimately result in vascular compromise and necrosis. When occurring
in adults, this disorder is usually secondary to hernias of the stomach through the diaphragm
(Wasselle and Norman, 1993). In children, twisting occurs primarily due to laxity of the gastric
mesentery ligaments (Cribbs et al., 2008).

Specifically, the stomach may twist about its

longitudinal axis (organoaxial), its short axis (mesenteroaxial), or a combination of the two
(Sevcik and Steiner, 1999). The clinical presentation of acute gastric volvulus in adults is often
chest pain, unproductive vomiting, vomiting of blood, and inability to pass a nasogastric tube
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(Miller et al., 1991), while in children symptoms may include vomiting, distension, and pain
(Cribbs et al., 2008). Diagnosis is made clinically based on symptoms and confirmed by barium
studies and CT scans (McElreath et al., 2008). Treatments remains surgical with the strategy to
decompress and reduce the volvulus, correct concomitant factors such as hernias and necrotic
tissue, and anchor the stomach to the anterior abdominal wall or perform an anastomotic bypass
of the twist (antral-fundal gastrogastrostomy) to prevent future movement (Rashid et al., 2010).
Gastronomy tubes are usually placed in children with volvulus to prevent future movement and
allow feeding (Cribbs et al., 2008).

4. Congenital Microgastria
Congenital microgastria is another extremely rare (only about 60 known cases) (Vasas et
al., 2011) developmental gastric condition characterized by failure of foregut growth during the
5th week of embryonic development (Ramos et al., 1996).

These patients present with

obstruction-like symptoms including vomiting, reflux, and esophageal dilation (Kroes and
Festen, 1998). Retarded stomach growth also manifests as iron and vitamin B12 deficiencies due
to decreased acid and intrinsic factor production. This condition is usually associated with
VACTERL (vertebral defects, anal atresia, cardiac defects, tracheo-esophageal abnormalities,
renal anomalies, and limb malformations) and other developmental abnormalities including
asplenia due to improper rotation and development of the dorsal mesogastrium (Aintablian,
1987; Filippi et al., 2008; Hernaiz Driever et al., 1997). The role of Sonic hedgehog (Shh) and in
particular the Gli transcription factors with VACTERL syndrome (Kim et al., 2001) may shed
light on the underlying molecular mechanisms associated with congenital microgastria.
Diagnosis is made using imaging modalities including contrast radiography and ultrasonography,
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and treatment is individualized. Milder cases are treated with feeding strategies, while more
severe cases are treated with a double lumen distal Roux-en-Y jejunal reservoir (Hunt-Lawrence
pouch) operation allowing for increased stomach volume (Neifeld et al., 1980; Velasco et al.,
1990).

5. Gastric Diverticulum
Gastric diverticulum disease consists of outpouchings of the stomach wall that typically
present asymptomatically in adults with an incidence of about 0.04% (Rashid et al., 2012).
These diverticula are classified as either: a) true congenital, containing all gastric tissue layers
and usually located on the posterior wall of the cardia; or b) partial acquired, lacking the
muscularis and usually located in the antrum (Rodeberg et al., 2002). A congenital muscle
weakness, lack of a peritoneal membrane, and invading arterioles all may be contributing factors
in this condition (Mohan et al., 2010). Diagnosis is usually incidental upon radiological studies,
and surgical excision is only needed if the diverticulum is at risk to bleed, perforate (Rodeberg et
al., 2002), or become malignant (Fork et al., 1998).

6. Gastric Duplication Cysts
Duplication cysts are defined as heterotopic epithelium lined by muscle located in or near
the wall of the GI tract. Less than 10% of all GI duplication cysts consists of aberrant gastric
epithelium (Macpherson, 1993). When found in the stomach proper, they are located on the
greater curvature(Macpherson, 1993). Symptoms vary depending on the type of heterotopic
epithelium and location in the GI tract, with gastric cysts often presenting with symptoms of
peptic ulcer disease. Because of their rarity (an incidence of 17 per 1 million births (Bonacci and
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Schlatter, 2008)), the research into this disorder is limited, and currently a handful of hypotheses
exist involving formation of invaginations during embryonic development that aberrantly persist
into duplication cysts (O'Donnell et al., 2005). Imaging modalities including CT scan and
transabdominal ultrasound are used for diagnosis, and surgical excision is usually the
recommended treatment (Semrin, 2010).

7. Teratomas
Teratomas are germ cell tumors defined as having all three germ cell layers: endoderm,
mesoderm, and ectoderm. These rare tumors are further classified into immature and mature
depending on differentiation status with immature teratomas more likely to become malignant
(Peterson et al., 2012). Gastric localization of teratomas is extremely rare with only about 100
documented cases, and when they do occur in the stomach, teratomas tend to be exophytic and
on the posterior greater curvature side (Corapcioglu et al., 2004). The causative mechanism of
teratomas remains unknown (Oosterhuis and Looijenga, 2005); however, interesting work
implicates the origins of this germ cell tumor to primordial germ cells using genetic imprinting
(Bussey et al., 2001) and animal model techniques (Kimura et al., 2003). Occurring mostly in
males (Yoon et al., 2000), gastric teratomas may cause distension, vomiting, hematemesis, and
perforation depending on the growth pattern (Sharif et al., 2010). CT scan is the gold standard
for diagnosis (Singh M, 2012), and use of serum tumor markers (a-fetoprotein (AFP) and human
beta-choriogonadotropin (HCG)) is important in the diagnosis and follow-up (Gobel et al.,
2000). Treatment is usually surgical excision for the mature variety, while chemotherapy is used
in conjunction with surgery for immature teratomas (Romagnani et al., 2006). Understanding of
this rare tumor type will become increasingly important in the future as basic science findings
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involving human embryonic stem cells and induced pluripotent stem cells are being translated
into the clinical realm (Blum and Benvenisty, 2009).

II. Adult/Acquired Clinical Disorders
A. Histological Development of the Stomach
The acquired clinical disorders of the stomach occur in the “adult” stomach. Because the
gastric epithelium is continuously renewed throughout life from multipotent stem cells, adults
can acquire developmental disease based on abnormal differentiation of progeny cell lineages
(Fenoglio-Preiser C.M., 1999). I have divided the adult clinical disorders discussion into lineage
specific categories and, in doing so, I am tasked with explaining in detail the cells of each
lineage. Karam, Lee, and Leblond did much of the seminal work describing the dynamics of
stomach epithelium differentiation in the mouse using electron microscopy and 3H-thymidine
pulse labeling. Despite small differences as will be described including lineage turnover times
(about twice that seen in mice (Fenoglio-Preiser C.M., 1999; Karam and Leblond, 1995; Karam
et al., 2003; Macdonald et al., 1964)), the mouse and human stomachs seem to share remarkable
similarities in development, physiology and cell biology.
Grossly, the human stomach is divided into four anatomic regions: the cardia, the fundus,
the body/corpus, and the antrum (Fig. 2A).

The cardia is the short transition region of

predominantly mucous glands on the border with the esophagus closest to the gastroesophageal
junction, the fundus (the outpouching, hunchback portion of the stomach along the greater
curvature) and body make up the major portion of the stomach, and the antrum (or pylorus) is the
distal area leading to the pyloric sphincter.

A key anatomic difference in mice is that they have
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an enlarged proximal gastric region called the forestomach, which can be considered, in part, an
extension of the esophagus and is, similarly, lined by mature stratified squamous epithelium.
Each subanatomic region of the human stomach contains unique gastric invaginations or
glands comprised of distinct histological cell types.

The cardiac glands comprise simple

columnar, mucus-secreting epithelial cells. Architecture in the antrum is similar, though, in
addition to mucus glands, there are abundant endocrine cells (specifically, gastrin secreting G
cells and somatostatin-secreting D cells). In the mouse, careful nucleotide pulse-chase labeling
studies have shown that antral glands are continuously renewed bi-directionally from the isthmal
region with pit or surface mucus gland cells turning over every 3 days, and basal gland cells
turning over with a more variable rate of 1-60 days (Fig. 2B) (Lee, 1985; Lee and Leblond,
1985a; Lee and Leblond, 1985b).
The glands of the fundus/body or oxyntic glands contain four distinct regions, from
surface to base: the pit, isthmus, neck and base (Fig. 2C). Eleven separate cell types (Karam and
Leblond, 1995) have been found in the oxyntic glands but for our purposes I will characterize
and examine these cell types in terms of their developmental lineages. In the isthmus resides the
self-renewing stem cell, which, as in the antrum, bidirectionally differentiates and migrates
(Karam and Leblond, 1993a).

Interestingly, in mice a clear “granule free” stem cell was

identified by electron microscopy, but all isthmal cells in humans seem to have at least some
granules (Karam et al., 2003). Those cells that migrate up from the stem cell towards the lumen
of the stomach become the surface pit (foveolar) mucus secreting cells; turnover of this lineage is
rapid occurring every 3 days in mice just as in the antrum (Karam and Leblond, 1993b). The
acid secreting parietal cells terminally differentiate and move in both directions, luminally and
basally; these cells survive for 54 days in mice (Karam, 1993). In humans, parietal cells seem
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only to migrate towards the base, as they are not observed in the pit region (Karam et al., 2003).
Cells destined to become pepsinogen- secreting zymogenic cells (chief cells), mature from
isthmal stem cells through a mucus neck cell intermediate as they migrate towards the base.
These neck cells take 1-2 weeks to migrate and terminally differentiate into chief cells (Ramsey
et al., 2007); cells in this lineage turn over once every 190 days in mice (Karam and Leblond,
1993c). It is important to note that in mice, intrinsic factor is not typically produced in parietal
cells as in humans but rather in chief cells (Shao et al., 2000). Finally, enteroendocrine cells
(predominantly histamine-producing enterochromaffin like, ECL cells) differentiate and mostly
migrate towards the base with a lineage turnover rate of 60 days (Karam and Leblond, 1993d;
Thompson et al., 1990). It is in this complex setting of multiple simultaneous cell movement and
maturation that acquired adult disorders occur.

Adult/Acquired clinical disorders are

summarized in Table 1

B. Disorders
1.

Surface Pit Cells
These mucus secreting cells populate the most apical region of the gastric gland and

undergo rapid turnover and renewal (estimated at 4-6 day half-life in human (Macdonald et al.,
1964)).

Functionally, their mucus and bicarbonate secretory product protects the stomach

epithelium from the damaging effects of luminal acid and digestive enzymes (Bhaskar et al.,
1992).

a. Foveolar Hyperplasia
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Foveolar hyperplasia is defined histopathologically as an overgrowth of surface pit cells
associated with underlying mucosal injury such as chronic gastritis. There are multiple disease
states/underlying causes, so I will not discuss foveolar hyperplasia diagnostic and therapeutic
interventions in isolation. However, newly gained mechanistic insights have shed light on how
pit cell growth is hyperstimulated. Helicobacter colonization can induce IL-1β release from
activated macrophages in areas of foveolar hyperplasia, which in turn stimulates neutrophils and
mesenchymal cells to release the growth factor, HGF (Yasunaga et al., 1996). Mouse models in
which HGF activator is genetically ablated do not display the reactive foveolar hyperplasia post
gastric injury (Yamagata et al., 2012). TGFα has been implicated in foveolar hyperplasia in a
mouse model (Goldenring et al., 1996) and TGFα/EGF signaling in humans with Ménétrier
disease, which will be discussed later.
Foveolar hyperplasia occurs usually in the setting of atrophic gastritis (i.e., where there is
chronic inflammation and atrophy of parietal cells, discussed in more detail below). Mouse
models have shown that parietal cells express and need the morphogen Sonic hedgehog (Shh) for
acid secretion (Stepan et al., 2005). Genetic ablation of Shh in mice caused decreased acid
secretion, hypergastrinemia, foveolar hyperplasia, and a reduced ability for the stomach mucosa
to heal (Xiao et al., 2013; Xiao et al., 2010). Loss of Shh has been associated with neoplastic
progression in humans as well, thus making Shh signaling a valid clinical target post gastric
injury (Shiotani et al., 2005). Importantly, gastrin secreted from antral G cells (to be discussed in
detail in the enteroendocrine section) has been shown to have a similar causative role in foveolar
hyperplasia (Nomura et al., 2005b; Wang et al., 1996)

b. Ménétrier Disease
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Ménétrier disease is a chronic adult disease characterized by enlarged rugal folds due to
surface mucus pit cell overgrowth. Symptoms include pain, vomiting, bloating, weight loss, and
edema in large part due to hyper mucus secretion leading to hypoproteinemia (Fenoglio-Preiser
C.M., 1999; Rich et al., 2010).

The definitive diagnostic procedure is gastroscopy and

confirmatory biopsy (Lambrecht, 2011). Unlike foveolar hyperplasia, in which the foveolar
overgrowth is secondary to epithelial damage response and a potentially complex set of
associated signaling pathways, the causative process in Ménétrier disease has long been thought
to be specifically increased TGF-α signaling in foveolar pit cells (Dempsey et al., 1992;
Goldenring et al., 1996). Activation of EGF receptors that bind EGF and TGFα as ligands in the
setting of normal gastrin levels, redirects lineage specification towards the surface mucus cells at
the expense of parietal and zymogenic cell lineages (Coffey and Tanksley, 2012; Nomura et al.,
2005a),. These observations have spurred exciting novel treatments of this disorder targeting
this particular signaling cascade. The chemotherapeutic drug cetuximab (Erbitux), that blocks
TGF-α activation of its receptor, is now being developed as a promising first line treatment,
shown to be effective clinically to increase parietal cell numbers and stomach acidity(Burdick et
al., 2000; Fiske et al., 2009; Settle et al., 2005).

2. Enteroendocrine Cells
Enteroendocrine cells are located at the base of the gastric gland. Their function is
primarily to control parietal cell acid secretion through release of gastrin, histamine and
somatostatin.

In response to distention, digested proteins, and postprandial cholinergic

innervation, antral G cells release the peptide hormone gastrin (Schubert and Makhlouf, 1992).
Gastrin primarily mediates fundic ECL cell histamine release, although it may also directly
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stimulate parietal cell acid release. Histamine from the ECL cells stimulates parietal cell H-2
receptors to activate cAMP signaling, the ultimate effect of which is to recruit H,K ATPase
transporters to membranes that ultimately communicate with the glandular lumen, thereby
initiating and augmenting H+ release (Schubert, 2009). The principal inhibitory hormone is
somatostatin from the D cells, which directly inhibits G cell gastrin, ECL histamine, and parietal
cell acid secretion (Schubert, 2009).

a. Hypergastrinemia
Hypergastrinemia is a condition caused either directly by gastrin-secreting tumors
(Zollinger-Ellison syndrome, discussed below) or, indirectly, by increased gastric pH secondary
to atrophic gastritis (and other abnormal epithelial differentiation states like intestinal metaplasia
and

cancer),

vagotomy,

or

pharmacological

inhibition

of

gastric

acid

secretion.

Hypergastrinemia is characterized by serum gastrin levels above the normal range of 150 pg/mL.
(Orlando et al., 2007). When hypergastrinemia is secondary to increased gastric pH, clinical
symptoms will vary depending on the primary cause. Importantly, symptoms may be masked
when acid production is inhibited pharmacologically (usually through proton pump inhibitor
therapy). In these patients, discontinuation of therapy can cause rebound dyspepsia and sudden
impairment of gastric emptying (McCarthy, 2010).

Histologically, hypergastrinemic states

present with increased epithelial hyperplasia of gastrin’s cellular targets: parietal cells and ECL
cells. The underlying effects of increased gastrin levels have been extensively studied using
genetic tools available in rodent models (Jain and Samuelson, 2006). In H,K ATPase deficient
mice, increased cell proliferation caused by impaired parietal cell acid secretion was rescued
upon genetic ablation of gastrin (Franic et al., 2001). In mouse models overexpressing gastrin,
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increased levels of heparin-binding epidermal-like growth factor (HB-EGF) and TGF-α (Sinclair
et al., 2004; Wang et al., 2000) have been found in parietal and surface mucus cells. It is still
unclear how gastrin acts to initiate proliferation; whether it is through induction of growth factors
like EGF/TGFα or via more direct signaling to stem/progenitor cells (Kazumori et al., 2001).
Serum gastrin measurements, secretin test of gastrin release, and basal acid output are used
diagnostically to differentiate gastrinomas (i.e. gastrin-producing tumors causing direct
hypergastrinemia) from other, secondary hypergastrinemic states (Del Valle J, 2003a).
Therapies should be aimed at treating the underlying cause, usually the agent causing the
gastritis (e.g., Helicobacter) or causing the acid inhibition in non-neoplasia-related
hypergastrinemia.

b. Zollinger-Ellison Syndrome
Zollinger-Ellison syndrome is a rare disorder characterized by excessive gastrin secretion
from a neuroendocrine tumor resulting in aberrant mucosal growth and hypersecretion of acid
(aka a gastrinoma). These neoplasias are usually located in a triangular area marked by the
cystic and common bile ducts, the second and third parts of the duodenum, and the pancreas (Del
Valle J, 2003a). Patients with gastrinomas usually present with peptic ulcer disease and diarrhea.
The growth promoting effects of gastrin coupled with the difficulty in recognizing this disease
(Corleto et al., 2001), make early diagnosis an important factor in preventing malignant
progression and improving outcomes (Weber et al., 1995).

Current clinical diagnostic

logarithms involve measuring serum gastrin with concomitant pharmacologic control of peptic
ulcer disease (e.g. via proton pump inhibitors). After endoscopic confirmation of peptic ulcer
disease healing, PPI treatment is discontinued and gastric acid levels are measured. Once
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hypergastrinemia is confirmed with gastric pH <2, other conditions can be excluded and curative
surgical resection of the gastrinoma can be performed (Ito et al., 2012; Metz, 2012). The
causative mechanism for the formation of these neoplasias is currently unknown, but they have
been associated with several genetic defects (Yu et al., 2000) including mutations in the tumor
suppressor gene p16 (Muscarella et al., 1998; Serrano et al., 2000) and the oncogene HER-2/neu
(Evers et al., 1994).

Interesting work has associated Zollinger-Ellison syndrome with the

autosomal dominant disorder, multiple endocrine neoplasia type 1 (MEN1). Mutations in the
MEN1 gene cause inactivation of the tumor suppressor Menin that has many roles in inhibiting
cell proliferation (Wu and Hua, 2011).

Classically, MEN patients present with

hyperparathyroidism, pancreatic endocrine tumors, and pituitary and adrenal adenomas.
Gastrinomas with Zollinger-Ellison syndrome are the most common endocrine tumor type seen
in MEN1 patients occurring in 21-70% of those patients (Gibril et al., 2004). Genetic linkage
testing can be used diagnostically in MEN1 patients (Larsson et al., 1992), and new gene
therapies aimed at replacing MEN1 gene function are promising in reducing cancer cell
proliferation rates (Walls et al., 2012).

c. Carcinoid Tumors
Carcinoid tumors are rare endocrine tumors that arise from fundic ECL cells and usually
occur in the setting of hypergastrinemia associated with chronic gastritis and pernicious anemia
(type 1), or MEN1 syndrome (type 2); an aggressive sporadic form (type 3) that is gastrinindependent also exists (Borch et al., 1985; Lehy et al., 1992; Rindi et al., 1993). Carcinoid
tumors spawned by excessive gastrin secretion are usually asymptomatic aside from the
underlying condition.

Sporadic carcinoids are often also asymptomatic and are usually
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discovered incidentally. They can, however, cause symptoms such as bleeding, diarrhea, weight
loss, and atypical carcinoid syndrome (characterized by flushing, headaches, shortness of breath,
and lacrimation) (Borch et al., 2005; Burkitt and Pritchard, 2006).

Diagnosis is based on

gastroscopy, biopsy and histological analysis for ECL cell markers (chromagranin A), and
somatostatin receptor scintigraphy and ultrasound or abdominal CT to look for metastasis
(Scherubl et al., 2010). Therapy for type 1 and type 2 gastric carcinoid tumors is surgical
resection, which can be augmented by antrectomy (to decrease gastrin levels by removing G
cells) and octreotide (a somatostatin analog and inhibitor of gastrin) (Lawrence et al., 2011).
Type 3 carcinoids demand more aggressive treatment with gastrectomy and chemotherapy
(Lawrence et al., 2011). The strong association with MEN1 syndrome independent of sporadic
Zollinger Ellison Syndrome (Lehy et al., 1992) has led to the theory that loss of heterozygosity at
the MEN1 gene loci plays a role in gastric carcinoid formation (Cadiot et al., 1993; Debelenko et
al., 1997). Further insights into the pathogenesis of this disease have been made using unique
rodent models including the cotton rat (Sigmodon hispidus), which spontaneously develop gastric
carcinoids (Cui et al., 2000), and the Natal multimammate mouse (Mastomys natalensis)(Nilsson
et al., 1993). Experiments using the Mastomys model have confirmed the ECL cell growthpromoting roles of gastrin (Kidd et al., 2000) and histamine (Modlin et al., 1996). Specifically,
recent reports have shown that gastrin and histamine may mediate AP-1 transcriptional activation
(Kidd et al., 2004), increase growth factor expression (TGF-α and EGFR (Tang et al., 1996),
CCN2/CTGF (Kidd et al., 2007), and polyamines (Kidd et al., 1998)), and induce the expression
of anti-apoptotic proteins (mcl-1(Pritchard et al., 2008), clusterin (Fjeldbo et al., 2012)).
Ultimately, these animal models have proven to be useful to test and validate potential new
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clinical therapies including the novel gastrin (cholecystokinin-2) receptor antagonist Netazepide
(YF476) (Kidd et al., 2010; Martinsen et al., 2003).

3. Parietal Cells
Parietal cells are the primary gastric acid and intrinsic factor secreting cells located in the
body and fundic regions of the stomach. In the unstimulated state, the H,K ATPase proton
pumps are stored in an elaborate tubulovesicle membrane system within the cell.

Upon

stimulation, these membranes are trafficked to fuse with the plasma membrane to form the
intercanalicular system which increases surface area for increased acid release. Stimulation of
acid secretion is mediated by histamine, gastrin, and acetylcholine.

Briefly, as previously

discussed, histamine released from fundic ECL cells and gastrin released from antral G cells
stimulates parietal cell H2 and CCK2 receptors, respectively. Postganglionic vagal or ENS
stimulation releases acetylcholine to stimulate M3 muscarinic receptors.

Both gastrin and

acetylcholine lead to phospholipase C mediated mobilization of intracellular calcium (Del Valle
J, 2003b). Alternatively, histamine acts to increase intracellular cAMP levels through adenylate
cyclase activation (Del Valle J, 2003b). Both pathways lead to well established cell biological
events that result in proton pump mobilization and acid secretion (Yao and Forte, 2003). The
principal inhibitor of acid secretion is somatostatin, produced by endocrine D cells, which, in
addition to inhibiting gastrin release from G-cells and histamine release from ECL cells, directly
inhibits parietal cell cAMP levels (Del Valle J, 2003b). Occasional studies have also found that
intrinsic factor secretion is stimulated by the same factors that increase acid secretion (Del Valle
J, 2003b)
.
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a. Peptic Ulcer Disease
Peptic ulcer disease is characterized by mucosal erosions that are caused by imbalances
between acid secretion and the mechanisms that protect against acid-induced damage to the
mucosa. Acid hypersecretion, NSAID toxicity, and H pylori infection are the most common
etiologies. In cases of pure acid hypersecretion, the cause is usually hypergastrinemia in the
setting of Zollinger-Ellison syndrome, which has already been discussed. Here, I will focus on
the latter two etiologies. Although I discuss it in the “parietal cell” section, peptic ulcer disease
is a multifaceted mucosal disorder that affects multiple cell lineages. Peptic ulcer disease can be
viewed simply as a breakdown in mucosal protection. The barrier in the most general sense
comprises the interplay among stomach acid, surface mucus production, the ability of the
epithelium to self-renewal, blood flow, inflammation, and molecular regulators, such as
prostaglandins (PGE2 and PGI2) (Wallace, 2008). Clinically, peptic ulcer disease manifests as
pain, bloating satiety, nausea and/or vomiting (Yuan et al., 2006). NSAIDs are thought to cause
peptic ulcer disease via inhibition of the enzyme COX1 (PTGS1), which produces protective
prostaglandins. Thus, selective inhibitors of the other prostaglandin-producing enzyme COX2
(PTGS2) have been adopted (Laine et al., 1999) to spare the gastric mucosa from barrier effects.
However, recent evidence has revealed that COX2 inhibition might also have deleterious effects
on mucosal health (Chan et al., 2004; Hippisley-Cox et al., 2005; Mizuno et al., 1997). This has
led to the current hypothesis that both COX-1 and COX-2 have mutually protective effects in the
stomach through synthesis of prostaglandins that reduce gastric hypermotility, vascular damage,
and neutrophil activation (Laine et al., 2008; Taha et al., 1999; Wallace et al., 1990).
Colonization by the gram negative bacterium, H pylori, causes chronic gastritis. H pylori
generally favors the antrum or transitional regions between the fundus/body and antrum, though
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it also can chronically infect the fundus/body, too (see below). H pylori is estimated to infect
half the world, and infected individuals are usually asymptomatic; however, when symptoms
arise, patients with predominantly antral colonization tend to experience overproduction of acid
in the fundus/body (Genta, 2003). Thus, H pylori is one etiology for hypersecretion of acid and
the ultimate cause of the vast majority of duodenal peptic ulcers.

On the other hand,

fundus/body predominant colonization increases risk of gastric peptic ulcers and carcinogenesis
(to be discussed in the neck cell/zymogenic cell lineage section) (Suerbaum and Michetti, 2002).
H pylori causes pathology through interplay between toxins it produces and the inflammation
induced in the host. The ability of H pylori to survive, navigate, and adhere in the acidic gastric
lumen is facilitated by the bacterial enzyme urease, bacterial flagella, and the bacterial surface
protein BabA binding to Lewis B blood group antigen on host cells (Suerbaum and Michetti,
2002). Once bound to the gastric epithelium, pathogenic strains of H pylori usually harbor the
toxin CagA on a pathogenicity island that also encodes a type IV secretion system to inject CagA
into the host cell. CagA in turn elicits a variety of responses including disruption of cell
junctional complexes (Amieva et al., 2003), transduction of MAPK pathway growth signals
(Mimuro et al., 2002), activation of SHP-2 phosphatase (Higashi et al., 2002), and initiation of
host transcriptional activity (Hirata et al., 2002). In addition, H pylori strains can also secrete
another toxin, VacA, a vacuolating toxin that inserts in the host cell membrane, forms anionselective channels (Szabo et al., 1999), and induces a cytochrome c release mediated cell death
response (Galmiche et al., 2000). The host inflammatory response to these microbial factors is
mediated by cytokines (interleukin-1β, interleukin-2, interleukin-6, interleukin-8, and tumor
necrosis factor alpha (TNF-α)) and involves recruitment of neutrophils, lymphocytes, plasma
cells, and macrophages (Suerbaum and Michetti, 2002). Specifically, NF-κB mediated IL-8
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production leads to the neutrophil recruitment classically noted by pathologists during H pylori
induced gastritis (Brandt et al., 2005; Sharma et al., 1998). This Th1 predominant inflammatory
response (Mohammadi et al., 1996) allows persistent colonization of the microbe (Tummala et
al., 2004). An antecedent Th17 response has been shown to be induced by H pylori to trigger
the Th1 and subsequent inflammatory response (Luzza et al., 2000; Shi et al., 2010); studies have
also suggested that H pylori may suppress this Th17 activation in order to promote immune
tolerance and persistent colonization (Kao et al., 2010; Oertli et al., 2013).

This ability of H

pylori to persist may also be due to its ability to survive intracellularly (Amieva et al., 2002; Oh
et al., 2005) and to evade host autophagy defenses through VacA toxin action (Raju et al., 2012;
Terebiznik et al., 2009). Importantly, due to their overlapping effects on the inflammatory
response, H pylori infections and NSAID use can synergistically increase the development and
progression of peptic ulcer disease (Huang et al., 2002).
Endoscopy is currently the gold standard in diagnosing peptic ulcer disease with
simultaneous testing for H pylori (assayed by culture, histological examination, the rapid urease
test (RUT), and polymerase chain reaction (PCR)). Treatment involves the first line, so-called,
triple therapies (proton pump inhibitor, amoxicillin, and clarithromycin) and secondary
quadruple (proton pump inhibitor, bismuth, tetracycline, and metronidazole) therapies to
eradicate the bacterium (Luther et al., 2010; Malfertheiner et al., 2011; Malfertheiner et al.,
2002)

Additionally, administration of misoprostol (a PGE1 analog), use of H2-receptor

antagonists, proton pump inhibitor therapy, and switching to a selective COX2 inhibitor (Laine
et al., 2008; Yuan et al., 2006) can all aid treatment, depending on exact etiology (e.g., NSAID
use with H pylori infection). Several new classes of NSAIDs are in development that capitalize
on insights gained from basic science. As previously discussed, it is neutrophil activation that is
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thought to be the common mechanism for mucosal damage. Nitric oxide has been shown to
regulate epithelial barrier permeability, increase gastric blood flow, inhibit neutrophil invasion,
and facilitate gastric mucosal healing (Lanas et al., 2000; Wallace and Miller, 2000). To address
both prostaglandin and nitric oxide mechanisms, several new cyclooxygenase-inhibiting nitric
oxide donators are being developed (Fiorucci et al., 2003; Lohmander et al., 2005) including
Naproxcinod (Baerwald et al., 2010). In addition, inhibitors of 5-lipoxygenase, an enzyme that
produces pro-inflammatory leukotrienes from arachidonic acid as a result of COX inhibition, are
being packaged with COX inhibitors (Bias et al., 2004). Additional lines of therapy being
develop involve using phosphatidylcholine to enhance mucosal barrier function (Lichtenberger et
al., 2009) and hydrogen sulfide to reduce inflammation (Wallace, 2007). With regard to H
pylori, new treatment algorithms are being tested (Malfertheiner et al., 2011) with alternative
therapies including probiotics and phytomedicine (Vitor and Vale, 2011). The ultimate goal for
much of the research into eradication has now shifted towards effective vaccine production,
given the rising incidence of antibiotic resistant variants (Megraud, 2004). Several candidate
vaccines are in development based on animal studies aimed at circumventing host
immunoregulation, which seems to suppress the natural immune response that would be
sufficient to eradicate H Pylori (Czinn and Blanchard, 2011).

b. Autoimmune Gastritis/Pernicious Anemia
Autoimmune gastritis is an autoimmune disease characterized by autoimmune destruction
of parietal cells due to autoantibodies to the parietal cell H/K ATPase (Karlsson et al., 1988) and
intrinsic factor (Bardhan et al., 1968). Clinically, these patients may present with achlorhydria or
hypochlorhydria from parietal cell damage, decreased pepsinogen levels, hypergastrinemia with
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ECL and G cell hyperplasia, iron deficiency and cobalamin (B12)-deficient (i.e. pernicious
anemia) (Genta, 2003). Autoimmune gastritis patients often show a genetic HLA association
(Oksanen et al., 2010) and possibly an inciting role of H pylori infection (Veijola et al., 2010).
Immunologists have long studied this disease, because it is an autoimmune disease with wellestablished auto antigen target, the H,K ATPase proton pump (D'Elios et al., 2001). In a mouse
model with a transgenic T cell receptor specific for H,K ATPase, scientists were able to induce
autoimmune gastritis after transferring T cells to immunodeficient mice; Th1, Th2, and Th17
CD4 subtypes were all shown to play a role in development of gastritis (Stummvoll et al., 2008).
Peripheral extra-thymic deletion and Treg suppression have been found to mechanistically
prevent these H/K ATPase–specific T cells from becoming pathogenic (DiPaolo et al., 2007;
DiPaolo et al., 2005; Read et al., 2007). Despite these insights, diagnosis of this condition is
made usually after presentation and diagnosis of megaloblastic anemia due to vitamin B12
deficiency. Noninvasive serum screens for low pepsinogen, high gastrin, low serum ghrelin
(Checchi et al., 2007), and auto antibodies are first line diagnostic tests followed by subsequent
endoscopic confirmation of mucosal atrophy and surveillance for advanced stage disease
complications like polyps, carcinoids, and cancer (Annibale et al., 2011; Toh et al., 2012).
Conventional treatment involves vitamin B12 replacement (Annibale et al., 2011; Toh et al.,
2012). Several potential areas of treatment are being pursued including extrathymically induced
T regulatory cells (iTregs) that can be induced, expanded, and administered to attenuate stomach
pathology in a mouse model of autoimmune gastritis (Nguyen et al., 2011). An alternatively
novel approach being investigated in all autoimmune diseases is the use of gene therapy to
introduce autoantigens into bone marrow stem cells to promote immune tolerance (Alderuccio et
al., 2009).
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b. Atrophic Gastritis
Chronic atrophic gastritis is a pathologic condition secondary to chronic infection with H
Pylori characterized by loss of parietal cells and consequent changes in the chief cell lineage (to
be discussed in detail in the chief cell lineage section), usually also associated with secondary
foveolar hyperplasia and hypergastrinemia produced by endocrine cell response to loss of
parietal cell acid production. As mentioned, H pylori infection can be asymptomatic, induce
peptic ulcer disease, and also cause atrophic gastritis with increased risk for progression to
gastric adenocarcinoma or lymphoma. In general terms, disease typically starts in the antrum
with hypersecretion of acid often causing duodenal ulcers, as discussed. Several theories have
served to explain the hyperchlorhydria associated with this initial phase. It is believed that H
pylori infection causes alkalization of the antrum, loss of G cell inhibitory mechanisms, and
ultimately hypergastrinemia-induced acid secretion (Gillen et al., 1998; Hamlet and Olbe, 1996;
Moss et al., 1992; Olbe et al., 1996). If the disease progresses, it can spread to cause loss
(atrophy) of parietal cells in the fundus/body, which allows the bacteria to colonize the fundic
and corpus portion of the stomach, because pH increases to levels tolerated by the bugs (ElZimaity, 2008). H pylori initiates death and dysfunction of parietal cells through many proposed
mechanisms, including: direct cagE pathogenicity island mediated NF-κB activation of the
inducible nitric oxide synthetase iNOS (Neu et al., 2002), upregulation of proapoptotic factors
(Hagen et al., 2008; Houghton et al., 2000), and disruption of cell junctions and architecture
(Murakami et al., 2013; Wang et al., 2008). Indirect effects of H pylori on parietal cells include
T cell cytotoxicity where T cells are induced to react against parietal cell antigens as in
autoimmune gastritis (Amedei et al., 2003; Claeys et al., 1998) and neutrophil activation as
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previously discussed. In addition, H pylori has been found to directly (Saha et al., 2010) and
indirectly (Beales and Calam, 1998; Wolfe and Nompleggi, 1992) decrease parietal cell acid
secretion. In fact, even the hypergastrinemia caused by infection has been found to induce
parietal cell death (Cui et al., 2006). Interestingly, recent work has shown that the H pylori
induced cytokine IL-1β blocks Sonic hedgehog expression (Waghray et al., 2010; Xiao et al.,
2010), thus providing a mechanistic link between parietal cell loss and subsequent foveolar
hyperplasia and chief cell metaplasia. Diagnosis and treatment are the same as those discussed
in peptic ulcer disease, mostly involving reducing acid secretion and eradication of H pylori.

4. Zymogenic (Chief) Cells
The zymogenic (aka Chief) cells are the major digestive enzyme secreting cells of the
stomach. These cells terminally differentiate from TFF2 (Trefoil factor family 2 or spasmolytic
polypeptide) and mucus-secreting cells in the neck of the gastric gland that migrate towards the
bases of the glands in the fundus/body. Large secretory vesicles containing precursor forms of
digestive enzymes like pepsinogen C are stored apically in zymogenic cells until regulated
secretion is signaled mainly through vagal cholinergic stimulation and additional histaminergic,
adrenergic, and peptide hormonal inputs (Gritti et al., 2000). These stimulatory signals are
transduced through phospholipase C activation of PKC and mobilization of intracellular calcium
stores, and cAMP activation of protein kinases. Once secreted, the inactive proenzyme form of
pepsinogen is catalyzed by luminal acidity into the active proteolytic pepsin enzyme form.
Physiologically, pepsin functions as an endopeptidase to initiate the first steps in luminal food
digestion; peptides liberated by this digestion in turn facilitate subsequent digestive motility,
secretions, and absorption (Del Valle J, 2003b).
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a. Atrophic Gastritis/SPEM
In the setting of chronic gastritis and atrophy of parietal cells, mature chief cells become
metaplastic, lose mature chief cell functions, and start re-expressing mucous neck cell markers,
like TFF2. This phenomenon has been extensively studied using mouse models, with the initial
observation made with model where infection with the Helicobacter pylori relative Helicobacter
felis recapitulates many aspects of human H pylori infection, including parietal cell atrophy,
foveolar hyperplasia, and mucus metaplasia (Wang et al., 1998). TFF2 has proven to be a good
marker for this chief cell mucous metaplasia in humans and rodent models (Schmidt et al., 1999;
Yamaguchi et al., 2002). Hence, the sequence of parietal cell loss with chief cell metaplasia has
been called Spasmolytic Polypeptide Expressing Metaplasia (SPEM), though it is also known as
pseudopyloric metaplasia or antralization, because the resulting glandular morphology (with
TFF2 expressing cells at the base and decreased or absent parietal cell) resembles that of the
normal antrum/pylorus. Additional mouse models based on parietal cell ablation genetically
(Ohnishi et al., 1996) or pharmacologically (Goldenring et al., 2000; Huh et al., 2012) have
demonstrated the requirement of parietal cells for proper chief cell maturation and maintenance.
Recent evidence has shown that upon oxyntic atrophy, not only do chief cells begin reexpressing immature markers, but they also become proliferative (Huh et al., 2012; Nam et al.,
2010; Nozaki et al., 2008). These proliferative events are likely independent of the foveolar
hyperplasia that also occurs during parietal cell loss (Nomura et al., 2005b). Mechanistically,
mouse models have shown that it is loss of parietal cells and reduction in homeostatic
differentiation signals: Sonic hedgehog (Xiao et al., 2010), TGF-β (Li et al., 2002; Yano et al.,
2006), Bone Morphogenic Protein (BMP) (Maloum et al., 2011; Shinohara et al., 2010) that
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initiate zymogenic cell dedifferentiation. Aberrant enteroendocrine signals may also play a role
in chief cell metaplasia (Nozaki et al., 2009; Wang et al., 2000).

MIST1 primer
A developmentally regulated transcription factor, MIST1 was initially characterized in
highly secretory tissues including the pancreas, salivary glands, digestive tract, and the
testes (Lemercier et al., 1997; Pin et al., 2000). Subsequent studies have elucidated that
MIST1 functions as a homodimer (Zhu et al., 2004) and binds to CATATG-type E-boxes
to transcriptionally activate its targets (Tran et al., 2007). Genetically engineered mice
deficient in MIST1 expression exhibited disruption of cellular polarity and secretory
defects in specifically the exocrine tissues (Pin et al., 2001). Additional studies in the
pancreas have further characterized these secretion defects and have revealed deficiencies
in calcium mediated exocytosis (Luo et al., 2005) and decreases in granule size and
organization (Johnson et al., 2004). Recent work has revealed that loss of MIST1, in
these tissues, is a necessary and consequential event during injury response and
subsequent tumorigenesis events (Alahari et al., 2011; Capoccia et al., 2013; Huh et al.,
2012; Kowalik et al., 2007; Lennerz et al., 2010; Shi et al., 2009). While some purport
that MIST1 may act through direct transcriptional targets in a traditional tumor
suppressor role (Jia et al., 2008), there remain many unanswered questions about the
importance of MIST1 in these secretory tissues (Goldenring et al., 2011; Mills and
Taghert, 2012; Pin, 2012).
Many reports indicate the same molecular and cellular changes in zymogenic cell
differentiation that occur in response to parietal cell atrophy in mouse models occur in humans
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(Capoccia et al., 2013; Goldenring et al., 2010; Lee et al., 2010). If the insult to parietal cells is
temporary (e.g., by a toxin), and parietal census is restored, than normal chief cell differentiation
is also restored (Capoccia et al., 2013; Huh et al., 2012; Khurana et al., 2013); thus, it is
generally thought that SPEM is a normal repair response to decrease elaboration of potentially
harmful substances (acid, digestive enzymes) and increase protective agents (mucus, trefoil
factor), while increasing proliferation to replace lost cells. Diagnosis of atrophy and metaplasia is
made on biopsy histopathologically. Clinical diagnosis and treatments have been previously
discussed. Specifically, H pylori eradication has been found to reverse SPEM (Ley et al., 2004;
Sung et al., 2000b; Zivny et al., 2003).

Improved diagnosis of early stages of chief cell

differentiation changes may result from histopathological biomarkers of chief cell damage, like
loss of the transcription factor MIST1 (see primer) and its direct targets (Lennerz Am J Path
2010; Capoccia JCI 2013); diagnostic tests of serum pepsinogen levels (in particular the ratio
between pepsinogen A, normally produced only in corpus zymogenic cells, and C, normally
produced in antral glands, corpus zymogenic cells, and the duodenal bulb Brunner’s glands, can
inform about loss of normal chief cell function) have been found to be predictive of atrophy,
metaplasia, and cancer initiation (Miki, 2006).

b. Intestinal Metaplasia
The ectopic expression of intestinal type epithelium in the stomach defines this
pathologic condition. A clear association between a sequence of predisposing events H pylori
infection, chronic gastritis, formation of SPEM, development of intestinal metaplasia, and
ultimate carcinogenesis has been made (Correa, 1988; Uemura et al., 2001). In a Mongolian
gerbil animal model, infection with H pylori induced SPEM formation that later progressed into
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intestinal metaplasia (IM) (Yoshizawa et al., 2007). Corroborating these findings, a mouse
model deficient in amphiregulin also develops SPEM, and those same metaplastic glands further
progress into intestinal metaplasia (Nam et al., 2009). The idea of IM arising from a SPEM
precursor is supported by the finding that intestinal genes start to become expressed in
subpopulations of SPEM cells (Weis et al., 2012) and that IM is formed by monoclonal
conversion of a multipotent proliferative precursor (McDonald et al., 2008). Mechanistically,
formation of intestinal metaplasia must arise from a re-expression of primitive intestinal factors.
Among these factors are the master intestinal transcription factors, CDX-1 (Fujii et al., 2012) and
CDX-2 (Barros et al., 2012) whose increased expression has been found in human IM (Almeida
et al., 2003). Genetic mouse models have proven that ectopic stomach expression of both factors
is sufficient to cause intestinal metaplasia (Mutoh et al., 2004; Silberg et al., 2002) with CDX-2
acting as the initiating factor (Mutoh et al., 2009).

H pylori induced expression of BMP

signaling has been shown to induce CDX-2 expression and represses the stomach specifying
transcription factor SRY-related HMG-box 2 (SOX-2) (Asonuma et al., 2009; Barros et al.,
2008; Camilo et al., 2012). H pylori CagA has also been shown to effect E-cadherin association
and activate β-catenin mediated CDX1 expression (Franco et al., 2005; Murata-Kamiya et al.,
2007). In addition, loss of parietal cells and hypochlorhydria has also been shown to induce
inflammation and expression of intestinal genes (Zavros et al., 2005). Diagnosis of IM remains a
key prognostic in the future development of stomach cancer; current surveillance options include
endoscopic biopsy and use of serum biomarkers to monitor atrophy (Correa et al., 2010).
Treatment remains focused on HP eradication. However, as opposed to atrophy and SPEM,
whether elimination of H pylori reverses IM has been controversial (Zivny et al., 2003) with
reductions in IM (Ley et al., 2004; Sung et al., 2000b; Zhou et al., 2003) and reductions only in
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atrophic gastritis (Rokkas et al., 2007; Wang et al., 2011) seen upon treatment. In fact, CDX2
expression levels have been found to remain elevated despite eradication (Satoh et al., 2002).
Other pharmacologic agents such as antioxidants and COX-2 inhibitors may play beneficial roles
in preventing IM addition to H pylori eradication (Dinis-Ribeiro et al., 2012).

d. Gastric Cancer
The study of gastric cancer defines a vast and ever expanding field of knowledge, as is
fitting for the world’s second most common cause of cancer death. For this review, I will
specifically focus on adenocarcinomas, which represent the bulk of the cancers in the stomach.
In particular, I choose to focus on the non-cardia type of gastric cancer, as adenocarcinomas of
the cardia overlap in etiology, epidemiology, and prognosis with mechanisms of carcinogenesis
in the distal esophagus and gastro-esophageal junction.

Gastric adenocarcinomas of the

body/antrum (so-called distal gastric adenocarcinomas) are generally classified roughly by their
histological features: either intestinal (which resemble to varying degrees, colorectal tumors and
are largely glandular) or diffuse (which are poorly differentiated, and defined by invasion of
isolated, single cells) types (Leung, 2003). The former is the most common type, tends to occur
in older individuals, displays geographic variations, and is generally decreasing in incidence
throughout the world (Peleteiro et al., 2012; Wu et al., 2009b). Gastric cancer of any type tends
to have terrible prognosis in the absence of active, endoscopic screening protocols of populations
at risk, because it usually remains asymptomatic, and symptoms are non-specific until the tumor
becomes large or metastatic (Leung, 2003). H pylori infection is thought to be at the root of the
vast majority of intestinal-type adenocarcinomas, but only about 1% of patients with chronic
infection will go on to develop cancer (Huang et al., 2003; Uemura et al., 2001). Thus, given the
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regional variation in prevalence, additional environmental factors (Larsson et al., 2006; Torres et
al., 2013; Tsugane and Sasazuki, 2007) and genetic susceptibilities (Gonzalez et al., 2002; Loh et
al., 2009) have been proposed to play roles in carcinogenesis.
The majority of work exploring the mechanistic causes of gastric cancer has focused on
the intestinal-type cancers, with study of the multiple underlying host and pathogen signaling
pathways (Wu et al., 2010). In general, as opposed to pancreatic cancer (where mutant K-RAS
plays a predominant role in carcinogenesis) or colorectal cancer (where APC mutations and
aberrant Wnt signaling predominate), gastric cancer does not seem to have any predominant
pattern of aberrant/mutant signaling at its root (Capoccia et al., 2009). I will briefly touch on
some of the many aberrant signaling pathways that have been shown to be involved in at least
some gastric cancers (Fig. 3). As previously discussed, H pylori mediates activation of the NFκB transcriptional signaling pathway (Brandt et al., 2005; Sharma et al., 1998). In addition to its
role in inducing inflammation, NF-κB has been shown to upregulate COX2 (Sung et al., 2000a)
mediated prostaglandin E2 (Oshima et al., 2004) expression. Sustained COX2 mediated PGE2
activation leads to increased growth factor release and gastric carcinogenesis in a mouse model
of cancer formation (Oshima et al., 2004). H pylori through its CagA-containing pathogenicity
island can initiate activation of β-catenin (Franco et al., 2005; Murata-Kamiya et al., 2007). Wnt
pathway signaling has been shown to be important in a population of antral gastric stem cells
(Barker et al., 2010), and its activation has been correlated with gastric cancer (Kurayoshi et al.,
2006; Oshima and Oshima, 2010). In fact, the effects of COX2 and Wnt pathway activation are
synergistic and act to further promote carcinogenesis (Oshima et al., 2006). The role of TGF-β
signaling has also been explored.

Smad phosphorylation transduces TGF-beta signals to

transcriptional activation of RunX3 induced apoptosis pathways (Yano et al., 2006).
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Mouse

models deficient for RunX3 (Li et al., 2002) or Smad4 (Xu et al., 2000) show cancer formation,
as does increased STAT3 signaling induced by mutation of the common cytokine receptor
GP130 (Jenkins et al., 2005; Judd et al., 2004; Judd et al., 2006). However, paradoxically, TGFβ is re-expressed in cancers with complex roles in repressing immune surveillance, initiating
EMT, and inducing angiogenesis (Achyut and Yang, 2011). Similarly, BMP signaling also
seems to have a bi-functional role in carcinogenesis and in cancer. In mouse models, disruption
of BMP pathway function resulted in aberrant epithelium homeostasis with increased
proliferation (Maloum et al., 2011; Shinohara et al., 2010). But BMP also can induce CDX-2
expression as previously described (Asonuma et al., 2009; Barros et al., 2008; Camilo et al.,
2012) and promote carcinogenesis (Thawani et al., 2010). As discussed previously, the parietal
cell morphogen Sonic hedgehog is often lost during atrophic gastritis (Shiotani et al., 2005) and
may be downregulated directly by H pylori induced IL-1β (Waghray et al., 2010; Xiao et al.,
2013).

Hedgehog signaling also follows a similar trend of reemergence during cancer

progression (El-Zaatari et al., 2007; Saze et al., 2012). Mechanistically, HP mediates NF-κB
activation resulting in upregulation of the hedgehog targets Gli-1 and Bcl-2 to promote growth
and inhibit apoptosis (El-Zaatari et al., 2013; Martin et al., 2010). The interdependence and
crosstalk of these cancer promoting pathways is again evidenced by the finding that the
hedgehog pathway may signal through the TGF-β pathway during cancer progression (Yoo et al.,
2008). Notch pathway activation is also associated with gastric cancer (Sun et al., 2011) and has
been shown to induce COX-2 expression (Yeh et al., 2009). In fact, a mouse model aberrantly
overexpressing Notch in the stomach resulted in dedifferentiation, proliferation, and tumor
formation (Kim JEM 2011). Upregulation of fibroblast growth factor signaling through receptor
overexpression and activation has been found in gastric cancer (Shin et al., 2000; Ye et al., 2011)
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along with direct activation of this pathway by H pylori CagA mediated SHP2 signal
transduction (Katoh and Katoh, 2006). Clearly, reactivation of these important developmental
pathways is important in carcinogenesis. The finding of developmental pathways reactivation in
cancer has presented new therapeutic pathways to target with new TGF-β inhibitors (Kano et al.,
2007) and FGF receptor inhibitors (Zhao et al., 2010) being developed.
Outside the realm of developmental growth factors, gastrin and chronic inflammation
have been shown to be major components in gastric cancer formation.

A mouse model

overexpressing gastrin showed increased susceptibility to developing gastric cancer with a
synergistic effect upon subsequent Helicobacter infection(Takaishi et al., 2009b; Wang et al.,
2000). However, another model lacking the SHP2-binding site on the gp130 receptor family, as
mentioned above, has shown that tumorigenesis occurs even in the absence of hypergastrinemia
(Jenkins et al., 2005; Judd et al., 2004; Judd et al., 2006). These mice display a chronic
inflammatory state due to hyperactivation of the STAT3 signaling pathway.
independent role of inflammation to mediate gastric cancer was established.

Thus, the
The gastrin-

deficient mouse model recapitulated many of the findings regarding the gastrin-independent
transformative potential of chronic (Huang et al., 2012) inflammation through IFNγ activated
STAT3 pathway activation (Zavros et al., 2005). Studies have even postulated a protective role
of gastrin to cancer formation through its ability to upregulate the tumor suppressing and healing
trefoil factors, TFF1 and TFF2 (Khan et al., 2003; Tu et al., 2007). Thus gastrin and STAT3
pathway activation both are being targeted for cancer therapy (Ajani et al., 2006; Giraud et al.,
2012).
The molecular events that lead to diffuse-type gastric carcinomas, many of which are
characterized by mucus-stuffed so-called signet ring cells, have been more clearly elucidated
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under a common signaling theme. Seminal work established a hereditary form of diffuse-type
gastric cancer that resulted from a germline mutation in the E-cadherin gene (Guilford et al.,
1998). Mouse models mimicking the human genetics by expressing only one copy of the Ecadherin gene showed increased susceptibility to cancer initiation independent of β-catenin/Wnt
pathway activation (Humar et al., 2009). In a murine system, it was shown that complete genetic
ablation of E-cadherin in adult mice was sufficient to produce signet ring lesions (Mimata et al.,
2011), and those progressed to cancer if p53 was also ablated (Shimada et al., 2012). In humans,
E-cadherin promoter methylation leads to a second hit inactivation (Humar et al., 2009) in
patients heterozygous for functional E-cadherin that results from H pylori induced IL-1β
stimulation of NF-κB transcriptional activation of DNA methyl transferase activity through
iNOS and NO production (Huang et al., 2012).
While discussing the cellular signals involved in tumorigenesis it is often easy to ignore
which cells become responsive and receptive to those signals or, in other words, the cell of origin
for cancer. I have included the cancer discussion in the chief cell section because there is
evidence that chief cells dedifferentiate to become the proliferating cells in SPEM (Huh et al.,
2012; Nam et al., 2010; Nozaki et al., 2008). Tracking of IM has shown that it develops from
SPEM and clonally progresses to dysplasia (Gutierrez-Gonzalez et al., 2011; McDonald et al.,
2008). Thus, it is possible that the dedifferentiation of mature chief cells gives rise to the cancer.
However, other gastric cell lineages with the right growth impetus have been shown to have the
ability to dedifferentiate and become multipotent in mouse models (Kim and Shivdasani, 2011;
Quante et al., 2010). In fact, studies in mice have found that bone marrow-derived cells can be
recruited to sites of stomach injury and give rise to adenocarcinoma (Houghton et al., 2004).
This “dedifferentiation” of mature cells into cancer is at odds with alternative theories that
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stomach cancer may progress from an undifferentiated stem cell precursor. Antral tumors in
mice have been shown to develop clonally from multipotent cells marked by expression from the
Lgr5 gene locus (Barker et al., 2010) marked by expression from a transgenic villin promoter (Li
et al., 2012). The difficulty in studying these cells is the lack of markers. Several markers have
been proposed including CD44 (Khurana et al., 2013; Takaishi et al., 2009a), CD90 (Jiang et al.,
2012), and CD133 (Fukamachi et al., 2011).

Identification of these markers will lead to

therapies that specifically target these cancer stem cells (Jiang et al., 2012; Khurana et al., 2013;
Smith et al., 2008).
Early detection and H pylori eradication therapy has been demonstrated to be effective at
cancer prevention (Ito et al., 2009; Wu et al., 2009a), but as discussed previously, the benefits
start to decrease with advancement of carcinogenesis towards SPEM and IM, indicating diffuse
repatterning of the gastric epithelium that is often referred to as a “point of no return” (Peleteiro
et al., 2012; Wong et al., 2004). Unfortunately, the early detection protocols involve endoscopic
surveillance and biopsy, which are too expensive to initiate in regions where gastric cancer
incidence is relatively much lower (e.g., the US, northern Europe) than in the far east where it is
by far the most common cancer killer (e.g., Japan, South Korea) (Dan et al., 2006). New
chemotherapy combination regimes are being implemented (Wagner et al., 2010) along with
radiotherapy and biological agents targeting classic cancer pathway targets including HER2,
EGFR, and VEGF (Price et al., 2012).

Novel immunotherapies are also being developed

utilizing dendritic cell-based vaccines, priming of natural killer cells, T cell based therapies to
recognize and attack cancer cells (Amedei et al., 2011).

Conclusions
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It is clear that our knowledge of the pathology and pathophysiology of the stomach has
and continues to increase since ancient times. With the advent of modern genetics, cell biology,
and biochemistry we are building new avenues exploring the molecular mechanisms behind
congenital and acquired diseases. However there is still much we do not know. Much light has
been shed on the developmental pathways that are important in formation and differentiation of
the stomach, but an overarching interconnected model that might be clinically useful has yet to
be proposed. And therein lies the complexity of the problem. Multiple signals to multiple
receptors on multiple cell types all respond simultaneously during stomach development and
disease. The beauty of modern science has been the ability to study complex systems in isolation
and there again is its greatest weakness.

For example, it is clear that during chronic

inflammation every stomach lineage is affected and responds. How can we tease out which cell
is the cell of origin that proceeds towards carcinogenesis? Efforts have started to concentrate on
identifying gastric stem cell markers. But many new studies have demonstrated the plasticity of
terminally differentiated cells in the stomach to transdifferentiate and possibly even
dedifferentiate. In fact, much of our knowledge comes from work using genetic murine models.
With fundamental differences between mice and men, do we have the best physiological model
to study gastric diseases? Despite these unknowns, exciting new gene stem cell markers and
gene expression studies are being performed currently that seek to unify and create a systemsbased network for understanding normal development and disease.
Clinically, the challenges are now greater than ever. Our knowledge about the causes of
rare developmental disorders has remained largely unchanged since their discoveries. Increased
survival rates have largely benefited from advances in radiological and surgical interventions.
Clearly, there is a need to further understand these congenital diseases. In fact, the same can be
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said about the adult diseases. Stomach cancer remains a leading cause of mortality throughout
the world, and despite near eradication of H pylori here in the United States, stomach cancer
rates are actually increasing among certain demographics (Anderson et al., 2010). A growing
demand exists for new noninvasive screening modalities including new biomarkers for diagnosis
and therapeutic efficacy monitoring. Current therapy is bimodal; from mitigation of symptoms
on one end of the spectrum to aggressive surgery and cancer pharmacotherapy on the other end.
New safe treatment options that utilize our basic science insights must focus on the stomach as
an interconnected network. We must continue to translate our findings from the bench back to
the clinics. In this review, we have taken a developmental biology centric view, however future
studies must apply our knowledge of stomach development and integrate those insights with new
epidemiological evidence and modern genetic approaches. The traditional Chinese medicine
holistic belief of interdependence and interconnectivity hold true and are concepts that we would
be wise to continue to apply in our modern pursuits of stomach clinical cures.
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Figure Legends

Figure 1. Anatomic development of the human stomach. Embryonic gastric developmental
milestones of enlargement, rotation, and asymmetric curvature establishment.

Figure 2. Histologic development of the human stomach. A. Gross anatomic regionization of
the human stomach. B. Antrum and C. Corpus gastric unit architecture with regions, direction of
migration and differentiation, major cell types, turnover times (* based on murine data), and
main secretory products.

Figure 3. Re-emergent developmental pathways during gastric cancer progression. Well
understood developmental pathways important in gastric carcinogenesis.

Table 1. Developmental/congenital clinical disorders with underlying disease mechanisms,
diagnostic approach, and current therapies.

Table 2. Differences between human and murine stomach anatomy and histology.

Table 3. Adult/acquired clinical disorders with underlying disease mechanisms, diagnostic
approach, and current therapies.
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Table 1. Developmental/congenital Clinical Disorders with Underlying Disease Mechanisms, Diagnostic
Approach, and Current Therapies
Disorder
Etiologies
Diagnosistic Approach
Therapies
Stomach Wall Outpouchings,
Contrast Radiography and
Surgical excision and
association with epidermolysis
Gastric Atresia
Ultrasonography, novel
novel gene replacement
bullosa (ITGA6, ITGB6, PLEC1 gene
genetic testing
therapy
mutations)
Surgical treatment of
Clinical symptoms with
hernia, anchoring of
Secondary to hernia, laxity of mesentary
Gastric Volvulus
barium studies and CT
stomach to
ligaments
scans
abdominal wall, and
gastronomy tubes
Congenital
Failure of foregut growth, association
Contrast Radiography and
Surgical enlargement of
Microgastria
with VACTERL
Ultrasonography
stomach
Congenital muscle weakness, lack of
Gastric
Surgical excision if
peritoneal membrane, invading
Radiological studies
complications
Diverticulum
arterioles
Gastric
CT scan and
Duplication
Persistant embyronic invaginations
Surgical excision
Ultrasonography
Cysts
CT scan and monitoring of
Surgical excision and
Teratomas
Aberrant primordial germ cells
AFP and HCG serum
chemotherapy
tumor markers
Motility

See Chapter 3 and Chapter 6
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Table 2. Differences Between Human and Murine Stomach Anatomy and Histology
Mouse
Human
3 (Forestomach, Body/Corpus, and
4 (Cardia, Fundus, Body/Corpus, and
Antrum)
Antrum)
Anatomic Regions
See Figure 5.2
About twice that seen in Mice
Histological Turnover Time
Granule free
Contain granules
Isthmal stem cell ultrastructure
Parietal Cell Differentiation
Luminally and Basally
Basally
Migration
Major Intrinsic Factor Secretory
Zymogenic Cells
Parietal Cells
Cell
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Table 3. Adult/Acquired Clinical Disorders with underlying disease mechanisms, diagnostic approach, and current therapies
Therapies
Disorder
Etiologies
Diagnosistic Approach
Foveolar
Injury induced growth factors, loss of Shh,
See Atrophic
See Atrophic Gastrits/SPEM
Hyperplasia
hypergastrinemia
Gastrits/SPEM
Surface Pit Cells
Alleviation of symptoms,
Ménétrier Disease
Increased TGF-α signaling
Endoscopy and biopsy
surgery, blocking TGF-α
signaling
Serum gastrin measurements,
Gastrinomas, atrophic gastritis, inhibition of
Hypergastrinemia
secretin test of gastrin release,
Treat underlying causes
acid secretion, BMP signaling pathway
and basal acid output
Diagnosis by exclusion (High
Zollinger-Ellison
Gastrinoma due to genetic mutations,
Surgery, novel MEN1 gene
Enteroendocrine
gastrin levels with gastric pH<2),
syndrome
associated with MEN1
therapy
Cells
MEN1 linkage testing
Gastroscopy, biopsy, somatostatin
Hypergastrinemia, associated with MEN1,
Surgical resection,
receptor scintigraphy
Carcinoid Tumors
growth promoting effects of gastrin and
octreotide, chemotherapy,
CT/ultrasound to look for
histamine
gastrin antagonists
metastasis
Serum screens for pepsinogen,
Autoimmune
Autoantibodies to PCs, immunologic inciting
gastrin, ghrelin, and
B12 replacement, new
Gastritis
role of H pylori
autoantibodies, endoscopy for
immunologic therapies
Parietal Cells
complications
HP induced PC death (loss of differentiation
HP eradication (triple and
Atrophic
Endoscopy testing for HP, serum
signals, ZC metaplasia, foveolar hyperplasia,
quadruple therapies),
Gastritis/SPEM
PGC tests
hypergastrinemia
vaccine development
Zymogenic (Chief)
Cells

Intestinal
Metaplasia

SPEM progression, re-expression of CDXs
and repression SOX2

Gastric Cancer

HP infection, remergence of developmental
pathways, abberrant growth signals, and
chronic inflammation
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Endoscopic biopsy, serum
biomarkers

HP eradication

Early detection endoscopy and
biopsy

Surgery, chemotherapy,
radiotherapy, targeting
specific developmental
pathways, blocking growth
signals, immunotherapies

CHAPTER 3: RAB26 and RAB3D are Direct Transcriptional Targets
of MIST1 That Regulate Exocrine Granule Maturation

This chapter is adapted from the published work:

Tian, X., Jin, R. U., Bredemeyer, A. J., Oates, E. J., Blazewska, K. M., McKenna, C.
E. and Mills, J. C. (2010). RAB26 and RAB3D are direct transcriptional targets of
MIST1 that regulate exocrine granule maturation. Mol Cell Biol 30, 1269-84.
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Abstract
Little is known about how differentiating cells reorganize their cellular structure to perform
specialized physiological functions.

MIST1,

an evolutionarily conserved transcription factor, is

required for the formation of large, specialized secretory vesicles in gastric zymogenic (chief)
cells (ZCs) as they differentiate from their mucous neck cell progenitors. Here, we show that
MIST1

binds to highly conserved CATATG E-boxes to directly activate transcription of 6 genes,

including the small GTPases RAB26 and RAB3D. We next show that RAB26 and RAB3D expression
is significantly downregulated in Mist1−/− ZCs, suggesting that MIST1 establishes large secretory
granules by inducing

RAB

transcription. To test this hypothesis, we transfected human gastric

cancer cell lines stably expressing MIST1 with RFP-tagged pepsinogen C, a key secretory product
of ZCs. Those cells upregulate expression of RAB26 and RAB3D to form large secretory granules,
whereas control, non-

MIST1-expressing

expressing cells requires

RAB

cells do not. Moreover, granule formation in

activity because treatment with a

transfection of dominant negative

RAB26

RAB

MIST1-

prenylation inhibitor and

abrogate granule formation. Together, our data

establish the molecular process by which a transcription factor can directly induce fundamental
cellular architecture changes by increasing transcription of specific cellular effectors that act to
organize a unique subcellular compartment.
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Introduction
Developmentally regulated transcription factors (TFs) play central roles in cell fate
specification and differentiation of all cell types. During the complex process of specified
cellular differentiation, certain TFs are turned on only at the final steps of the transcription
regulation hierarchy. Presumably, those TFs directly activate major cell effector genes and in
turn govern the establishment of a differentiated cell’s designated morphology and function.
There is emerging evidence that there might indeed be a limited number of TFs that are
employed in diverse tissues to induce specific gene cassettes that regulate cell structure. For
example, it was recently shown that differentiation in general, no matter the tissue, induced
preferential expression of the same types of genes that govern secretion and communication with
extracellular space (13). Further, it has been shown that X-box binding protein 1 (XBP1), a
transcription factor that is also developmentally regulated and required for wholesale changes in
cell structure in certain cell lineages, directly activates multiple secretory pathway genes that
help establish the abundant rough endoplasmic reticulum and mitochondria needed by
specialized secretory cells, such as plasma cells, pancreatic acinar cells, and intestinal Paneth
cells (30, 33, 56, 59). Another example of a developmentally important TF that regulates cell
structure is TFEB, a bHLH recently shown to upregulate a cohort of target genes that specifically
regulate lysosome function and biogenesis(54).
The corpus of the adult murine stomach is a useful system for studying the role of
developmentally regulated TFs in coordinating cell structural changes because the gastric
epithelium comprises multiple secretory cell lineages that are constantly renewed in a
spatiotemporally organized fashion (6, 28, 39). The zymogenic (aka chief) cell (ZC) lineage
occupies the base of the gastric unit, migrating from the stem cell zone and passing first through
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a distinct mucous neck cell progenitor phase, before rapid terminal differentiation that includes
dramatic expansion of the rER and apical accumulation of large secretory vesicles filled with
pepsinogen and other digestive enzymes (5, 29).
The bHLH transcription factor MIST1 is critical for ZC architectural maturation (50) (Fig.
1).

MIST1

is a developmentally regulated and highly cell lineage specific TF, with onset of

expression only during terminal differentiation of – along with ZCs – a handful of secretory cells
in mammals (26, 48, 49). MIST1-expressing cells, ranging from immunoglobulin-secreting
plasma cells (4) to alveolar breast lobular cells (69), are scattered in diverse tissues and have
little in common in either their developmental origins or in the specific substances they
elaborate. However, they do share a specialized physiological function: high-capacity secretion
of proteins, indicating that

MIST1

may be the transcriptional architect initiating the subset of

structural changes required for such functionality. Indeed, loss of

MIST1

leads to smaller cell

cytoplasms, with smaller secretory granules, reduced secretory protein stores, and a decrease in
secretory capacity (5, 34, 50). Modulating cell architecture is likely a critical feature of normal
development because

MIST1

is a highly conserved gene from Drosophila to Zebrafish to

mammals, reflected not only by the high degree of homology among MIST1 orthologs but also the
specific sequence of the genomic cis-element they bind, CATATG-type E-boxes (18-20, 45, 46).
To coordinate specific changes in cell structure, MIST1 must directly activate transcription
of a group of cellular effector genes that coordinate structural changes. This cassette of structuremodifying genes would likely be conserved across tissues and species. However, no

MIST1

targets that might coordinate such structural changes have yet been identified. Ras-like, small
GTPases are important regulators of vesicular formation and transport in eukaryotic cells,
making them potential structure-regulating genes (15, 17). It has been shown that Rab3d
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expression is decreased in Mist1−/− pancreatic acinar cells, but Rab3d has not yet been shown to
be a direct target of

MIST1,

and Rab3d is expressed in non-Mist1-expressing cells as well.

Furthermore, transgenic expression of Rab3d was insufficient to restore the defects caused by
loss of

MIST1

function in pancreatic acinar cells (26), indicating that other, as yet unidentified,

MIST1

targets must also play a role. A paralogous

RAB

to

RAB3D, RAB26,

has not been

extensively studied, but its expression is restricted to a limited number of highly secretory cells
where it has been proposed to be involved in regulated vesicular secretion (40, 64, 68).
Here, we show that

MIST1

is sufficient to upregulate 16 genes in 2 different gastric cell

lines. We further show that it directly associates with CATATG E-boxes in 6 of those genes that
have highly evolutionarily conserved CATATG E-boxes within the first intron. Two
induced genes,
MIST1,

RAB3D

and

RAB26,

MIST1–

stood out as representing a possible mechanism by which

acting at the level of transcription, could regulate formation of exocrine secretory

granules in differentiating cells. We show that RAB3D and RAB26 are expressed in gastric ZCs in
the corpus of mouse stomach in a MIST1-dependent manner. We next developed a system to test
the functional importance of MIST1 induction of these RABs. We show that gastric epithelial cells
stably expressing

MIST1,

but not control cell lines, produce large ZC-like secretory granules

when they are transfected with RFP-tagged pepsinogen C (PGC). Expression levels of

RAB26

and RAB3D were also specifically induced in those cell lines. Finally, we show that formation of
large granules in these cells is dependent on RAB activity, because granule formation is abrogated
by: 1) inhibition of RAB26 and RAB3D function by disrupting RAB prenylation and 2) transfection
with a dominant negative

RAB26

construct. We therefore propose that

MIST1

regulates large

secretory granule formation, a key aspect of differentiated secretory cell function, via activating
transcription of

RAB26

and

RAB3D.

Together, our data demonstrate how a developmentally
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regulated TF can induce secretory cell architectural changes by transcriptionally regulating
specific membrane trafficking genes.
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Materials and Methods
Mice
All experiments involving animals were performed according to protocols approved by the
Washington University School of Medicine Animal Studies Committee. Germline Mist1−/− mice
were generated as described previously (49) and maintained in a specific pathogen free barrier
facility. Control mice were the littermates of Mist1−/− mice resulting from heterozygote by
heterozygote crosses.

Immunofluorescence
Stomachs were prepared and stained as described (50). Briefly, stomachs were inflated with
freshly prepared methacarn fixative and suspended in fixative for 15-30 mins at RT, followed by
multiple rinses in 70% ETOH, arrangement in 2% agar in a tissue cassette, and routine paraffin
processing. Sections (5 μm) were deparaffinized and rehydrated, then antigen retrieval was
performed by boiling in 50 mM Tris-HCl, pH 9.0. Slides were blocked in 1% BSA, 0.3%
Triton-X100 in PBS, then incubated in primary followed by secondary antibodies (see below).
Slides were incubated 5 mins in 1 μg/ml bisbenzimide (Invitrogen, Carlsbad, CA) prior to
mounting in 1:1 glycerol:PBS.
For immunofluorescent analysis of cultured cells, cells were grown in Lab-Tek Chamber
Slide 4 Well Permanox slides (Thermo Fisher Scientific, Rochester, NY) and fixed in 4%
paraformaldehyde for 10 mins at RT. For antibody staining, slides were permeabilized by 0.1%
Triton-X100 in PBS and blocked in 2% BSA, 0.05% Triton-X100 in PBS. Fluorescence
microscopy and imaging were performed using a Zeiss Axiovert 200 microscope with Axiocam
MRM camera at RT. Optical sectioning was performed using the Apotome adaptor following

98

calibration. In most cases, 1 μm sections were taken from cell-substrate interface to the full
height of the cell. Contrast (maximal, minimal, and midtone) adjustment and fluorescent channel
overlay, and pseudocoloring were performed in Adobe Photoshop (Adobe Systems, San Jose,
CA). All adjustments were performed on the entire image equally. Cartoon cell traces and
illustrations were performed using Adobe Illustrator (Adobe Systems, San Jose, CA).
The following primary antibodies were used for immunostaining: goat (1:2000) antihuman gastric intrinsic factor (GIF) (gift of Dr. David Alpers, Washington University); sheep
anti-PGC (1:10,000, Abcam), rabbit anti-actin (1:200, gift of Dr. Thaddeus Stappenbeck, clone
AC-40; Sigma, St Louis, MO). Secondary antibodies used were: Alexa Fluor 488, 594 or 647
conjugated donkey anti-goat, anti-rabbit, anti-sheep, or anti-mouse (1:500, Invitrogen).

Immunoflurescent quantification
Immunofluroescent quantification to determine cytoplasmic fluorescence intensity was
performed in ImageJ software. For tissue sections, the cytoplasm was divided into regions fully
apical to and fully basal to the nucleus. Mean fluorescent intensity was determined in each region
after subtraction of background; background was determined by averaging PGC fluorescence in
4 parietal cells – which do not express PGC – in the same unit. Results were compiled from 51
cells from 7 gastric units in two separate knockout mice and 50 cells from 6 units in two control
mice.
For cell line vesicle quantification,
PGC-RFP and appropriate treatment.

MIST1

stably expressing lines were transfected with

Number of large vesicular cells (defined as cells

containing 3 or more vesicles, each ≥ 1.5 μm), diffuse vesicular cells (cells with no visible
vesicles), and total number of PGC-RFP transfected cells were scored. For eGFP-hRAB26T77N
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fluorescence intensity quantification, MIST1 stable cell lines were co-transfected with PGC-RFP
and eGFP-hRAB26T77N. 16 bit images captured in Zeiss Axiovision software were analyzed in
ImageJ as follows: mean green and red cytoplasmic fluorescent intensities were determined for
large vesicular cells (defined as above) and diffuse vesicular cells (defined as ≥135 intensity
units above background, no vesicles ≥1 μm) in each region after subtraction from the median
background (green and red fluorescence in an area with no cells) and normalization to average
nuclear green fluorescence (nuclei were green due to expression of MIST1-eGFP) for ≥10 cell
nuclei/field. 245 cells were scored across 3 transfections.

Electron microscopy
For transmission electron microscopic studies, stomachs were fixed, sectioned, stained, and
imaged as described (50). For tEM of cell lines, cells were plated on Lab-Tek Chamber Slide 4
Well Permanox slides (Thermo Fisher Scientific). After rinsing in PBS, they were fixed in
modified Karnovky’s fixative (2.5% glutaraldehyde, 2% paraformaldehyde in 0.1 mmol/l
cacodylate buffer). tEM thin sections were cut directly from cell cultures embedded on the
original Permanox substrate. To quantify vesicle size, fields of

MIST1-stable

and eGFP-control

cells were randomly selected, digital images captured at 4000x magnification, and ImageJ was
used to determine areas of all vesicle profiles in all cells in the field in each TIFF image. 20 cells
were analyzed from each cell line (~500 total vesicles scored).

Cell lines and transient transfection
HGC-27 cells (HPACC, Porton Down, UK) were maintained at 37°C in 5% CO2 in DMEM
supplemented with 10% fetal bovine serum, 1% non essential aminoacids, 1% glutamine and 100
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ng/ml each of penicillin and streptomycin. AGS cells (from ATCC, Manassas, VA) were grown
in RPMI-1640 supplemented with 10% fetal bovine serum, 0.9% glutamine, 0.4% HEPES, 1%
Na pyruvate, 2.5% glucose, and 100 ng/ml each of penicillin and streptomycin. Cells were
passaged every 3 days using Trypsin-EDTA. For transient transfection, 1 x 106 AGS or HGC-27
cells were transfected via electroporation using the Nucleofector I (Amaxa-Lonza, Basel,
Switzerland), program B-023, and cell line transfection solution V.

The following plasmids

were used per electroporation: 3 μg PGCRFP (see below), 5 μg eGFP-hRAB26T77N (see below),
or 3 μg pmaxGFP (Amaxa-Lonza). Cells were replated on Lab-Tek Chamber Slide 4 Well
Permanox slides and routinely analyzed 24 hours post transfection.

GeneChip analysis
Untransfected HGC and AGS control plates were grown to 70-80% confluency on 10 cm dishes.
For cells transfected with either

MIST1-eGFP

or Control eGFP vector, 1 x 106 AGS or HGC-27

cells were transfected with 1.5 μg pmaxGFP plus either 3 μg MIST1 cDNA or 3 μg empty vector
using the transfection conditions described in the text. The GFP+ population of each transfectant
was isolated by flow cytometric cell sorting using a FACSVantage (Becton-Dickinson, San Jose,
CA) at 24 hours post-transfection and then replated for an additional 24 hours before harvesting.
Cells were harvested with trypsin-EDTA. RNA was extracted using a QIAGEN RNAeasy kit,
and RNA quality was verified by visualization on an agarose gel. 5 ug total RNA was used to
prepare labeled target using Affymetrix GeneChip One-Cycle Target Labeling reagents. 10 μg
labeled target cRNA was hybridized to HGU133_Plus_2 GeneChips. For both AGS and HGC-27
cells, expression profiles of MIST1 + pmaxGFP-transfected cells were compared with profiles of
empty vector + pmaxGFP-transfected cells. An initial, inclusive candidate
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MIST1

target list was

generated by determining by dChip analysis (70) the transcripts that had a 90% confidence lower
bound fold-change increase of ≥ 1.2 and an intensity greater than 100 in 4 independent
comparisons, combined as follows: (AGS-MIST1 vs. vector transfected AND vs. untransfected) OR
(HGC-27 vs. vector
AGS- and HGC-

AND

vs. untransfected). This list of 211 genes was then filtered to generate

MIST1-induced

transcripts by filtering genes whose expression intensity was

<100 in MIST1-transfected cells and whose mean fold-change was <1.5 in MIST1-transfected cells
vs. either control population. 32 AGS and 59 HGC probe sets met those criteria, and 18 of those,
representing 16 individual genes were shared (Fig. 2A). GeneChip datasets have been deposited
in GEO (GSE16924).

Bioinformatic analysis of MIST1 targets
ECR Browser (44) was used to analyze the human genomic sequence for each gene 5’ to the
transcription start. Sequence was analyzed up to 50 kb or until an exon from the neighboring
gene was reached. The first intron up to 50 kb was also analyzed. When alternate splice forms
exist, the farthest documented 5’ exon was used, and the intron following it was considered the
first intron. CATATG sequences were identified within analyzed sequences using the dreg
application in the EMBOSS suite. Conservation among species aligned in the ECR Browser was
then determined at each of these CATATG sites. Note that only human, chimp, cow, dog, rat,
mouse, opossum, and chicken were available in the ECR Browser at time of analysis, so
conservation undoubtedly extends across numerous species not diagrammed in Fig. 3. All 16
putative MIST1 targets were analyzed in this way. 6 genes showed the conserved intronic pattern
depicted in Fig. 3A,B. 7 genes showed scattered or no CATATG sequence with any conservation
restricted to primates. Two genes (MAP2K5 and
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FIGN)

were slight variants. MAP2K5 was highly

conserved throughout and showed sporadic CATATGs that were conserved with no single,
predominant site and no particular pattern to the species conservation (not shown). FIGN has a
short intron 1 and has two highly conserved CATATGs in the second intron (not shown). In
addition to the 16 putative targets, we also analyzed the following

RAB

family members for

conserved CATATGs: RAB3A,B,C; RAB27A,B; RAB37; RAB9A,B. Many of those had no CATATG
sites; none had sites conserved outside primates.

Establishment of MIST1-eGFP and eGFP stable lines
1 x 106 HGC-27 cells were transfected with 3 μg MIST1-eGFP cDNA or 3 μg eGFP cDNA using
the transfection conditions described above. After 24 hours, transfectants were replated at
limiting dilution under selection with 500 ng/µl Geneticin (Gibco-Invitrogen). Wells that grew
out over 14-21 days were analyzed by flow cytometry for level and homogeneity of GFP signal.

Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed after Im and coworkers (22). ̴108 HGC
cells that stably express
μl of

MIST1

MIST1GFP

fusion proteins were harvested for one ChIP experiment. 15

antiserum (rabbit polyclonal anti-human

MIST1)

or serum from the rabbit prior to

immunization (“pre-immune” control) together with protein A/G plus agarose (Santa Cruz
Biotechnology, Santa Cruz, CA) was added to the cell lysate for immunoprecipitation. Regular
PCR and quantitative-real-time PCR were performed (these and all other primer sequences
available upon request) to assess quantity of genomic sequences immunoprecipitated by either
pre-immune or

MIST1

antiserum, as well as a 1:10 dilution of the cell extract prior to

immunoprecipitation.
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RAB inhibitor studies
3-PEHPC, an analog of the bisphosphonate drug risedronate, was generated as previously
described (10). 3-PEHPC was stored in a stock solution of 106 mM at 4°C in aqueous solution
at pH 6.3. For cell culture experiments, 3-PEHPC was added directly to the appropriate dilution
in tissue culture media. Multiple concentrations were tested up to 5mM, and effectiveness was
determined by dispersion of transfected eGFP-RAB26 plasmid (Jin et al., unpublished
observations). Based on these experiments, a final concentration of 5mM was used in all
experiments described in this manuscript.

In situ hybridization
Rab26 cDNA was obtained from OpenBiosystems (MMM1013-98478848). Rab3d cDNA was
obtained via amplification from a mouse stomach cDNA library and cloned into T-easy vector
(Promega, Madison, WI). DIG-labeled RNA probes were synthesized via in vitro transcription
following plasmid linearization (Roche Applied Sciences, Indianapolis, IN; 11277073910). The
anti-sense RNA probe was synthesized with T7 RNA polymerase, the sense using Sp6 RNA
polymerase. Adult B6 strain mice were perfused with 0.9% NaCl and 4%PFA sequentially, the
stomachs was removed and further fixed in 4% PFA at 4°C for 8 h or more. Tissue was blocked,
frozen, and sectioned as previously described (50). Sections (20 μm) were dipped in water
several times to remove OTC, fixed in 4% PFA, treated with Proteinase K, refixed in 4% PFA
and then treated with 0.1 M triethanolamine before incubating in hybridization buffer (50%
Formamide, 5x SSC, 1x Denhart’s, 250 µg/ml yeast tRNA, 500 µg/ml Salmon Sperm DNA,
100ug/ml Heparin, 5mM EDTA and 0.1% Tween-20) for 1-2h at 65°C. The tissue sections were
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incubated with DIG-labeled RNA probes in hybridization buffer overnight at 65°C. After RNA
hybridization, slides were washed in 2x SSC at 65°C for 15 min and then at room temperature
for 5 min, followed by Rnase (1µg/ml in 2x SSC) incubation at 37°C for 30 min and washes with
2x SSC (RT) for 5 min twice and 0.2x SSC (60°C) for 30 min twice. DIG-RNA hybridized to
tissue sections was visualized by incubating the slides first in blocking solution (1% BSA in
PBS) for 1h and with anti-digoxigenin antibody (Roche; 1:2000) at 4°C overnight, followed by
washing in PBT (PBS, 0.1% Tween-20), equilibrating in alkaline phosphatase (AP) staining
buffer (100 mM Tris, pH 9.5; 50 mM MgCl2; 100 mM NaCl and 0.1% tween-20) and color
development with NBT/BCIP (Roche) until a strong signal was detected in the sections
hybridized to anti-sense probes; specificity was confirmed by lack of signal in sense-hybridized
sections developed in the same experiments for the same length of time. Reactions were stopped
by PBT, and sections were mounted in 1:1 glycerol:PBS.

Graphing and statistics
All graphs and statistics were performed in GraphPad Prism, except the Venn diagram which
was generated using BioVenn(21) and then traced using Adobe Illustrator. Statistical analysis
was, in the case of simple control vs experimental comparison by student’s t test. Otherwise,
significances determined by one-way ANOVA test with Dunnett’s Multiple Comparison
correction.

Laser-capture microdissection (LCM) and qRT-PCR
Preparation of stomach frozen sections for LCM has been described previously (50). Briefly,
stomachs were excised immediately following sacrifice, quickly flushed with RT PBS, inflated
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by duodenal injection of O.C.T. (Sakura Finetek, Torrance, CA), frozen in Cytocool II (RichardAllen Scientific, Kalamazoo, MI) and cut into serial 7 µm-thick cryosections which were
mounted on Superfrost slides (Fisher Scientific), fixed in 70% ETOH, rehydrated in nucleasefree water (nuclease-free solutions from Ambion, Austin, TX) and then incubated in Alexa Fluor
488 conjugated Griffonia simplicifolia-II (GS-II) (diluted 1:500 in nuclease-free water) for 15
mins. Sections were washed in nuclease-free water and dehydrated in graded ethanol, followed
by xylene. ZCs were identified as corpus cells that were basal to GS-II labeling and which did
not show the dark silhouettes and characteristic shape of parietal cells following xylene
dehydration. Four wildtype and 5 Mist1−/− of mice were used for dissection (PixCell II LCM
apparatus, 7.5 µm spot diameter; CapSure HS LCM caps, Arcturus, Mountain View, CA) to
generate two caps per mouse. RNA was purified by PicoPure kit (Arcturus), and RNA integrity
was confirmed by Agilent 2100 Bioanalyzer (Palo Alto, CA). QRT-PCR was only performed on
RNA that had sharp 18s and 28s bands. All RNA from each cap was treated with DNAse I
(Invitrogen) and then reverse transcribed using the SuperScript III (Invitrogen) standard protocol
(most cDNA syntheses started with 10 ng of total RNA). Measurements of cDNA levels were
performed by qRT-PCR using a Stratagene (La Jolla, CA) MX3000P Detection System, and
Absolute QPCR SYBR Green Mix (Thermo Scientific) fluorescence was used to quantify
relative amplicon amount of mouse

RAB3D, RAB26,

CCPG1, and 18S. Data analysis to allow

expression of qRT-PCR data in terms of cycles above background, normalized to 18s amplicon
intensity, was performed as described in detail (5).
QRT-PCR from stable

MIST1-expressing

and eGFP-control HGC cells was performed

after RNA isolation using TRIzol-solubilized tissue extract (Invitrogen) following the
manufacturer's protocol, quantification using the Beckman Coulter DU 640 Spectrophotometer
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(Fullerton, CA), and cDNA synthesis as described (5) (1 µg of starting total RNA was used).
Measurements of cDNA levels for

RAB3D, RAB26

and 18S were performed and analyzed as

described above.

Plasmid preparation
phMist1-EGFP-C1 expression plasmid was constructed with the coding region of human

MIST1

cDNA (Open Biosystems, Huntsville, AL, IMAGE ID: 8322448) followed by a 30 aa peptide
linker added in-frame to the amino terminus of EGFP in pEGFP-C1 (Clontech Laboratories, Inc.,
Mountain View, CA) by the restriction site-free PCR method of ribocloning ((1),
http://barnes1.wustl.edu/~wayne/riboclon.htm) using Klentaq-LA enzyme (2), a kind gift of
Wayne Barnes, Washington University, and accurate PCR conditions. The riboprimers used did
not match the vector or target products so they were first elongated on longer bandaid primer
templates. The vector region was amplified by PCR using primers DNA3as and pEGFP-DNA3sb
with V5s and EGFP-V5asb on pEGFP-C1 DNA. The hMist1 target was PCR amplified using
DNA3s and hMist-DNA3b with V5as after sequential elongations on bandaids hMist-V5b3,
hMist-V5b2, and hMist-V5b1. The construct coding region pMT6-5 (5416 bp) was verified
correct by DNA sequencing.
The ‘pcDNA3.1 PGCRFP’ fusion construct was generated using a modified sequence
overlap extension PCR strategy. The PGC fragment was amplified by PCR from a
‘pcDNA3.1PGC’ plasmid (a kind gift of Dr. Susan Guttentag, University of Pennsylvania; (16))
with T7 primer (forward) and a reverse primer that contained both the PGC 3’end and RFP 5’
end coding sequence separated by a small linker sequence. The RFP sequence was amplified by
PCR from a ‘pCS2 Notch-RFP’ plasmid (kind gift of Dr. Rafi Kopan, Washington University)
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and a forward primer (complementary to the reverse primer used to amplify the PGC fragment)
and a reverse primer. The PGC and RFP fragments were then purified and mixed together with
T7 and RFP reverse primer to amplify the PGC-RFP fusion fragment. This PCR fragment was
then digested with EcoRI and XhoI and cloned into pcDNA3.1 vector that was linearized with
the same pair of restriction enzymes.
pEGFP- hMist1-C1 (designed by a similar method to phMist1-EGFP-C1) was
monomerized to pmEGFP-hMist1-C1 by site-directed mutagenesis using reverse and forward
primers (58) to convert leucine 222 to lysine and introduce a new restriction site, AflII. meGFPhRab26 expression plasmid was constructed with the coding region of hRab26 cDNA (Open
Biosystems, IMAGE ID: 5262795) added in-frame to the carboxyl terminus of EGFP replacing
the hMist1 coding region in pEGFP-hMist1-C1 by the restriction site-free PCR method of
ribocloning, (1), http://barnes1.wustl.edu/~wayne/riboclon.htm) using Klentaq-LA enzyme (2)
and accurate PCR conditions as above. The vector region was PCRed using primers DNA3as and
pcD3LKs on pmEGFP-hMist1-C1 DNA. The hRab26 target was PCR amplified using DNA3s
and hRab26-DNA3b with pcD3LKas and hRab26-pcD3LKs. The construct coding region (5583
bp) was verified correct by DNA sequencing.
meGFP-hRab26 was mutagenized to meGFP-hRab26T77N by site-directed mutagenesis
to convert threonine at amino acid position 77 to an asparagine and introducing a new BbsI
restriction site. The construct coding region was verified correct by DNA sequencing.
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Results
Identifying

MIST1

direct targets that might regulate secretory cell granule formation and

establishment of apical-basal polarity
During maturation, ZCs undergo three dramatic changes in cell biology; they: 1) greatly
upregulate their rER network, 2) form large exocrine secretory granules; 3) expand their apical
cytoplasm, with their nuclei moving basally. Mist1 expression begins as zymogenic cells (ZCs)
start to differentiate from their mucous neck cell precursors (50); it is involved in both
formation/maintenance of the secretory granules and in the apical-basal reorganization. In the
absence of Mist1, ZCs exhibit markedly smaller zymogen-containing, secretory vesicles relative
to wildtype (Fig. 1A,C,E). Vesicle size, as measured on tEM from multiple ZCs in multiple
gastric units, decreases from a mean of 0.40±0.03 μm2 (wildtype) to 0.14±0.02 μm2
(Mist1−/−mice; p<0.001; Fig. 1B,C). The defects in apical-basal organization are illustrated in
Fig. 1B,D. The ratio of supranuclear to infranuclear secretory vesicle fluorescence decreases
from an apical predominance of 4.2±0.7:1 to essentially equal distribution of apical and basal
granules (ratio of 1.49±0.06:1) in Mist1−/− ZCs (Fig. 1D). The changes reflect inappropriate
basolateral trafficking of granules and/or overly apical positioning of the nucleus. MIST1 loss of
function defects are summarized in the diagram in Fig. 1E. Loss of MIST1 does not result in
decreased rER(50).
To determine the genes that might be activated by

MIST1

to regulate cellular structural

changes, we transiently transfected either MIST1 or empty vector control plasmid into two human
gastric cell lines (AGS and HGC-27). eGFP plasmid was cotransfected under both conditions,
and high GFP-expressing (i.e., highly transfected cells) were isolated by fluorescence activated
cell sorting (FACS).

Global gene expression changes specific to
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MIST1

transfection were

assayed by Affymetrix HGU133_Plus_2 GeneChips. A total of 16 genes exhibited increased
expression (90% confidence interval ≥1.2-fold change, intensity difference ≥100) in both MIST1transfected cell lines relative to respective parental and empty vector-transfected control
populations (Fig. 2 and Table 1).

MIST1 directly

associates with conserved CATATG E-boxes in 6 MIST1–induced genes

To determine which

MIST1-induced

genes were likely direct targets of

MIST1,

we first

examined the entire genomic region upstream to the transcription start sites and the entire first
intron of each gene for conserved E-box sequences of the CATATG type, shown previously to
be the binding site for both mammalian

MIST1

ARRDC3, CCPG1, FNDC3A,

all contain remarkably conserved CATATG sequences

and

SERPINI1

(62) and DIMMED, its fly ortholog (19, 45, 46).

within the first intron (Fig.3A). The RAB3D gene has the canonical MIST1 binding site in a region
between 167 and 205 bp downstream of the end of the first exon in multiple species (Fig. 3B).
RAB26

has a similarly located CATATG that is conserved in multiple mammalian genomes;

however, the only CATATG in the 5’ upstream and intronic genomic DNA we examined is in a
region 11.3 kb upstream of the

RAB26

transcription start (Chr16: 2127505), a location also

conserved in chimpanzee (Fig. 3C). The remainder of the 16

MIST1-activated

genes showed no

conserved CATATG sites in the first intron.
To confirm direct

MIST1

binding to the conserved CATATG sites, we performed

chromatin immunoprecipitation (ChIP) on HGC-27 gastric cells stably expressing a MIST1-eGFP
plasmid (henceforth, HGC-MIST1). Primers closely flanking the conserved CATATG sites shown
in Fig.3A,B,C generated amplicons in the

MIST1-immunoprecipitated

genomic DNA fragments

with greater efficiency than from preimmune-precipitated DNA in all 6 genes (Fig. 4). In

110

contrast, primers to control regions without CATATG sequences generated little to no amplicon
in the

MIST1-immunoprecipitated

CCPG1, SERPINI1,
MIST1,

and

FNDC3A

DNA. We also examined non-conserved CATATG sites in

(FIG. 4). Only the site in

CCPG1

showed possible occupation by

though this site was within 5 kb of the conserved CATATG, and genomic DNA was

fragmented to an average size of 1 kb in these experiments. Hence, we cannot rule out that a
MIST1

small population of longer genomic DNA fragments derived from precipitation of

at the

conserved site might account for amplification at this region. Overall, the results indicate that
MIST1

occupies specific transcription regulatory elements in

RAB26,

and RAB3D genes.

ARRDC3, CCPG1, FNDC3A, SERPINI1,

Rab3d and Rab26 are ZC-specific and Mist1-dependent in vivo
Of the 6 MIST1-regulated genes, two, RAB3D and RAB26, have been previously proposed to
play a role in regulated secretion (15). Thus, we reasoned that these two
cellular effectors that

MIST1

RABs

might be the

induces to govern maintenance and formation of large secretory

granules in exocrine secretory cells. We examined other related
involved in regulated exocytosis (RAB3A,B,C;

RAB27A,B;

and

RAB

RAB37)

genes purported to be

and did not find similarly

conserved CATATG sequences (not shown), nor was expression of these other
members affected by forced

MIST1

expression (Fig. 2B). Thus,

RAB3D

and

RAB26

RAB

family

appear to be

specific and direct targets of MIST1 transcriptional regulation.
If

RAB3D

ZCs and be

and

RAB26

regulate secretory granule formation, they should be expressed in

MIST1-dependent

in vivo. In situ hybridization showed that

expression in mouse stomach was confined to

MIST1–expressing

5A,B). To determine whether either Rab depended on
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MIST1

RAB26

and

RAB3D

ZCs in wildtype mice (Fig.
expression, we laser-capture

microdissected ZCs from the bases of Mist1−/− mice and their wildtype littermates. In Mist1−/−
mice,

RAB26

message was barely detectable above background signal (1.9 cycles above water;

n=3 independent mice and dissections), whereas it was expressed at 11-fold higher levels in
wildtype mice (p<0.01; FIG 5C). Mist1−/− mice also showed a significant decrease (8-fold,
p<0.001) in RAB3D expression (Fig 5C). Hence Rab26 and Rab3d are transcriptionally regulated
by MIST1 in vivo as well.

Expression of pepsinogen-RFP in

MIST1-expressing

stable lines causes formation of large

exocrine secretory granules
Our results so far showed that: 1) loss of

MIST1

leads to small secretory granules and

defects in the apical compartment where those granules mature; 2) expression of two putative
regulators of exocrine granule homeostasis,
MIST1;

and 3)

RAB3D

and

RAB26

RAB3D

expression is

expressing cells. Thus, the data indicate that
transcriptional activation of

RAB3D

and

RAB26,

is directly regulated in vitro by

MIST1-regulated
MIST1

in vivo specifically in Mist1

regulates vesicle maturation via direct

and RAB26. To functionally test that hypothesis, we needed

an in vitro system where the role of RABs in large secretory vesicle dynamics could be assessed
mechanistically. We designed a construct comprising one of the principal constituents of ZC
secretory granules, pepsinogen C (PGC) fused at the carboxyl terminus to red fluorescent protein
(RFP). Fig. 6 shows that stable HGC-MIST1 cells transiently transfected with this construct
developed multiple large PGC-containing granules. The results of multiple (n=8) separate
transfections showed, highly reproducibly, that 23.0±1.2% of the cells with RFP fluorescence
detectable above background had ≥3 vesicles of ≥1 µm in size. In control HGC cultures stably
expressing eGFP alone (without

MIST1),

cells with these large secretory granules were rarer
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(7.5±1.5%, p<0.001 by one-tailed t-test between

MIST1

and control), whereas cells with bright

diffuse PGC-RFP were far more common (4.3±0.2% MIST1 vs. 11.2±0.6% control, p<0.001; Fig.
6A,B).
When examined on their tissue culture substrate using transmission EM, both

MIST1-

expressing and control cells with PGC-RFP contained multiple secretory vesicles (Fig. 6C),
whereas non-transfected cells did not (not shown). However HGC-MIST1 cells formed vesicles
that tended to cluster together and were each over twice as large as the vesicles found in control
cells (0.70±0.12 μm2 vs. 0.34±0.11 μm2, p<1x106; Fig. 6C-E). Fig. 6D demonstrates how
vesicles could be seen undergoing exocytosis. We observed no consistent difference in cell
proliferation, apoptosis, or cell morphology between
(not shown). Finally, we treated cultures of

MIST1-expressing

MIST1-expressing,

cell lines and controls

PGC-RFP transfected cells with

the secretagogue, carbachol (100 μm), which greatly increased formation and trafficking of large
PGC-RFP granules (not shown), indicating that these cell lines can respond to a physiologic,
muscarinic agonist that induces release of zymogen-containing granules in ZCs in vivo.

Large exocrine granule formation requires RAB prenylation and RAB26 activity
Using qRT-PCR, we confirmed that cells stably expressing
constitutively expressed higher levels of
4.1±0.9 and

RAB3D

RAB

transcripts.

RAB26

MIST1,

as expected,

was constitutively expressed at

at 15.0±8.2- fold higher levels (n=6 independent experiments; p<0.001 and

<0.005) in HGC-MIST1 cells relative to those stably expressing a control eGFP vector alone (Fig.
7A).
We next sought to ascertain whether formation of large PGC-RFP granules required the
RAB

expression induced by

MIST1.

We transfected HGC-MIST1 cells with PGC-RFP in the
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presence of 5mM 3-PEHPC (3, 10), an inhibitor of RAB geranylgeranyl transferase (RGGT), the
enzyme that catalyzes the addition of geranylgeranyl groups to the carboxy terminal di-cysteine
(CC or CXC) motifs in

RAB3D

and

RAB26

(55). We used the minimal concentration of 3-PEHPC

that completely dispersed the normal cellular localization of an eGFP-RAB26 construct. Once
RABs

lose the ability to localize to their defined cellular compartments, they no longer function.

As hypothesized, inhibition of

RAB

function led to loss of the large PGC-RFP granules (Fig.

7B,C). Cells with large granules decreased ~4-fold in the presence of inhibitor (p<0.001),
equivalent to levels in the non-MIST1-expressing control cells (Fig 7E).
The cellular localization and expression of

RAB3D

in exocrine secretion has been

relatively well studied (38, 66). RAB3D is important for secretory-granule homeostasis in diverse
secretory cells. Although there is some controversy about its primary function (51, 63), it is
generally thought that

RAB3D

regulates release of mature secretory granules, likely by tethering

them to elements of the cortical actomyosin mesh (7, 37). Given that

RAB3D

already had an

established role in exocrine granule homeostasis, we decided to further examine the role of
RAB26

in this process.
To determine if more targeted disruption of

RAB26

zymogenic vesicle formation, we designed a point mutant
close conservation of the

RAB26

RAB26

function could inhibit large
(eGFP-RAB26T77N) based on

GTP binding region with the analogous

RAB3D

sequence

(RAB3DT36N), which acts as a dominant negative when the equivalent threonine is mutated to
asparagine in the G2 box region responsible for coordinating Mg2+ binding (7); for structure of
RAB26,

see: (65)). As expected, eGFP-RAB26T77N did not localize to a specific membrane

compartment like wildtype

RAB26,

which is perinuclear (Jin et al., unpublished observations).
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Rather eGFP-RAB26T77N distributed throughout the cytoplasm in a pattern similar to that of
wildtype RAB26 in the presence of 3-PEHPC (not shown).
Transfection of the dominant negative construct inhibited large granule formation in
HGC-MIST1 cells cotransfected with PGC-RFP (Fig. 7D). Overall, the percentage of cells
expressing large granules (n=3 independent experiments) decreased 28±5% (p<0.01; Fig. 7E).
When the effects of transfection of the dominant negative construct on the large, PGC-RFP
granular phenotype were correlated on a cell-by-cell basis, almost none of the cells with large
zymogenic granules were seen to express cytoplasmic eGFP-RAB26T77N (Fig. 7F,H).
Conversely, among those cells transfected with eGFP-RAB26T77N above background, almost
none showed the large vesicular phenotype (Fig. 7F), confirming that expression of eGFPRAB26T77N

prevented formation of the large PGC-RFP vesicles. In a control experiment, we

transfected a plasmid with eGFP alone in lieu of eGFP-RAB26T77N (Fig. 7G, H). Expression of
eGFP alone had no effect on formation of large PGC-RFP granules, indicating that the effects of
eGFP-RAB26T77N were specific to its function as a dominant negative RAB. Together, the data
demonstrate that RAB26 function is required for the formation of the large PGC granules.
A previous study showed that
Mist1−/− cells(26). We tested whether

RAB3D
RAB26

was not sufficient to rescue granulogenesis in

was sufficient to induce large granules in control

HGC cells, stably transfected with eGFP and not

MIST1.

Transfection of eGFP-RAB26 in these

cells in three independent experiments led to a higher fraction of cells with large PGC granules
(from 7.5±2.3% to 10.9±0.4%; not shown) that approached a statistically significant increase
(p<0.06 by one-tailed T-test) but did not approach the level seen in HGC-MIST1 cells. Thus,
although required for maturation of granules, RAB26, like RAB3D, does not seem to be sufficient
to rescue the loss of MIST1 function phenotype in the absence of other MIST1 targets.
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Discussion
Here, we demonstrate the role of

MIST1

in establishing the characteristic secretory

phenotype of zymogen exocrine cells through direct transcriptional activation of
RAB26.
RABs

RAB3D

and

These two RABs were the only ones increased following MIST1 transfection and the only

of those thought to be associated with secretory granule homeostasis that had conserved

MIST1-binding
RAB3D

and

E-box elements. Furthermore, ChIP confirmed that MIST1 directly associated with

RAB26

MIST1–expressing

E-boxes. We next showed that

RAB3D

and

RAB26

expression was specific to

cells in vivo and was also Mist1-dependent. Finally, we established an in vitro

system to test the functional importance of

RAB3D

and

RAB26.

Cells stably expressing MIST1, as

expected, have constitutively increased levels of both RAB3D and RAB26. When transfected with
an RFP-tagged zymogenic granule component PGC, these cells, but not controls, formed large
zymogenic secretory granules. Large granule formation required increased RAB activity, because
inhibition of RAB prenylation resulted in cells with smaller granules, indistinguishable from those
of non

MIST1-expressing

control cells. Previous studies have shown that

RAB3D

participates in

exocrine granule homeostasis but is not itself sufficient to induce large granule formation in
MIST1-expressing

cells(26, 38, 42, 51, 66). Here we show that forced expression of a

RAB26

dominant negative construct completely abrogates large vesicle formation, yet transfection of
RAB26

alone does not substantially rescue the mist1 loss of function granule phenotype. Thus,

like RAB3D, RAB26 is required but not sufficient for exocrine granulogenesis.
MIST1

is expressed by a limited number of specialized secretory cells in diverse tissues.

Loss of Mist1, in all reported cases, does not lead to a decrease in steady-state survival or
formation of these cell lineages, nor does it lead to a change in their cell fate. The fundamental
feature of loss of Mist1 function is that the cells that would express Mist1 are still generated,
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occupy their same in vivo niches, and secrete the same substances (32, 50, 73). However, loss of
MIST1

has profound effects on cell shape/architecture and cell function. With loss of

MIST1,

zymogen-secreting cells in stomach, pancreas, and salivary gland don't achieve their full size,
and their zymogenic granules become smaller as well. Pancreatic acinar cells grown in vitro
show smaller zymogen stores, altered Ca2+ currents, and loss of normal apical, perinuclear Golgi
localization (34).
Mist1 protein is highly conserved across species. The Drosophila ortholog of Mist1,
DIMMED,

shares 78% identity through the bHLH region and binds the same CATATG E-box

sequence in its known target gene (46, 62). Conservation between the two genes in these
distantly related organisms is such that expression of MIST1 can induce a

DIMMED

vitro (45). The zebrafish Mist1 orthologue shares 77% identity with mouse

MIST1

target gene in
in the bHLH

domain (18). Loss of zebrafish Mist1 leads to morphologic abnormalities in pancreatic, enzymesecreting cells (18). Gain of function experiments show that DIMMED is sufficient to orchestrate
increased secretory vesicle size (19, 20, 45) analogous to
manuscript. Thus,

MIST1

MIST1

gain of function in the current

is a developmentally regulated TF whose expression is induced during

terminal differentiation of selected secretory cells in diverse tissues with highly evolutionarily
conserved function.
Which genes might a single TF activate to effect complete remodeling of cellular
architecture? Two previously reported targets of

MIST1

in vitro in pancreatic cells are the gap

junction gene Connexin32 (GJB1) (52) and the cell cycle regulating p21(CIP1/WAF1;
Cdkn1a)(24). We do not detect

GJB1

expression in the gastric cell lines used in this manuscript

by GeneChip or qRT-PCR (Tian et al., unpublished observations), so we do not think this is a
MIST1

target in our system.

CDKN1

is expressed in ZCs in vivo and in gastric cell lines, but
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expression is not

MIST1-dependent

lower in ZCs than in other

in cell lines. Furthermore, in vivo, expression of

MIST1-negative

CDKN1

is

gastric epithelial cells (Tian et al., unpublished

observations), so this also seems an unlikely target to mediate the morphological changes
induced by MIST1.
It is possible that

MIST1

activates both tissue-specific and universal sets of genes. In this

work, we identified 16 genes whose expression is activated by MIST1 in two different gastric cell
lines. The majority of these genes are thought to function in secretion or membrane trafficking,
reinforcing our understanding of

MIST1

as a TF that enables terminally differentiating cells to

upregulate cellular effectors that establish a high capacity secretory architecture. In addition to
RAB3D

and

RAB26,

the subjects of the current manuscript, four other genes, including

CCPG1

were also direct targets of MIST1 as indicated by our chromatin immunoprecipitation studies (Fig.
4).

CCPG1

did not appear to be regulated by

MIST1

in gastric ZCs (Figure 5C, and data not

shown); however, CCPG1 is a large gene with multiple splice variants, and we have assayed only
one variant so far. We are currently analyzing the 10 genes without conserved CATATGs to
determine whether any of them bind MIST1 in a non-canonical fashion.
Are the increases in granule size and trafficking sufficient in themselves to effect the
apical-basal cell shape reorganization also induced by MIST1, or are other MIST1 targets involved?
We already know from previous studies that the cytoskeletal adaptor,
absence of

MIST1

CD2AP,

is critical in the

for maintaining cell shape, specifically cell height and ordered cell-cell

adhesion (Fig. 8), though

CD2AP

does not appear to be a target of MIST1(5). The experiments do

suggest, in any case, a role for other genes besides just Rab26 and Rab3d in the cell shape
changes MIST1induces.
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RAB26

clusters by sequence homology with the

RAB37, RAB27

which are critical for regulated secretion. However, whereas
(such as

RAB3D)

RAB27

and

and

RAB3

RAB3

subfamilies,

family members

are relatively ubiquitously expressed in specialized secretory cells in numerous

tissues, expression of

RAB26

appears to be more limited, with highest previously reported

expression in pancreatic and submandibular enzyme-secreting acinar cells, both of which express
MIST1

(40, 64, 68). A functional genomic screen also identified

RAB26

as a normal gastric gene

whose expression is downregulated in human cancer (67). The only previous functional study of
RAB26

showed that in salivary gland zymogen-secreting cells,

RAB26

was associated with

secretory granules (by cell fractionation and western blot), and injection of

RAB26

antibodies

inhibited exocytosis, consistent with our findings (40).
It is currently unclear what mechanisms

RAB3D

and

RAB26

use to induce formation of

larger secretory granules. Our current results and those of previous studies indicate that both
RAB26 and RAB3D

are required but not individually sufficient for the formation of large secretory

granules. The simplest model would be that MIST1 mediated vesicle maturation and trafficking is
dependent on a balance between RAB26 and

RAB3D

activity (Fig. 8), though we cannot currently

rule out a role for other direct targets. In a series of ongoing experiments (Jin et al., unpublished
observations), we have learned that RAB26 helps organize the apical cellular compartment where
immature secretory granules form and mature.

RAB3D

has been implicated downstream in

tethering vesicles to the apical cytoskeleton. Tethering vesicles would encourage vesicle
enlargement, because it would delay vesicle secretion and facilitate fusion of smaller, immature
vesicles. Thus,

RAB3D

and

RAB26

might coordinate sequential membrane compartments,

RAB26

encouraging homotypic fusion of immature granules and/or larger budding from the trans-Golgi
and

RAB3D

tethering maturing granules to the cortical cytoskeleton to await a signal for granule
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fusion with the plasma membrane. Together, these two

RABs

may represent the key cellular

effectors that carry out the developmental signal encoded by MIST1.

Prospectus
The process of cellular differentiation is typically understood as a sequence of transcription
factor inductions, each of which specifies the next step in the developmental program of a given
cell lineage. Any given terminally differentiated cell is thus ultimately specified by its unique
history of sequential transcription factor induction steps. That view explains well how each
differentiated cell in an organism ultimately comes to produce the unique set of proteins that
distinguish it from all other cells. But what induces the genes that high-capacity, secretory cells
all share, no matter what they actually secrete–the genes that lay down the secretory
architecture? Given the parsimony of evolution, it would make sense if these secretory cassettes
were induced by a limited number of tissue-independent but still developmentally regulated
transcription factors. Indeed, our recent survey of gene expression across multiple adult tissues
indicates this is so (13). In the current paper, we show how
for enacting cellular architecture, activates

RAB26

and

MIST1,

RAB3D,

a transcription factor critical

which in turn organize vesicle

trafficking to maximize apical production and maintenance of large secretory granules. The
mechanism we describe here will undoubtedly be only part of a much larger story, as we
continue to dissect the mechanisms of transcriptional regulation of cell architecture change.
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Figure Legends

Figure 1. Mist1 is required for development and maintenance of large zymogenic secretory
granules and apical-basal orientation. A, tEMs of ZCs from wildtype and Mist1−/− mice. Note
central position of nucleus along with reduced size of mature apical secretory vesicles in the
Mist1−/− ZC. "SV", mature secretory vesicles “N”, nucleus. B, Epifluorescence of wildtype and
Mist1−/− ZCs in the base of a gastric unit (oriented with stomach lumen to left, base to right).
Cell and granule orientation observed by immunolabeling with anti-gastric intrinsic factor (GIF,
red) labeling granules, anti-β-actin (green) labeling mesenchymal cells at base of cells and
gastric unit lumen, anti-E-cadherin (purple) labeling basolateral cell-cell borders, and
bisbenzimide (blue) labeling nuclei. Dashed white line: basement membrane. Right- cartoons of
fluorescently labeled cells. Note that Mist1−/− ZCs have nuclei closer to the lumen with fewer,
more basally localized secretory granules. C, Secretory vesicle areas from multiple ZCs were
quantified from tEM photomicrographs (“**” – p<0.01; “***” – p <0.001, for all figures). D,
Multiple ZCs from multiple mice were quantified for apical (luminal to the nucleus) and basal
(basal to nucleus) secretory granule immunofluorescence in immunolabeling experiments like
those in panel B. Each point is the ratio of apical to basal mean fluorescent intensity determined
by anti-pepsinogen C (PGC, a principal component of zymogenic granules) in an individual ZC.
Note that wildtype ZCs have predominately apical distribution of granules, whereas apical and
basal granule distribution is nearly equal in Mist1−/− ZCs. E, Cartoon showing ZCs arising from
mucous neck cell progenitors in the neck of the gastric unit. In the absence of Mist1, ZCs
migrating into the base exhibit apical-basal organization and granule formation/maintenance
deficits (panels C,E adapted from ref (50)).
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Figure 2. Transient transfection with

MIST1

in AGS and HGC-27 gastric cell lines increases

expression of a common cohort of genes. A, Venn diagram showing the number of Affymetrix
HGU133_Plus_2 GeneChips probe sets increased in two different gastric epithelial cell lines
(HGC-27 and AGS) following transient transfection with MIST1. B, The expression intensities on
the GeneChips for the 18 probe sets (16 genes) that were increased in both cell lines relative to
vector-transfected and untransfected controls.

Figure 3. Several genes activated by MIST1 overexpression have evolutionarily conserved, first
intronic canonical

MIST1

E-box sequences. A, All

MIST1-type

E-boxes (CATATG) were

identified in the first introns and 5’ to transcription start for the 16 human genes from Fig. 2 (see
methods). Evolutionary conservation was then determined relative to the other vertebrate species
listed in legend (species identified by 2 letter abbreviations of species names; eg, ‘Gg’ = Gallus
gallus). Genes are schematized to scale with numbered exons in blue and region of gene
analyzed in bold line. Note dramatic conservation of CATATGs located within 1 kb of end of the
first exon in these 4 genes (red brackets). Primers to each of these conserved intronic sequences
were analyzed for

MIST1

binding in Fig. 4; control primers were generated to assess

MIST1

binding to regions with no CATATG (amplicons indicated by arrows with boxed “C”s). In some
cases,

MIST1

binding to regions with non-conserved CATATGs (denoted by arrows with boxed

“M”s) was also assessed. B,C Schematic as in panel A for the two

RAB

genes induced by MIST1

transfection but with detailed sequence alignment at each CATATG. “*”-depicted consensus
sequence runs on antiparallel strand for the given species. Note that the conserved intronic
CATATG in

RAB26

has a single point mutation in humans and chimpanzees destroying the E-
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box. The genomes of those species have another

MIST1

binding site ~11.5 kb upstream of the

transcription start; bovine genomes have both intronic and 5’ sites.

Figure 4. Conserved

MIST1

E-box sequences are directly bound by MIST1. Gel electrophoresis

images of PCR amplicons representative of ≥3 independent chromatin immunoprecipitation
(ChIP) experiments using anti-MIST1 antibody followed by primers either to the conserved
intronic CATATG (“Mist1 site conserved”) or to non-conserved CATATG and control regions
denoted in Fig. 3. "Input 1:10" – genomic DNA prior to immunoprecipitation diluted 1:10;
"Preimmune" – immunoprecipitation from non-specific rabbit antiserum. All images taken from
PCR reactions run for 35 cycles, though each reaction was sampled at multiple cycles to ensure
amplification had not plateaued. Note conserved CATATG sequences show much stronger
amplification of

MIST1-bound

DNA than pre-immune-bound DNA, and no

MIST1-bound

DNA

was detectable at control sites without CATATGs. Non-conserved CATATG sites showed little
to no amplifiable MIST1-bound DNA.

Figure 5. Rab3d and Rab26 expression are zymogenic cell-specific and MIST1-dependent in vivo.
A,B In situ hybridization of mouse fundic gastric gland sections showing antisense
RAB26

RAB3D

and

signal confined to the ZCs at the base of the glands. Note the absence of signal in parietal

cells (arrowheads in the higher magnification view below each main panel). C, Quantitative RTPCR of LCM-dissected ZCs from Mist1−/− mice. RAB3D and RAB26 expression are significantly
decreased in these mice. Note y-axis expressed as Log2 relative to levels in wells containing no
cDNA following 18s normalization; hence, 0=essentially no detectable levels of given amplicon;
RAB26

expression in the Mist1−/− mice is nearly completely abrogated. Primers to another
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potential
MIST1

MIST1

target,

CCPG1,

indicate no significant change in expression, indicating loss of

specifically affects levels of the two RABs.

Figure 6. HGC-MIST1 cells form large exocrine granules upon PGC-RFP transfection.
Fluorescent microscopic image of HGC-27 cells stably expressing

MIST1-eGFP

A,

(green nuclear

staining) showing large PGC vesicles (arrowheads) that do not form in control cells (stable
expressing eGFP alone) upon transfection with PGC-RFP. B, The fraction of cells with multiple
(≥3), large (≥1 μm) vesicles and diffuse, bright vesicles is quantified across multiple experiments
(note the remaining cells showed above-background RFP but were too dim to categorize). C,
tEM of ZCs from HGC- MIST1 and control cells. Note the reduced size of secretory vesicles in
the (control) HGC-27 cells. “SV” – secretory vesicle. D, tEM showing exocytosis of vesicle
contents (arrowhead) in an HGC-

MIST1

cell. E, Vesicle sizes were quantified from tEM of

multiple HGC- MIST1 and control cells.

Figure 7. Large PGC-RFP vesicles in HGC-MIST1 cells are
PCR from 6 separate cultures of stable, HGCexpression of

RAB26

and

RAB3D

in

MIST1

MIST1-expressing

RAB

function dependent. A, qRT-

cells showing constitutively increased
cells relative to cells stably expressing

eGFP instead of MIST1-eGFP. B, Fluorescent microscopy showing PGC-RFP (red) vesicles after
transient transfection in HGC-MIST1 cells. C, Dispersion of PGC-RFP vesicles in HGC-MIST1
cells treated with 5 mM of the RAB inhibitor 3-PEHPC. D, Dispersion of vesicles in HGC-MIST1
cells transfected with RAB26T77N, a dominant negative RAB26 construct. E, Effects of inhibition
of RAB function on fraction of cells with large PGC vesicles is quantified. (p values by one-way
ANOVA test with Dunnett’s Multiple Comparison correction). “eGFP Ctrl” denotes stable
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eGFP-expressing control cells. F, The effects of dominant negative RAB26 transfection on PGCRFP vesicle formation were assessed by quantifying green (RAB26T77N) fluorescence intensity
in each cell, correlated with the distribution of red (PGC-RFP) fluorescence in the same cell.
“Large vesicular” cells were those with multiple (≥3), large (≥1 μm) vesicles; small vesicular
cells were those with substantial (see methods) red fluorescence that was not distributed in large
vesicles. The large vesicular phenotype occurred almost exclusively in cells with limited to
undetectable expression of dominant negative

RAB26:

only 5.16% of such cells had green mean

fluorescence intensity (mfi) ≥300 in 16 bit images, following background subtraction (blue line).
In contrast, 64.4% of cells effectively (≥300 mfi) co-transfected with RAB26T77N had the diffuse
or “small vesicular” phenotype, indicating those cells did not form large secretory vesicles (red
line). G, Transiently transfected eGFP has minimal effects on PGC-RFP vesicle formation,
indicating inhibition of large PGC granules is specific to effects of RAB26, not cytoplasmic GFP.
H, Graphical representation of mean green pixel intensity above background in HGC-MIST1 cells
with either small (diffuse) or large PGC-RFP vesicular phenotype following transient
transfection with meGFP-RAB26T77N or eGFP. Note that the large vesicular cells show little to
no meGFP-RAB26T77N expression. There is no correlation between expression of eGFP alone
and PGC vesicle phenotype.

Figure 8. Schematic illustrating how
differentiate into zymogenic cells.
RAB26

MIST1

MIST1

expression is induced as mucous neck cells

is modeled as acting primarily through

RAB3D

and

to regulate large zymogenic granules, though a role for other MIST1 targets in this process

has not necessarily been ruled out. Other targets of
basal cell shape reorganization induced by

MIST1.
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MIST1

are probably involved in the apical-

Based on an earlier study, the cytoskeletal

adaptor Cd2ap plays a role in this process but is not a target of

MIST1

not affected by loss of Mist1 expression.

Table 1. Function of genes upregulated by MIST1 transfection
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(5). Expansion of rER is
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Table 1. Function of genes upregulated by MIST1 transfection
Gene
Potential Functions
Reference
Genes that directly regulate vesicular formation and transport
RAB3D
Regulates vesicular
Millar et al.(38)
docking and fusion
during regulated
exocytosis
RAB26
Involved in regulated
Yoshie et al., Wagner et al., Nashida
vesicular secretion
et al. (40, 64, 68)
Factors that are secreted or associate with specialized membrane compartments
ACP2
Regulates lysosomal
Saftig et al.,(53)
acid phosphatase 2,
functions. Its deficiency Mannan et al.(36)
lysosomal
causes abnormal
lysosomal storage and
inclusions.
SLC31A2
Cellular Copper uptake
Zhou and Gitschier(71)
solute carrier family 31
(copper transporters),
member 2
SERPINI1
Secreted protein.
Stoeckli et al.,(60) Davis et al.(11,
serpin peptidase
Mutations associate with 12)
inhibitor, clade I
two families with
(neuroserpin), member 1 FENIB, an autosomal
dominant form of
dementia.
Ma et al.(35) Cohen et al.(8)
DISP1
Multitransmembrane
protein, hedgehog
dispatched homolog 2
transporter
Other genes that may potentially regulate vesicular transportation and cellular
architecture
Novel scaffolding
Kostenko et al.(31)
CCPG1
protein that regulates
guanine nucleotide
cell cycle progression
factor Dbs and promote
gene 1
CDC42 activation by
Dbs
FNDC3A
Obholz et al.(41),
fibronectin type III
Cell adhesion migration Shan et al.(57)
domain containing 3A
AQP3

aquaporin 3

Water channel in many
cell types
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Inase et al.(23)

ARRDC3

Arresting domaincontaining 3

FIGN

Fidgetin

Associated with the
plasma membrane,
endosomes, and
lysosomes during
endocytosis;
Plays a regulatory role
in cell proliferation

Oka et al.(43)

One of the “Meiotic” or Patel and Latterich(47), Cox GA et
subfamily-7 group of
al.(9)
AAA proteins. AAA
proteins are molecular
chaperones involved in a
variety of activities like
proteolysis, peroxisome
biogenesis, membrane
fusion, endosome
sorting, and meiotic
spindle formation.

Signaling molecules
Associates with TRAF
TRAF-interacting protein and regulates tumor
with forkhead-associated necrosis factor receptor
domain
signaling
MAP2K5
Interacts with MAPK7.
Mitogen-activated
MAP2K5/MAPK7
protein kinase kinase 5
protein cascade is a
novel signaling pathway
Genes whose molecular function are unclear
BRP44L
Unknown
Brain protein 44 like
MGC13057
Unknown
chromosome 2 open
reading frame 88
TIFA

FAM63A

Unknown

family with sequence
similarity 63, member A
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Ea et al.(14),
Kanamori et al.(27), Takatsuna et
al.(61)
Zhou et al.(72)

Jiang et al.(25)

CHAPTER 4: RAB26 Coordinates Lysosome Traffic and Mitochondrial Localization

This chapter is adapted from the published work:

Jin, R. U. and Mills, J. C. (2014). RAB26 Coordinates Lysosome Traffic and
Mitochonrial Localization. J Cell Sci 127, 1018-1032.

143

RAB26 Coordinates Lysosome Traffic and Mitochondrial Localization

Ramon U. Jin1 and Jason C. Mills1, 2, 3

Division of Gastroenterology, Departments of 1Medicine , 2Developmental Biology, 3Pathology
& Immunology, Washington University School of Medicine, St. Louis, MO 63110

Address correspondence to:
Jason C. Mills
Department of Medicine
Washington University School of Medicine, Box 8124
660 So. Euclid Ave.
St. Louis, MO 63110
Phone: 314 362-4258
FAX: 314 362-7487
e-mail jmills@wustl.edu

Running Title: RAB26, lysosome and mitochondria
Word Count: 7982 (excluding references)
Key words: MIST1; zymogenic cell; LAMP1; vesicle trafficking

Author Contributions
RUJ performed all experiments and drafted the manuscript. JCM edited the manuscript and
provided funding. RUJ and JCM conceptualized, designed, and interpreted the experiments.

143

SUMMARY
As they mature, professional secretory cells like pancreatic acinar and gastric chief cells induce
the transcription factor MIST1 (BHLHA15) to substantially scale up production of large
secretory granules in a process that involves expansion of apical cytoplasm and redistribution of
lysosomes and mitochondria. How a scaling factor like MIST1 rearranges cellular architecture
simply by regulating expression levels of its transcriptional targets is unknown. RAB26 is a
MIST1 target whose role in MIST1-mediated secretory cell maturation is also unknown. Here,
we confirm that RAB26 expression, unlike most Rabs which are ubiquitously expressed, was
tissue specific and largely confined to MIST1-expressing secretory tissues.

Surprisingly,

functional studies showed RAB26 predominantly associated with LAMP1/cathepsin D
lysosomes and not directly with secretory granules. Moreover, increasing RAB26 expression –
by inducing differentiation of zymogen-secreting cells or by direct transfection – caused
lysosomes to coalesce in a central, perinuclear region. Lysosome clustering in turn caused
redistribution of mitochondria into distinct subcellular neighborhoods. The data elucidate a
novel function for RAB26 and suggest a mechanism for how cells could increase transcription of
key effectors to reorganize subcellular compartments during differentiation.

INTRODUCTION
Rab proteins are the largest members of the Ras family of small protein GTPases with
more than 70 members identified in humans (Schwartz et al., 2007).

They are important

regulators of intracellular membrane and vesicle positioning and trafficking. By cycling between
GTP- and GDP-bound forms, they work like simple machines to define specific membraneassociated compartments within cells. Many Rabs - like RAB4, RAB5, RAB7, and RAB11 - are
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ubiquitously expressed (Gurkan et al., 2005; Jin et al., 2012; Zhang et al., 2007) performing
essentially the same function in diverse cells. RAB7, for example, aids the maturation of early
endosomes into late endosomes and ultimately coordinates transport to lysosomes (Bucci et al.,
2000; Feng et al., 1995).
In contrast, expression of some Rabs is largely confined to cells that perform specific
physiological functions. Among the best studied are the RAB27 and RAB3 families which are
expressed highly in specialized secretory cells. RAB27A and B function in the transport and
docking of mature vesicles destined for secretion (Fukuda, 2013) in melanocytes (Hume et al.,
2001) and T lymphocytes (Menasche et al., 2000). The RAB3 family includes RAB3A, B, C,
and D; the first three isoforms are predominantly neuronal, involved in neurotransmitter and
neuroendocrine hormone release (Geppert et al., 1994; Johannes et al., 1994; Schluter et al.,
2004; Weber et al., 1994), while RAB3D is expressed in a variety of extraneuronal secretory
cells, in particular exocrine serous cells in the pancreas, salivary glands, and stomach (Chen et
al., 2002; Millar et al., 2002; Ohnishi et al., 1997). Functionally, RAB3 isoforms all share a
similar role in mature secretory vesicle docking (Fukuda, 2008).
The primary function of serous exocrine cells is to synthesize, store, and secrete digestive
enzyme precursors. MIST1 (BHLHA15) is a bHLH transcription factor that acts as a scaling
factor in these cells (Mills and Taghert, 2012). MIST1 expression is a feature of all serous
exocrine cells (Lemercier et al., 1997; Pin et al., 2000). Recent work has begun to identify the
molecular targets that it scales up to establish a high-capacity, polarized secretory apparatus
(Capoccia et al., 2013; Direnzo et al., 2012; Garside et al., 2010; Jia et al., 2008; Johnson et al.,
2004; Pin et al., 2001; Rukstalis et al., 2003; Tian et al., 2010). For example, RAB3D was
identified as a target in both pancreatic and gastric exocrine cells (Johnson et al., 2004; Tian et
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al., 2010). We also identified RAB26, which is phylogenetically related to RAB3D (Fukuda,
2008; Pereira-Leal and Seabra, 2001) as a direct MIST1 target that is required for establishment
of large secretory granules (Tian et al., 2010). However, the mechanism of RAB26 function in
secretory cells has not been characterized (Azouz et al., 2012).
Here, we present work showing that RAB26 is not like other members of its phylogenetic
family because it does not directly associate with secretory vesicles, but rather with lysosomes.
Accordingly, scaling up expression of RAB26 causes increasing centripetal coalescence of
lysosomes to the perinuclear region in a GTP cycling dependent fashion. Furthermore, using
electron microscopy, immunofluorescence microscopy, and immunoblotting, we demonstrate
that the lysosomal coalescence caused by increased RAB26 also results in redistribution of
mitochondria into distinct cellular neighborhoods. Taken together, our data establish a role for
RAB26 as a novel lysosome-associated Rab whose expression is transcriptionally induced
specifically in secretory tissues to reorganize the cellular distribution of lysosomes and,
indirectly, mitochondria.

RESULTS
RAB26 Expression is Induced in Acinar Secretory Cells by MIST1
Previous reports have shown RAB26 to be expressed in secretory tissues (Nashida et al.,
2006; Tian et al., 2010; Wagner et al., 1995; Yoshie et al., 2000). To further elucidate the role of
RAB26, we assayed the expression pattern of this gene in a human tissue panel (Ge et al., 2005)
(http://sbmdb.genome.rcast.u-tokyo.ac.jp/refexa/) (Fig. 1A). In contrast to a more ubiquitously
expressed Rab (e.g., RAB7), RAB26 showed variable expression with high expression levels in
exocrine secretory tissues and in parts of the brain. The two RAB26 probesets showed strong
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correlation among the tissues examined (Pearson’s correlation coefficient of 0.9145) and
mirrored the known tissue distribution of the secretory cell transcription factor MIST1
(Lemercier et al., 1997; Mills and Taghert, 2012; Pin et al., 2000). Moreover, within specific
organs, RAB26 expression was confined to MIST1 expressing cell lineages like the serous
exocrine, digestive-enzyme-secreting zymogenic (chief) cells of the stomach, but not their
precursors, the mucus-secreting “neck cells” ((Capoccia et al., 2013; Geahlen et al., 2013); Fig.
1B). RAB26 expression was not scaled up in the absence of the transcription factor MIST1 in
either gastric units from Mist1−/− mice (Fig. 1B) or in another tissue populated by digestiveenzyme secreting cells, the pancreas (Fig. 1C).

We next decided to investigate RAB26

scalability in a cell culture system that would facilitate analysis of RAB26 expression level
relative to its subcellular distribution and function. First, we analyzed the well-established
secretory pancreatic cell line, AR42J, which expresses MIST1 (Jia et al., 2008) and can be
differentiated with dexamethasone treatment to upregulate MIST1 target gene expression (Limi
et al., 2012; Qiu et al., 2001) and increase amylase containing secretory vesicles (Logsdon, 1986;
Rinn et al., 2012) (Fig. 1D). In these cells, we found that upon differentiation, as in the stomach
and pancreas in vivo, RAB26 expression was induced substantially (Fig. 1D). We confirmed this
relationship between MIST1 and RAB26 in human gastric cell lines (Fig. 1E). Expression of
RAB26 was endogenously low in both AGS and HGC-27 cells (absent in non-epithelial U937
monocyte cells), but increased in a scalable manner upon MIST1 (not GFP control) transfection
(Fig. 1E; Pearson’s coefficient of 0.9660, indicating strong correlation). These data confirm that
RAB26 expression is MIST1-dependent and, based on our earlier studies showing direct MIST1
binding to the RAB26 promoter (Tian et al., 2010), we conclude that RAB26 is a direct
transcriptional target whose expression is scaled up by MIST1.
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RAB26 Localizes Specifically to LAMP1 Lysosomal Membrane-Associated Vesicles
To study the functional role of RAB26, we performed experiments in HGC-27 cells
because 1) they express low-level endogenous RAB26, even without MIST1 transfection (Fig.
1E); 2) we have previously shown that co-transfection of MIST1 and a cargo of digestive
enzyme induces a network of large secretory granules that would allow us to study the
interaction between RAB26 and those vesicles (Tian et al., 2010); and 3) they are more easily
transfected and larger than AGS or AR42J cells, facilitating detailed microscopy.

We

engineered an N-terminus monomerized EGFP fused version of RAB26 (EGFP-RAB26) to aid
in subsequent localization and trafficking studies.
We had previously shown that interfering with RAB26 function inhibited MIST1mediated granulogenesis (Tian et al., 2010) and hypothesized, based on the initial descriptive
publications (Nashida et al., 2006; Wagner et al., 1995; Yoshie et al., 2000), that RAB26 would
function somehow to traffic nascent or maturing secretory granules. To study RAB26-secretory
granule interactions, we induced a network of secretory granules by transfecting secretory cargo,
RFP-tagged Pepsinogen C, in cells stably expressing MIST1, a system we have previously
described (Tian et al., 2010). Using live cell, timelapse confocal microscopy, we observed,
unexpectedly, that the smaller EGFP-RAB26 vesicles did not fuse, or move in concert with the
larger PGC-RFP containing secretory granules (Movie 1). In addition, RAB26 vesicles showed
no overlap with immature secretory vesicles labeled with antibody against the prohormone
convertase, Furin (Fig. S1A). Finally, EGFP-RAB26 did not interact directly with amylase
secretory granules in AR42J cells (not shown).
RAB26 associated vesicles similarly did not overlap substantially with markers of the
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following other organelles: the ER (Calregulin), early endosomal (EEA1), Golgi (giantin), cisGolgi (GM130), or trans-Golgi markers (TGN46) compartments (Fig. S1B-F). The lack of
RAB26 association with the Golgi was of interest, because recent studies demonstrated that
RAB26 may occupy a recycling endosomal (Chan et al., 2011) or giantin positive Golgi
compartment (Li et al., 2012). Because of the proximity, if not substantial direct overlap, of
RAB26 vesicles with our trans-Golgi marker, we next examined membrane compartments that
interact with the trans-Golgi. RAB26 showed slight overlap but were often also proximal to
vesicles of the post Golgi sorting compartment, as marked by antibodies against CI-M6PR, AP1,
and GGA2 (Fig. S1G-J). The only other principal destination for microtubule associated vesicles
emerging from the Golgi – besides secretory vesicles – is lysosomes, so, by process of
elimination, we reasoned RAB26 was likely associated with lysosomes. Accordingly, antibodies
against the late endosome/ lysosome marker, LAMP1, substantially co-labeled RAB26associated vesicles (Fig. 2A, B). Confocal microscopy in RAB26-transfected HGC-27 cells
showed near complete colocalization of RAB26 with LAMP1 (Fig. 2B). Furthermore, confocal
live imaging of EGFP-RAB26 with LysoTracker revealed nearly identical movement of the two
fluors (Movie 2), indicating they both clearly defined the same, dynamic vesicle population. In
addition, transfection of a plasmid that was independently designed to encode endogenous, fulllength, non-fluorescent tagged RAB26 revealed colocalization with anti-RAB26 and antiLAMP1 antibodies (Fig. 2C). Finally, using immunoelectron microscopy, we found RAB26transfected cells showed significant labeling of large vesicular structures with both 12 nm antiRAB26 and 18 nm anti-LAMP1 gold particles. 82.4% of total cellular RAB26 particles and
91.9% of LAMP1 associated with these structures, which sometimes contained identifiable
cellular debris, consistent with lysosomes (Fig. 2D, E).
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As a control for potential mislocalization caused by overexpression, we next surveyed
endogenous RAB26 localization. Though expression of native RAB26 in HGC cells is relatively
low (Fig. 1E, 3C), we found endogenous RAB26 associated with LAMP1 lysosomes in rare
untransfected cells with higher levels (Fig. 3A, B). Immunoelectron microscopy showed that,
although untransfected cells lacked the larger grouped LAMP1-associated vesicular complexes
found in RAB26 overexpressing cells, the LAMP1-labeled vesicles that were present were also
decorated with lower-level RAB26 labeling (Fig. 3D).

Cell fractionation density gradients

further confirmed that both EGFP-RAB26 (detectable by antibodies to both GFP and RAB26)
and endogenous RAB26 protein were enriched in the purified lysosomal fraction as defined by
positive LAMP1 immunoreactivity (Fig. 3E). Finally, as an additional control, we designed and
transfected an N-terminal EGFP fused RAB3D plasmid, a close family member of RAB26 and
also a MIST1 target (Johnson et al., 2004; Tian et al., 2010). RAB3D had a distinct cellular
distribution apart from RAB26 with no lysosomal colocalization (Fig. S2A).
Our findings were applicable beyond HGC-27 cells as similar lysosome-RAB26
colocalization occurred in another gastric cell line (Fig. S2B), and epithelial cells from other
tissues including 5637 bladder cells (Fig. S2C). Likewise, in pancreatic AR42J cells, we found
that RAB26 vesicles formed a unique vesicle population separate from amylase containing
secretory vesicles (not shown), and again overlapping nearly completely with LAMP1 (Fig. S2D,
E).
There was also significant overlap of RAB26 and LAMP1 with the lysosomal acid
hydrolase, cathepsin D (CTSD) (Fig. 4A-C). RAB26 and LAMP1 often defined the membrane
portion of vesicles, whose interiors were filled with cathepsin D, as expected (Fig. 4A).
Moreover, we designed an RFP-tagged cathepsin D protein (CTSD-RFP) that also showed
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significant colocalization with EGFP-RAB26 upon co-transfection (Fig. 4C), providing an
independent non-antibody confirmation of the direct association of RAB26 with the lysosomal
compartment. EGFP-RAB26 also overlapped with another known Rab protein, RAB7 (Fig. 4D),
whose role in lysosomal trafficking has been well-established (Bucci et al., 2000). Combined,
these experiments definitively show that RAB26 defines the lysosomal subcellular location in
multiple cells.
To confirm that RAB26 associates with lysosomes actively, based on normal GTP/GDP
cycling and trafficking, we next designed single point mutant EGFP-RAB26 variants: one with a
threonine to an asparagine (EGFP-RAB26T77N) and another with glutamine to a leucine
(EGFP-RAB26Q123L) (Fig. 5A). Based on published RAB26 structural models (Protein Data
Bank accession code 2G6B) (Wang et al., 2006) and previous studies of Ras (Barbacid, 1987;
Feig, 1999; Scheffzek et al., 1997) and orthologous Rabs (Brondyk et al., 1993; Burstein et al.,
1992; Chen et al., 2002), EGFP-RAB26T77N would abolish Mg2+ coordinated GTP binding in
the G2 box region, and EGFP-RAB26Q123L would disrupt G3 box region mediated GTP
hydrolysis (Fig. 5B). When transfected, EGFP-RAB26T77N showed a diffuse cytoplasmic
distribution (Fig. 5C), and EGFP-RAB26Q123L showed a more dispersed vesicular distribution
(Fig. 5D). Neither EGFP-RAB26T77N nor EGFP control localized with LAMP1, and EGFPRAB26Q123L showed some correlation with lysosomes. Specifically, while most lysosomes
still co-localized with EGFP-RAB26Q123L, some EGFP-RAB26Q123L overlapped with nonLAMP1 labeled structures (Fig. 5D, E; Pearson’s coefficient of 0.384 compared to wildtype
EGFP-RAB26 with substantial co-labeling and Pearson’s coefficient of 0.702).

We next

analyzed RAB26-EGFP transfected cells in the presence of a prenylation inhibitor and found
wildtype RAB26 no longer trafficked to lysosomes, and we blocked GTP hydrolysis with non-
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hydrolyzable GTP analogs and found that RAB26-EGFP trafficked only partially to lysosomes,
phenocopying the Q123L GTP hydrolysis deficient mutant (not shown). To further investigate
extra-lysosomal EGFP-RAB26Q123L vesicle localization, we co-stained with EEA1, giantin,
and the CI-M6PR (not shown) revealing no substantial co-localization with Golgi, but partial
overlap with the endosomal compartments. Thus, we conclude RAB26 requires prenylation and
GTP binding to target to lysosomes, and dynamic GTP cycling to maintain localization on
lysosomes and avoid trafficking to other membranes as lysosomes recycle (Sridhar et al., 2013).

Increased RAB26 is Sufficient to Traffic Lysosomes Centripetally
To determine the consequences of RAB26 association with lysosomes, we analyzed the
effects of scaling up RAB26 expression, which occurs in tissues as differentiating secretory cells
increase RAB26 in response to the transcription factor MIST1.

To analyze the effects

specifically of scaling up RAB26 without the effects of other MIST1 targets, we took advantage
of the varying levels of expression induced by transient transfection in HGC-27 cells, whose
endogenous RAB26 levels are usually low. We noticed that HGC-27 cells with the highest
levels of RAB26 by EGFP fluorescence intensity showed lysosomal coalescence into a central,
perinuclear region, whereas cells with lower levels showed more diffuse, peripheral lysosomes
(Fig. 6A, B). Moreover, when we quantified this on a cell-by-cell basis, we found cells with
coalesced lysosomes almost always showed higher levels of RAB26 (MFI > 1000 on
normalized, 16 bit scale) than cells retaining diffuse lysosomes (MFI < 1000; Fig. 6B).
Transfection of the two RAB26 point mutants did not recapitulate this lysosome repositioning
phenomenon (Fig. 6C, D), indicating that the ability of RAB26 to bind and cycle GTP is
necessary for this process. In addition, cells transfected with EGFP or EGFP-RAB3D also failed
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to show centripetal lysosomal movement (Fig. 6C, D), revealing that this process is independent
of GFP overexpression and RAB26-specific. Quantification showed that, of cells with detectable
EGFP-RAB26, 30% displayed this central perinuclear lysosomal phenotype (Fig. 6D), whereas
only about 5-10% of EGFP+ cells transfected with various control constructs (EGFP alone,
EGFP-RAB26T77N, EGFP-RAB26Q123L, EGFP-RAB3D) showed this pattern of lysosome
distribution. These other transfected cells showed no change in lysosome distribution no matter
the levels of expression.
In addition, we examined the AR42J pancreatic acinar cell system, in which we were able
to differentiate, increase MIST1 and, scale-up RAB26 levels from moderate to high detectable
levels.

Increasing RAB26 (marked by anti-RAB26) correlated with striking centripetal

coalescence of LAMP1 vesicles to the perinuclear region (Fig. 6E). In other words, endogenous
RAB26 scaled up by cellular differentiation phenocopied transfection-mediated RAB26 scaling.
Localization of other vesicular structures including endosomes, the Golgi, and late
endosomes (not shown and Fig. S3A, B) were unaffected by transfection of EGFP-RAB26 or
any of its mutant forms. Transfection of RAB26 and RAB26 mutants had no significant effect
on: 1) overall levels of LAMP1 protein in cell cultures, 2) levels of cathepsin D; 3) lysosomemediated processing of cathepsin D to its smaller active form; 4) mTOR/S6K signaling, which
depends in part on lysosomal function (Fig. S4A).

In sum, RAB26 specifically localizes

predominately with lysosomes in a GTP/GDP dependent manner, and, as RAB26 levels are
scaled up, it reorients only lysosomes and not other vesicular compartments. Although global
lysosomal function does not appear affected by RAB26, more experiments would be needed to
analyze how RAB26 may mediate the many additional aspects of lysosome trafficking and
function.
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RAB26 Coordinates Reorganization of Mitochondria
To begin to address the potential cellular effects of scaling up RAB26, we returned to
ultrastructural analyses of transfected cells.

Supporting our immunofluorescence and

immunoelectron microscopy data, we found large clusters of electron-lucent vesicles,
morphologically consistent with lysosomes (Fig. 2D), only in the RAB26 transfected cells (Fig.
7A-E).

In our control cells, or in cells transfected with EGFP-RAB26T77N, EGFP-

RAB26Q123L, or EGFP, lysosomes were smaller and dispersed throughout the cytoplasm (Fig.
7C-E). We noticed that the lysosome clusters in the EGFP-RAB26 expressing cells largely
excluded mitochondria (Fig. 7A, B). Thus, instead of the diffuse mitochondrial network seen in
cells transfected with various control constructs (Fig. 7C-E), the mitochondria in RAB26transfected were clustered into distinct cellular neighborhoods. In fact, upon returning to our
initial immunoelectron micrographs, we found RAB26 occasionally labeling mitochondrial
membranes (3.17% of total labeling) adjacent to LAMP1-labeled lysosomes. Thus, RAB26
might also directly or indirectly affect cellular mitochondrial organization.
Accordingly, in cells expressing abundant EGFP-RAB26, we found mitochondria, like
lysosomes, were also clustered but into distinct subcellular regions that were specifically free of
lysosomes (Fig. 8A, B). Control cells showed mitochondria organized in the expected diffuse,
lattice-like network throughout the cell (Fig. 8A). Using live cell confocal microscopy, we were
able to observe mitochondrial interaction on the borders of the EGFP-RAB26 and LAMP1
lysosomal clusters (Movie 2,) including temporary areas of overlap with apparent mitochondriallysosomal fusion or membrane exchange highlighted in frames from Movie 2 (Fig. 8C). When
we quantified the cell area of mitochondria as a percentage of total cell area in EGFP-RAB26
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transfected cells, we found it to be significantly reduced relative to controls (Fig. 8D). In fact,
when whole cellular populations were analyzed for mitochondrial density by western blot for the
mitochondrial outer membrane marker, TOM20, we found a significant reduction (n = 3
independent transfections per construct) only when functional RAB26 was transfected,
indicating trimming of mitochondria across the whole population (Fig. 8E). However, when
mitochondrial function was analyzed using dyes sensitive to mitochondrial membrane potential
(CMXRos (Poot et al., 1996)) and superoxide damage production (MitoSOX Red
(Mukhopadhyay et al., 2007)), we found that while mitochondria were reduced in cells
overexpressing RAB26, those that remained were largely intact and functional, as was the case
for all controls analyzed (Supp Fig. 4B, C).

Taken together, our data show that RAB26

repositions lysosomes and reorganizes mitochondria.

DISCUSSION
Here, we find, in multiple cell types, that RAB26 associates with and traffics lysosomes,
which is surprising both because lysosome-associated Rabs are rare and because RAB26 was
initially characterized in the rat pancreas as being associated with secretory vesicles (Wagner et
al., 1995). However, these earlier results were generated using antibody staining in fixed tissue
sections and cell fractionation density gradient enrichment of granules (Nashida et al., 2006;
Yoshie et al., 2000). In fact, secretory granules and lysosomes are not easily distinguishable by
density gradient properties (Pasquali et al., 1999), and the mature secretory granule markers,
syntaxin 6 and γ-adaptin, used as markers of secretory granules in previous analyses of RAB26,
are also involved in Golgi sorting to lysosomes and late endosomes (Ghosh et al., 2003;
Robinson, 1990). Those markers have been found to be specifically removed from mature
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secretory granules (Klumperman et al., 1998). Moreover, in a large screen of mast cell Rabs that
regulate secretion, transfected RAB26, which mast cells do not normally express, was also found
to be perinuclear and associated with a vesicular compartment that was expected to be LAMP1
positive (Azouz et al., 2012).
Recent studies found RAB26 to be associated with RAB11 recycling endosomes (Chan et
al., 2011) in Drosophila neurons, and a giantin-positive Golgi sorting compartment (Li et al.,
2012) when transfected into HEK293 cells. These results would seem to contradict those of the
current manuscript, though we have focused here exclusively on exocrine secretory cells, trying
to mimic the effects of scaling RAB26 as occurs in differentiating cells in tissue. Thus, RAB26
may traffic differently depending on cell type; however, there are other possible explanations as
well for our seemingly differing findings. There is overlap between Golgi, endosome, and
lysosome markers as lysosomes mature through sorting and trafficking (Ghosh et al., 2003;
Griffiths et al., 1990; Luzio et al., 2000; Moore et al., 2004; Peden et al., 2004; Saftig and
Klumperman, 2009). RAB7, the most well studied lysosomal Rab protein (Bucci et al., 2000),
has also been implicated in endosomal trafficking (Feng et al., 1995). In fact, its close relative,
RAB7B, is found to co-localize with both Golgi and lysosomal markers (Progida et al., 2010).
The transient nature of these dynamic and constantly communicating compartments (Saraste and
Goud, 2007) complicate all subcellular localization studies. In the current manuscript, we have
used multiple secretory cell types and multiple modalities to examine both endogenous and
transfected RAB26, which we argue reinforces our conclusions that RAB26 is predominantly
lysosome-associated in dedicated secretory cells.
That lysosomes cycle between peripheral and central regions has been well documented
with various motor proteins (Hollenbeck and Swanson, 1990; Lin and Collins, 1992), and
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cytoskeletal filaments (Cordonnier et al., 2001; Matteoni and Kreis, 1987) implicated in this
traffic. Much work has also elucidated the role of the Rab family in lysosomal movement and
function. Specifically, RAB4, 5, 9, and 11 have been shown to coordinate endosomal traffic into
and out of maturing lysosomes (Saftig and Klumperman, 2009). However, only RAB7 has been
well established as the key cellular regulator of late endosome to lysosome trafficking, and
overexpression of RAB7 causes central lysosome movement, while T22N and N125I point
mutants leave lysosomes dispersed (Bucci et al., 2000). There is some evidence that two other
ubiquitously expressed Rabs, RAB34 (Wang and Hong, 2002) and RAB36 (Chen et al., 2010),
also function to redistribute lysosomes centrally (Colucci et al., 2005). Interestingly, these Rabs
share a common effector, RILP (RAB7-interating lysosomal protein), crucial for inducing dynein
mediated movement (Cantalupo et al., 2001; Jordens et al., 2001; Wang and Hong, 2005).
RAB26 may also mediate lysosomal rearrangement through RILP interactions.
Mitochondria are constantly pruned and recycled in post-mitotic cells. Under conditions
of oxidative stress, the normal steady-state mitochondrial recycling (Lipsky and Pedersen, 1981;
Terman et al., 2010) is scaled up to maintain physiological function and forestall apoptosis in a
process that depends on lysosome-mediated pruning (Green and Kroemer, 2004). Mitochondria
are delivered to lysosomes via many routes (Ashrafi and Schwarz, 2013). For example, damaged
mitochondria, as tracked by their membrane marker TOM20, can be delivered directly to
lysosomes (Soubannier et al., 2012).
Our findings indicate that scaling up RAB26 might enhance the ongoing baseline direct
trafficking events between lysosomes and mitochondria.

Little is known about lysosome-

mitochondria interactions in tissues that are not under constant oxidative damage. In exocrine
tissues, mitochondria play a crucial role in secretagogue mediated calcium signaling (Tinel et al.,
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1999) that depends on their subcellular positioning (Park et al., 2001). Increasing RAB26 may
be an inherent mechanism for secretory cells to reorganize mitochondria and to focus them in
areas where they can facilitate calcium delivery to secretory granules. We observed only partial
reduction in mitochondrial numbers, no matter how high expression of RAB26 in a given cell;
thus, RAB26 may prune or cluster, rather than destroy, mitochondria.
Our studies have confirmed that RAB26 is not ubiquitous but, rather, is specifically
expressed in only certain cell lineages. Thus, we expect that it would be sufficient but not
required for lysosome mediated mitochondrial reorganization because other more universal
mechanisms must be present in all cells. In fact, our two point mutants do not act as dominant
negatives in affecting lysosomal movement or preventing oxidative damage initiated
mitochondrial degradation (not shown). In addition, siRNA mediated knockdown of endogenous
RAB26 similarly had no effect on lysosomes or mitochondria (not shown). RAB3D, another
direct MIST1 target and secretory cell specific Rab protein shows a similar ability to “scale-up”
vesicle dynamics; when overexpressed in acinar cells, RAB3D enhances regulated secretion
(Ohnishi et al., 1997). However, when Rab3D is deleted regulated secretion is unaffected
(Riedel et al., 2002). Thus, these exocrine cell specific Rabs represent a subset of “scale-able”
cellular effectors that enhance cellular dynamics.
In digestive-enzyme secreting tissues such as the pancreas and stomach, RAB26
expression is almost wholly dependent on the transcription factor, MIST1 (Tian et al., 2010). In
the absence of MIST1 and, thus RAB26, exocrine secretory cells display aberrant secretory
vesicle organization, maturation, and secretion (Direnzo et al., 2012; Johnson et al., 2004; Luo et
al., 2005; Pin et al., 2001; Ramsey et al., 2007; Tian et al., 2010). Interestingly, Mist1−/−
exocrine cells also exhibit aberrant lysosomal trafficking (Capoccia et al., 2013; Direnzo et al.,
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2012; Pin et al., 2001). Furthermore, in wildtype MIST1-expressing cells mitochondria are
organized into distinct subcellular neighborhoods (similar to what we see with increased
RAB26), while in Mist1−/− cells, mitochondria are dispersed throughout the cell, resulting in
abnormal calcium flux (Luo et al., 2005). From our previous study, no other direct MIST1
targets seem to have clear roles in lysosome movement, mitochondria reorganization, or Rab
protein function (e.g., neither guanine nucleotide exchange factors, GTPase-activating proteins,
nor other identified Rab effectors are known MIST1 targets) (Tian et al., 2010). Thus, RAB26
function may be an important and crucial unrecognized aspect in MIST1 regulated cell secretory
function.
Loss of MIST1 results in increased susceptibility to pancreatitis (Alahari et al., 2011;
Kowalik et al., 2007; Zhu et al., 2004), and, in wildtype mice, pancreatitis leads to silencing of
Mist1 (Shi et al., 2013; Shi et al., 2009).

Acute pancreatitis is caused by inappropriate

interaction between lysosomal enzymes and zymogen constituents of secretory granules (Gaiser
et al., 2011; Halangk et al., 2000; Saluja et al., 1997), which leads to mitochondrial
disorganization (Mareninova et al., 2006; Odinokova et al., 2009). Thus, one mechanism for
how MIST1 might suppress acute pancreatitis is by trafficking of lysosomes and mitochondria
through RAB26. Future experiments will have to address whether loss of RAB26 in MIST1expressing cells causes disrupted lysosome/mitochondrial mediated damage, though deletion of
tissue-specific Rabs in vivo has not been that informative (e.g., Rab3d null mice have only a mild
phenotype (Riedel et al., 2002)) perhaps because they are sufficient for scaling up specific
aspects of secretion but not absolutely required.
Our data clearly show that coalescence of lysosomes and mitochondria is caused by
expression of higher levels of RAB26.

The changes occur whether endogenous RAB26
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expression is increased by MIST1 during differentiation or if it is directly transfected to higher
levels. Thus, our studies exemplify how a transcription factor like MIST1 can scale up a specific
target gene during maturation to redistribute organelles in a way that enhances the specific
physiological function the cell must perform in the adult organism. In other words, we provide
mechanistic evidence for how transcription factors like MIST1 can act as scaling factors to
control cell architecture simply by increasing expression of specific genes that encode cellular
effectors (Mills and Taghert, 2012). It will be interesting to determine how the scaling of
RAB26 by MIST1 might work in more detail, whether RAB26 acts as a rheostat (i.e., the more
RAB26 expression increases, the more centralized lysosomal trafficking there is) or more like a
binary switch (i.e. low levels do not change lysosomal distribution, high levels cause lysosomes
to coalesce centrally).
In summary, we propose a mechanism whereby a transcriptionally controlled novel Rab
protein can regulate critical, physiologically relevant cell structural adaptations. RAB26 through
its ability to reposition lysosomes can, in turn, effect mitochondrial reorganization.
Mitochondria and lysosomes are critical for the formation, maintenance, and secretion of
zymogen granules. Therefore, we posit that RAB26 is a novel, lysosome-associated, tissue and
cell-type specific, small protein GTPase that can be “scaled-up” by the transcription factor
MIST1 to enhance the secretory function of exocrine cells.

MATERIALS AND METHODS
GeneChip analysis.
Human

tissue

expression

data

was

obtained

from

the

LSBM

RefExA

database

(http://sbmdb.genome.rcast.u-tokyo.ac.jp/refexa/) (Ge et al., 2005). Human cell line expression
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data prepared as previously discussed (Tian et al., 2010).

Mouse gene chip arrays were

generated as previously discussed (Capoccia et al., 2013). Heat maps of RAB26 expression
levels were generated by dChip analysis (Zhong et al., 2003). Correlation between RAB26
probesets was calculated using GraphPad Prism to generate Pearson’s correlation coefficients
based on raw read values.

Cell Lines / Transfection
HGC-27 and AGS cells were maintained as previously described (Tian et al., 2010). 5637 cells
(gift from Dr. Indira Mysorekar, Washington University) were maintained at 37°C in 5% CO2 in
RPMI 1640 supplemented with 10% fetal bovine serum, 0.9% glutamine, 0.4% HEPES, 1% Na
pyruvate, 2.5% glucose, and 100 ng/mL each of penicillin and streptomycin. AR42J cells
(ATCC, Manassas, VA) were maintained in F12K media supplemented with 20% fetal bovine
serum, 1.0% glutamine, and 100 ng/mL each of penicillin and streptomycin. Dexamethasone
(100 nM, Sigma-Aldrich, St. Louis, MO) was added to cells for 48 hours to induce secretory
differentiation.

For transient transfection, AGS or HGC-27 cells were transfected via

electroporation using Nucleofector II (Lonza, Basel, Switzerland), program B-023, and cell line
transfection solution V. For each electroporation, 3 µg PGC-RFP (see below), 5 µg EGFPRAB26 (see below), 5 µg EGFP-RAB26T77N (see below), 5 µg EGFP-RAB26Q123L (see
below), 5 µg EGFP-RAB3D (see below), 3 µg CTSD-RFP (see below), or 3 µg pmaxGFP
(Lonza) plasmid was used. In some experiments and other cell lines, we also used TransIT-2020
and TransIT-LT1 Transfection Reagent (Mirus, Madison, WI) according to manufacturer’s
protocol. For visualization, cells were replated on Lab-Tek Chamber Slide 4-well Permanox
slides (Thermo Fisher Scientific, Rochester, NY) and routinely analyzed 24-72h posttransfection.
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MIST1-EGFP expressing stable cell lines were established as previously described (Tian et al.,
2010).

Immunofluorescence / Cell Imaging
For immunofluorescence analysis, cultured cells were transfected and stained as described
previously (Tian et al., 2010). Fluorescence microscopy and imaging were performed using a
Zeiss Axiovert 200 microscope 20X (Plan-Apochromat, 0.8 NA), 40X (Plan-Neofluar 0.85 NA)
and 63X objectives (Plan-Apochromat, 1.4 NA) with Axiocam MRM camera and AxioVision
software. Additional, confocal microscopy and imaging were performed using a Zeiss LSM510
microscope with 40X (EC Plan-Neofluar, 0.75 NA) and 63X (Plan-Apochromat, 1.4 NA)
objectives using LSM510 software.

Live cell imaging was performed using an Olympus

FluoView FV1000 microscope equipped with 60X objective (PLAPON 60XO, 1.42 NA)
maintained at 37°C in 5% CO2 with images captured using the FV10-ASW software or using a
Zeiss LSM510 confocal microscope with 63X objectives (Plan-Apochromat, 1.4 NA) maintained
at 37°C in 5% CO2 with images captured using the Zeiss LSM510 software. Contrast (maximal,
minimal, and midtone) adjustment and fluorescent channel overlay and pseudocoloring were
performed with Photoshop (Adobe Systems, San Jose, CA). All adjustments were performed on
the entire image equally.
The primary antibodies used for cell immunostaining: rabbit anti-amylase (1:100,
Calbiochem, CA), rabbit anti-RAB26 (1:100, ProteinTech Group, Chicago, IL), rabbit antigiantin (1:1000, Covance), rabbit anti-EEA1 (1:250, Abcam), rabbit anti-furin (1:500, Thermo
Scientific), goat anti-calregulin (1:100, Santa Cruz), rabbit anti-GM130 (1:250, BD Biosciences,
San Jose, CA), sheep anti-TGN46 (1:250, Serotec, Oxford, UK), rabbit anti-CI-M6PR (1:500);
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mouse anti-AP1 (1:500); rabbit anti-CTSD (1:150); and mouse anti-GGA2 (1:500) (gifts from
Dr. Stuart Kornfeld, Washington University), mouse anti-LAMP1 (1:40, Santa Cruz, Santa Cruz,
CA), mouse anti-LAMP1 (1:50, clone H4A3, developed by J. Thomas August and James E. K.
Hildreth and obtained from the Developmental Studies Hybridoma Bank under the auspices of
the NICHD maintained by The University of Iowa), rabbit anti-RAB7 (1:150, Cell Signaling
Technology, Danvers, MA). Secondary antibodies used were Alexa Fluor 488-, 594-, and 647conjugated donkey anti-goat, anti-rabbit, anti-sheep, and anti-mouse antibodies (1:500;
Invitrogen, Carlsbad, CA). LysoTracker and MitoTracker (Invitrogen) were used at 75 nM and
250 nM concentrations, respectively, according to manufacturer’s instructions. MitoTracker
CMXRos and MitoSOX Red (Invitrogen) were used at 100 nM and 2 µM concentrations,
respectively, according to manufacturer’s instructions.

Immunofluorescence Quantification
For pixel-to-pixel overlap of EGFP-RAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, and
GFP with LAMP1, cells were transfected and stained for LAMP1 as described and confocal
images were taken from at least 10 cells per condition. Thresholded Pearson’s correlation
coefficients were calculated using Volocity image analysis software (PerkinElmer, Waltham,
MA).
For lysosome distribution quantification, cells were transfected as described with EGFPRAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, EGFP-RAB3D, or GFP plasmids. Post
transfection, lysosomes were stained with a LAMP1 antibody as described. Blinded to treatment
conditions, sixteen-bit images captured in Zeiss Axiovision software were analyzed with ImageJ
software as follows. Central lysosomes (bright concentrated staining around perinuclear region),
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diffuse lysosomes (disperse cytoplasmic staining), transfected cells, and total cells determined by
total nuclei counted using technique developed by (Selinummi et al., 2005) were scored. 65 low
power fields comprising three independent experiments were examined totaling approximately
10,000 cells counted per condition.
For enhanced

green

fluorescent

protein

EGFP-RAB26 fluorescence

intensity

quantification, cells were transfected with EGFP-RAB26 and stained for LAMP1. Sixteen-bit
images captured in Zeiss Axiovision software were analyzed with ImageJ software as follows.
We determined mean green cytoplasmic fluorescence intensities in each region after subtraction
from the median background (green in an area with no cells).

These same cells were then

scored individually for their lysosome distribution (as defined above). A total of 180 cells were
scored across three transfection experiments.
For mitochondrial area quantification, cells were transfected and stained as previously
described. Sixteen-bit images captured in Axiovision software were analyzed with ImageJ
software as follows.

Area selection tool was used to outline mitochondria, and area was

measured using the Analyze area measurement tool. Multiple cells were scored across three
transfection experiments.

Plasmid Preparation
PGC-RFP, EGFP-RAB26, and EGFP-RAB26T77N mammalian expression plasmids were
constructed as previously detailed (Tian et al., 2010). To generate EGFP-RAB26Q123L, EGFPRAB26 was mutagenized by site-directed mutagenesis to convert the glutamine at amino acid
position 123 to a leucine, and a new XhoI restriction site was introduced. pcDNA3.1-RAB26
plasmid was constructed using the same approach as EGFP-RAB26 using backbone plasmid
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pcDNA3.1/V5-His-TOPO (Invitrogen) with the first amino acid of the His-tag modified to a stop
codon. The monomeric EGFP-RAB3D expression plasmid was constructed with the coding
region of human RAB3D cDNA (IMAGE identification number 3861912; Open Biosystems)
added in frame to the carboxyl terminus of EGFP, replacing the RAB26 coding region in EGFPRAB26 by ribocloning (Barnes, 1994; Barnes, 2006). PCR was performed on the vector region
by

using

primers

DNA3as

(GGCAATTCCACCACACTGGACTAGu)

and

pcD3LKs

(GGGCAATTCTGCAGATATCCAGCAc) on EGFP-RAB26 DNA. The RAB3D target was
PCR amplified using DNA3s (ACTAGTCCAGTGTGGTGGAATTGCc) and hRAB3D-DNA3b
(GGGTGTCTCCAGCTGATGCCATGGCGGCAATTCCACCACACTGGACTAGTG)
pcD3LKas

(GTGCTGGATATCTGCAGAATTGCCc)

and

with

hRAB3D-pcD3LKs

(GATGCTCCAGCCCCCCAGCCCTCCTCTTGTAGCTGCTAGGGCAATTCTGCAGATATC
CAGCAC). The pcDNA3.1 CTSD-RFP fusion construct was generated with the human CTSD
region of pcDNA3.1-hCTSD-myc (gift from Dr. Stuart Kornfeld) added in frame to the amino
terminus of RFP, replacing the PGC coding region in PGC-RFP by ribocloning. PCR was
performed

on

the

vector

region

by

using

primers

DNA3as

and

RFPs

(GCCTCCTCCGAGGACGTCAu). The hCTSD target was PCR amplified using DNA3s and
hCTSD-DNA3b (GCTGGAGGGCTGCATGGCGGCAATTCCACCACACTGGACTAGT) with
RFPas

(ATGACGTCCTCGGAGGAGGc)

(CGAGGCTGCCCGCCTCGCCTCCTCCGAGGACGTCAT).
were verified to be correct by DNA sequencing.

Density Gradient Ultracentrifugation Lysosomal Enrichment
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and

hCTSD-RFPs

All construct coding regions

Lysosomes were isolated with the Pierce Lysosomal Enrichment Kit of Tissue and Cultured
Cells (Rockford, IL) according to manufacturer’s protocol. Briefly, cells were transfected as
described, pelleted, and homogenized using a Dounce tissue grinder. Nuclei were removed and
then lysate was ultracentrifuged on prepared Optiprep density gradients using Beckman Coulter
Optima L-100 XP ultracentrifuge (Fullerton, CA). Fractions were removed and subjected to
western blot analysis.

Western Blot Analysis
Mouse tissue was flash frozen in liquid nitrogen and homogenized in RIPA buffer using a
PowerGen700 (Fischer Scientific, Pittsburg, PA). Cells were transfected as described and lysed
in RIPA buffer. Proteins were quantified by DC protein assay (Bio-Rad) and then separated on
NuPAGE Bis-Tris gels (Invitrogen), transferred to Immobilon polyvinylidene difluoride
(Millipore, Bedford, MA) or Amersham Hybond ECL nitrocellulose (GE Healthcare,
Buckinghamshire,

United

Kingdom)

membranes,

and

detected

by

Immobilon

chemiluminescence (Millipore). Primary antibodies used were mouse anti-LAMP1 (1:1000,
Developmental Studies Hybridoma Bank), rabbit anti-GFP (1:1500, Santa Cruz), rabbit antiRAB26 (1:800, ProteinTech Group Chicago, IL), rabbit anti-MIST1 (1:500, described previously
in (Pin et al., 2000)), mouse anti-TOM20 (1:1000, BD Biosciences), rabbit anti-cathepsin D
(1:2000, gift from Dr. Stuart Kornfeld, Washington University), rabbit anti-mTOR (1:1000, Cell
Signaling Technology), rabbit anti-phospho-p70 S6 kinase (1:1000, Cell Signaling Technology),
rabbit anti-p70 S6 Kinase (1:1000, Cell Signaling Technology), and rabbit anti- α/β tubulin
(1:1500, Cell Signaling Technology).

Secondary antibodies were horseradish peroxidase–

conjugated donkey anti-rabbit, and anti-mouse (Santa Cruz Biotechnology, Santa Cruz, CA).

166

Quantifications of immunoblots were done by scanning sixteen-bit images into ImageJ.
Band intensities for TOM20 and α/β tubulin were selected and calculated using Analyze mean
gray value measurement tool. Standardized values were calculated by the ratio of TOM20 signal
to α/β tubulin signal.

Protein Structure Analysis
RAB26 protein structure was obtained from Protein Data Bank, accession code 2G6B (Wang et
al., 2006). Image was generated using Protein Workshop (Moreland et al., 2005) with surfaces
(Xu and Zhang, 2009).

Electron Microscopy
For transmission electron microscopy studies, cells were transfected as previously described and
plated on Lab-Tek Chamber Slide 4-well Permanox slides (Thermo Fisher Scientific). After
being rinsed in PBS, they were fixed in modified Karnovsky’s fixative (2.5% glutaraldehyde, 2%
paraformaldehyde in 0.1 mmol/liter cacodylate buffer). TEM thin sections were cut directly from
cell cultures embedded on the original Permanox substrate.
For immunoelectron microscopy studies, EGFP-RAB26 or EGFP controltransfected
HGC-27 cells were trypsinized, pelleted, and fixed on ice for 1 hour in PBS, 4%
paraformaldehyde, 0.05% glutaraldehyde. Subsequent sample processing was performed as
previously described (Beatty, 2008). After incubation with primary antibodies against RAB26
(1:50, ProteinTech Group) and LAMP1 (1:25, Developmental Studies Hybridoma Bank) sections
were then washed and probed with anti-rabbit conjugated to 12 nm and anti-mouse conjugated to
18 nm colloidal gold (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).
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Quantification of labeling specificity of RAB26 and LAMP1 was performed by calculating
cellular areas of lysosomes, mitochondria, nucleus, cytoplasm, and plasma membrane using
ImageJ Area selection tool and Analyze area measurement tool.

Areas were compared to

counted 12 nm RAB26 and 18 nm LAMP1 labeling within 100 nm of the same cellular areas.
Multiple cells from 5 fields were counted.

Graphing and Statistics
All graphs and statistics were determined with GraphPad Prism and then visualized using Adobe
Illustrator. Statistical analysis was, in the case of simple control-versus-experimental condition
comparison, by Student’s t-test. Otherwise, significances were determined by one-way analysis
of variance (ANOVA) test with Dunnett’s multiple-comparison correction.
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Figure Legends

Figure 1.

Expression of RAB26 is cell and tissue-dependent, and inducible by the

transcription factor MIST1. A. Expression of RAB7 and RAB26 in REFEXA database of
human tissues (http://sbmdb.genome.rcast.u-tokyo.ac.jp/refexa/). All tissues are labeled with
highly RAB26 expressing secretory tissues highlighted below. Gene expression is shown with
relative scale (0 to 200) with red=high, blue=low expression. B. Microarray analysis of RAB26
gene expression from isolated populations of gastric ZCs and their precursor neck cells from
wild-type and Mist1−/− mice.

Arrows indicate location of isolated cell populations in

representative H&E gastric gland images. Gene expression for microarray analyses are shown
with relative expression scale (-3.0 to 3.0) with red=high, blue=low expression. C. Western blot
analysis of indicated proteins from two wildtype and two Mist1−/− mice.

D.

Immunofluorescence of AR42J acinar cell differentiation upon treatment with dexamethasone
(Dex); amylase secretory vesicles are red; endogenous RAB26 are green. E. Gene expression
analysis of RAB26 expression from AGS and HGC-27 gastric cell lines before and after
transfection with either GFP or MIST1; a non-epithelial monocyte control cell line is also shown
(U937). Scale bars = 20 µm.

Figure 2. RAB26 localizes to LAMP1 positive lysosomal vesicles. A. Immunofluorescence
of HGC-27 cells transfected with EGFP-RAB26 (green) and co-immunostained with LAMP1
(red).

B.

Confocal image of EGFP-RAB26 (green) transfected HGC-27 cells stained for

LAMP1 (red). Insets show unmerged RAB26 (green) and LAMP1 (red) positive membranes.
(Cell border outlined, “N” – nucleus). C.

RAB26 without GFP tag (pcDNA3.1-RAB26)
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transfected HGC-27 cells co-stained with anti-LAMP1 (green) and anti-RAB26 (purple). D.
Immunoelectron micrographs of HGC-27 cells transfected with EGFP-RAB26. Representative
low magnification cell shown with insets and additional panel highlighting large labeled vesicles
with anti-RAB26 (12 nm gold particles, yellow arrowheads) and anti-LAMP1 (18 nm gold
particles, white arrowheads). E. Graph with left bar showing average percent total cellular area
of lysosomes, mitochondria, nucleus, cytoplasm, and plasma membrane in multiple quantified
cells. Right bars show fraction of total RAB26 or LAMP1 gold particles associated with each of
those compartments. Scale bars = 20 µm unless indicated.

Figure 3. Endogenous RAB26 is also lysosome-associated. A. Immunofluorescence imaging
of endogenous RAB26 staining (green) in a rare HGC-27 cell with moderate RAB26 levels costained for LAMP1 (red). B. Confocal immunomicroscopy of endogenous RAB26 (green) and
LAMP1 (red) (“N” – nucleus). Arrowheads indicate colocalization of RAB26 and LAMP1
vesicles. C. Lower magnification epifluorescence of HGC-27 cells with more representative,
low-level endogenous RAB26 (green) and LAMP1 (red). D. Immunoelectron micrographs of
control GFP transfected HGC-27 cells. A representative cell is shown at low magnification with
several panels showing electron lucent structures labeled with anti-LAMP1 (18 nm, white
arrowheads) and sparsely labeled with anti-RAB26 (12 nm, yellow arrowheads). E. Density
gradient cell fractionation experiment with numbered density fractions analyzed for lysosomes
with anti-LAMP1 antibody; EGFP-tagged RAB26 by both anti-GFP and anti-RAB26 antibodies
(middle and lower panel); and endogenous RAB26 by anti-RAB26 immunoblotting (lower
panel). Scale bars = 20 µm unless indicated.
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Figure 4. RAB26 localizes with other lysosomal markers. A. Confocal image of a HGC-27
cell transfected with EGFP-RAB26 (green) and immunostained for LAMP1 (red) and cathepsin
D (blue) (Cell border outlined, “N” – nucleus). Inset highlights higher magnification of a
lysosomal vesicle (arrowhead) that contains membranous RAB26 and LAMP1 with interior
cathepsin D. B. Immunofluorescence staining of EGFP-RAB26 (green) transfected HGC-27
cells with cathepsin D (red). C. Epifluorescence microscopy of HGC-27 cells co-transfected
with EGFP-RAB26 (green) and RFP-tagged cathepsin D (CTSD-RFP, red).

E.

Immunofluorescence staining of EGFP-RAB26 (green) transfected HGC-27 cells with RAB7
(red). Scale bars = 20 µm.

Figure 5. Design and characterization of RAB26 point mutants. A. Amino acid sequence of
EGFP-RAB26 plasmid with EGFP sequence (green) and human RAB26 sequence (black)
labeled. The EGFP-RAB26T77N and EGFP-RAB26Q123L were constructed by the indicated
point mutations (shown in red) in the RAB26 sequence converting a threonine to an asparagine,
and a glutamine to a leucine, respectively. B. Ribbon diagram of the crystal structure of RAB26
generated by FirstGlance in Jmol (ver. 1.03) from http://molvis.sdsc.edu/fgij/fg.htm?mol=2G6B
(PDB ID: 2G6B; (Wang et al., 2006)). GNP bound RAB26 with the mutated threonine (T77) and
glutamine (Q123) labeled and emphasized with their atomic structures.

C.

Confocal

fluorescence microscopy of the distribution of EGFP-RAB26T77N (green) transfected HGC-27
cells immunostained with LAMP1 antibody (red) (Cell border outlined, “N” – nucleus). Right
panels show epifluorescence microscopy of EGFP-RAB26T77N (green) co-stained for LAMP1
(red). D. Confocal fluorescence microscopy of the localization of EGFP-RAB26Q123L (green)
transfected HGC-27 cells immunostained with LAMP1 antibody (red). Inset indicates areas of
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overlap (solid white arrowheads) of EGFP-RAB26Q123L vesicles with lysosomes (transparent
arrowhead) (Cell border outlined, “N” – nucleus).

Right panels show epifluorescence

microscopy of EGFP-RAB26Q123L (green) co-stained for LAMP1 (red).

E. Pearson’s

correlation coefficient quantification of pixel-to-pixel colocalization of multiple cells transfected
with EGFP-RAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, and GFP with LAMP1
lysosomes. (“***” – p < 0.001, one-way ANOVA test with Dunnett’s correction). Scale bars =
20 µm.

Figure 6. Scaling of RAB26 expression leads to perinuclear localization of lysosomes. A.
Fluoresence microscopy of HGC-27 cells transfected with EGFP-RAB26 (green) and stained for
anti-LAMP1 (red). A long and short exposure is shown to highlight the differences in RAB26
levels with the cells expressing highest (“*”) and more moderate (solid white arrow) levels of
RAB26 indicated. B. Histogram of EGFP-RAB26 transfected cells immunostained for LAMP1
with either diffuse (red line) or clustered (blue line) LAMP1 lysosomal distribution plotted vs.
binned fluorescence intensity of EGFP-RAB26. C. Epifluorescence microscopy of HGC-27
cells transfected with EGFP-RAB26T77N, EGFP-RAB26Q123L, EGFP-RAB3D, and EGFP
expression plasmids (green) co-stained with anti-LAMP1 (red). D. The percentage of EGFPRAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, EGFP-RAB3D, and EGFP transfected
HGC-27 cells from multiple cell fields with coalesced perinuclear LAMP1 structures quantified
by cell count and plotted (“***” – p <0.001, one-way ANOVA test with Dunnett’s correction).
E.

Immunofluorescence microscopy of untreated (-Dex) or dexamethasone treated (+Dex)

AR42J cells stained for endogenous RAB26 (green) and LAMP1 (red). Scale bars = 20 µm.
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Figure 7.

RAB26 overexpressing cells show ultrastructural rearrangements.

A. B.

Transmission electron micrographs of EGFP-RAB26 HGC-27 cells with clustered electronlucent lysosome vesicles (‘L’) highlighted in the insets with electron-dense mitochondrial
clusters indicated (‘M’) (“N” – nucleus, scale bars as shown).

Transmission electron

micrographs of C. EGFP-RAB26T77N, D. EGFP-RAB26Q123L, and E. EGFP transfected
HGC-27 cells (scale bars = 10 µm). F. G. H. Panels of immunoelectron microscopy of EGFPRAB26 transfected HGC-27 cells labeled with LAMP1 (18 nm, white arrowheads) and RAB26
(12 nm, yellow arrowheads) with mitochondria (‘M’) and lysosomes (‘L’) highlighted (scale bars
as shown).

Figure 8. RAB26 induced lysosomal clustering leads to mitochondrial reorganization. A.
Fluorescence microscopy of EGFP-RAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, and
EGFP transfected HGC-27 cells (green) co-stained for lysosomes (anti-LAMP1, red) and
mitochondria (MitoTracker, purple). B. Confocal section of EGFP-RAB26 expressing cell
(green) with stained for lysosomes labeled in red (anti-LAMP1) and mitochondria labeled in
purple (MitoTracker).

Perinuclear mitochondria free zones are indicated (‘*’) (Cell border

outlined, “N” – nucleus). C. Live confocal timelapse microscopy of EGFP-RAB26 (green),
LysoTracker labeled lysosome (red), and MitoTracker labeled mitochondria (purple) vesicle
dynamics. Insets highlight RAB26 (green, filled white arrowhead) and mitochondria (purple,
open white arrowhead) interactions (time stamps of images from Movie 2 shown, “N” –
nucleus). D. Quantification of mitochondrial area/total cell area measured from multiple HGC27 cells transfected with EGFP-RAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, and EGFP
(‘*’- p <0.05, one-way ANOVA test with Dunnett’s correction). E. Densitometry quantification
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of western blots (triplicate experiments) of mitochondrial membrane density using TOM20 and
α/β tubulin markers for EGFP-RAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, and EGFP
transfected HGC-27 cells (“***” – p <0.001, one-way ANOVA test with Dunnett’s correction).
Scale bars = 20 µm.
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Supplemental Figure Legends

Supplemental Figure 1. RAB26 does not localize to the immature secretory vesicle,
endosomal, Golgi, or post-Golgi sorting compartments. EGFP-RAB26 (green) transfected
HGC-27 cells immunostained for: A. immature secretory vesicle marker, Furin (red); B.
endoplasmic reticulum marker, Calregulin (red); C. early endosomal marker, EEA1 (red); D.
Golgi marker, Giantin (red); E. cis-Golgi marker, GM130 (red); F. trans-Golgi marker, TGN46
(red); and G. post-Golgi/late endosome marker, CI-M6PR (red). Confocal microscopy of EGFPRAB26 (green) transfected HGC-27 cells immunostained for post-Golgi/endosomal markers: B.
CI-M6PR (red) C. AP1 (red), D. GGA2 (red). Insets indicate RAB26 vesicles (white filled
arrowheads) overlap with stained markers (open arrowheads) (Cell border outlined, “N” –
nucleus). Scale bars = 20 µm.

Supplemental Figure 2. RAB26 not RAB3D localizes to lysosomes. A. Immunofluorescence
microscopy of HGC-27 cells transfected with EGFP-RAB3D and co-stained for LAMP1 (red)
and cathepsin D (purple). Epifluorescence images of EGFP-RAB26 transfected: B. AGS,
gastric cells; C. 5637, bladder cells; and D. AR42J, pancreatic cells co-labeled for LAMP1 (red).
Panels indicate unmerged green and red channels. E. Confocal microscopy of an AR42J cell
transfected with EGFP-RAB26 and immunostained for LAMP1 (red). Arrowheads indicate
areas of overlap (Cell border outlined, “N” – nucleus). Scale bars = 20 µm unless indicated.

Supplemental Figure 3.

RAB26 does not affect Golgi or late endosomal distribution.

Fluorescence microscopy of EGFP-RAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, and
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EGFP transfected HGC-27 cells (green) co-stained for: A. giantin (red) and B. CI-M6PR (red).
Low magnification panels of EGFP-RAB26 transfected cells highlight giantin and CI-M6PR
distribution in transfected (green) and untransfected cells. Scale bars = 20 µm.

Supplemental Figure 4. RAB26 does not affect lysosomal or mitochondrial function. A.
Western blots (triplicate experiments) of EGFP-RAB26, EGFP-RAB26T77N, EGFPRAB26Q123L, and EGFP transfected HGC-27 cells comparing levels of LAMP1, cathepsin D,
mTOR, phosphorylated S6 kinase, total S6 kinase, and tubulin. B. Fluorescence microscopy of
EGFP-RAB26, EGFP-RAB26T77N, EGFP-RAB26Q123L, and EGFP transfected HGC-27 cells
(green) co-stained for: B. MitoTracker CMXRos (red) and C. MitoSOX Red (red) and
MitoTracker Deep Red (purple). Scale bars = 20 µm.

Movie 1. RAB26 does not co-localize with secretory vesicles. Live confocal timelapse
microscopy of HGC-27 cells transfected with EGFP-RAB26 (green) and PGC-RFP (red).
Images were taken at 3 second intervals and movie is displayed at 5 frames/second. White
arrows highlight RAB26 vesicle movement. Yellow arrows and circles show vesicle fusion or
fission events. Time stamp is shown in upper left corner and scale bar = 20 μm.

Movie 2. RAB26 localizes with lysosomes in mitochondrial free subcellular areas. Live
confocal timelapse microscopy of HGC-27 cells transfected with EGFP-RAB26 (green) stained
for lysosomes (LysoTracker, red) and mitochondria (MitoTracker Deep Red, Blue). Images
were taken at 40 second intervals and movie is displayed at 3 frames/second. White arrows
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highlight RAB26/LysoTracker vesicle movement. Time stamp is shown in upper left corner and
scale bar = 20 μm.
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Abstract
Exocrine cells like pancreatic acinar and zymogenic chief cells have a highly developed
secretory architecture that is rapidly established upon maturation. The evolutionarily conserved
transcription factor MIST1 governs normal apical secretory vesicle organization in these cells.
These effects have been attributed to MIST1 inducing transcriptional targets that directly interact
with the regulated secretory pathway. How MIST1 may influence trafficking of non secretory
vesicles has yet to be explored. In mouse exocrine cells that are null for Mist1, we found
disorganized subcellular distribution of lysosomes. Normally, lysosomes cluster in a centralized
basal compartment away from secretory granules, whereas in Mist1−/− exocrine cells, they
accumulate apically, associate with secretory vesicles, and ultrastructural examination shows
partially degraded cargo in lysosomes. Secretory vesicles in Mist1−/− exocrine cells are smaller,
though vesicle size is partially rescued by disrupting normal lysosomal hydrolase trafficking.
Thus, we propose MIST1 promotes normal accumulation of secretory granules in part by
protecting them from the cellular degradation/recycling machinery. These results illustrate how a
transcription factor can regulate cell architecture and have implications for disease processes like
acute pancreatitis where MIST1 is lost, and secretory vesicles are targeted by lysosomal
enzymes.
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Introduction
Survival of the whole organism is crucially tied to the function of each cell type that
constitutes its tissues and organs. These functions are inherently tied to the form or subcellular
architecture of these cells. The dramatic importance of this concept is best illustrated in single
celled prokaryotes, in which all aspects of shape are actively honed for the survival of the cell in
response to its environment (Young, 2006). In eukaryotes, form and function are collectively
referred to as “differentiation”.

In the last decade, it has become clear that a cell can

dedifferentiate, effectively stripping it of its identity and function (Takahashi and Yamanaka,
2006). In fact, this cellular identity crisis is a common link in many diseases including diabetes,
heart disease, and cancer (Kubin et al., 2011; Schwitalla et al., 2013; Talchai et al., 2012).
Specifically, loss of form and function is apparent in gastric and pancreatic cancer
tumorigenesis. In both cases dedifferentiation has been well studied and shown to progress
stepwise (Correa, 1992; Hezel et al., 2006) as mature cellular structure and function is lost.
In the pancreas and the stomach, studies have shown that the bHLH transcription factor,
MIST1, is one of these factors that maintains a secretory cell’s functionality (Pin et al., 2001;
Ramsey et al., 2007). Its loss has been found to directly render the cell more susceptible to
injury, metaplasia, and carcinogenesis ((Alahari et al., 2011; Kowalik et al., 2007; Lennerz et al.,
2010; Nam et al., 2010; Nozaki et al., 2008; Shi et al., 2013; Shi et al., 2009). Studies from our
lab using an inducible model of gastric atrophy and metaplasia show that MIST1 is one of the
first factors that is lost as mature zymogenic chief cells respond to injury and dedifferentiate in a
process known as pseudopyloric metaplasia (Huh et al., 2012).

Additional studies in the

pancreas using an inducible MIST1 knockout model, reveal that within hours of MIST1 loss,
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mature pancreatic acinar cells began to remodel their granules, cytoskeleton, and cellular
junctions (Direnzo et al., 2012).
Functionally, MIST1 does not act as a traditional differentiating factor in that in its
absence, cells still acquire mature characteristics but have compromised functionality (Capoccia
et al., 2013; Direnzo et al., 2012; Johnson et al., 2004; Pin et al., 2001; Ramsey et al., 2007). In
other words, MIST1 does not impart lineage-specific properties to those maturing cells that
express it. For example, in the stomach, in the absence of MIST1, mature gastric zymogenic
cells still express their usual array of endogenous secretory products (Bredemeyer et al., 2009).
However, these products are no longer packaged, maintained, or secreted normally (Capoccia et
al., 2013; Ramsey et al., 2007; Tian et al., 2010).

Analogously, the MIST1 ortholog in

Drosophila (called DIMM) is sufficient to confer many aspects of the regulated secretory
pathway when expressed ectopically but does not change the content of the vesicles (Hamanaka
et al., 2010; Park et al., 2011). Thus, MIST1 functions more to enhance the baseline secretory
machinery that all cells already possess (i.e., it is a Scaling Factor (Mills and Taghert, 2012)).
To understand its importance in physiology and pathophysiology, the critical question
becomes how MIST1 can effect substantial changes in cellular architecture by regulating
expression of specific genetic targets. Separate studies have identified various direct MIST1
targets (Garside et al., 2010; Jia et al., 2008; Rukstalis et al., 2003) but how the targets come
together to regulate an interconnected pathway is still unclear. MIST1 does control two small
GTPases, RAB3D and RAB26 (Direnzo et al., 2012; Johnson et al., 2004; Tian et al., 2010).
RAB3D has been shown to function in secretory vesicle maturation, and preliminary work based
only on subcellular localization indicated a similar role for RAB26 (Millar et al., 2002; Nashida
et al., 2006; Yoshie et al., 2000). However, recent studies from our lab have implicated a novel
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role of RAB26 in lysosomal movement and trafficking (Jin and Mills, manuscript in
preparation).

Thus, MIST1 might directly affect the degradative compartment in secretory

exocrine cells.
Here we dissect how a transcription factor might regulate the exocrine secretory
apparatus by suppressing the degradative lysosomal machinery to prevent premature destruction
of developing secretory granules. We show that, in addition to the reduction in secretory vesicle
size and general granule disorganization seen in exocrine tissues in Mist1−/− mice, there is a
dramatic increase in functional lysosomes.

Normally in gastric zymogenic cells, these

degradative vesicles are small, limited in number, and reside basally to large apical secretory
vesicles. But in the absence of MIST1, they expand apically out of the basal compartment to
engulf and degrade many of the forming vesicles. The phenomenon occurs rapidly upon MIST1
loss and persists for the lifetime of mature zymogenic cells in the absence of MIST1. Lysosome
up-scaling occurs in all another exocrine secretory tissue, the pancreas, once MIST1 is lost.
Lysosomal enzyme trafficking defective Gnptab−/− mice crossed to Mist1−/− showed partial
rescue of secretory vesicle size through prevention of the lysosomal mediated secretory vesicle
destruction in that there was a dramatic increase in undegraded secretory content inside the
accumulated lysosomes.

We conclude that MIST1 is a transcription factor that governs

trafficking in more than one vesicular compartment. In other words, MIST1 in part increases
stores of large secretory granules by suppressing their targeting to cellular degradative pathways.

Results
The bHLH Transcription Factor, MIST1, is Required for Large Granule Homeostasis
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Previous reports have shown that MIST1 (Bredemeyer et al., 2009; Capoccia et al., 2013;
Ramsey et al., 2007; Tian et al., 2010) is required for the formation of large secretory vesicles in
gastric zymogenic cells. To confirm these results, we examined the structure of gastric units
from WT and Mist1−/− mice. Both by H&E and transmission electron microscopy we found
aberrant secretory architecture in Mist1−/− ZCs (Fig. 1A). WT mice displayed the typical apical
cytoplasm containing large secretory vesicles (Fig. 1B, C). Mist1−/− mice lack this prominent
apex and, displaying smaller, apically localized secretory vesicles and more basally mislocalized
granules (Fig. 1B, C). In fact, when whole stomach levels of secretory vesicle constituents are
examined, Mist1−/− mice show an almost fifty percent reduction in global quantities of
pepsinogen C and gastric instrinic factor (Fig. 1B, C). When quantified on a vesicle by vesicle
basis, WT mice have a greater proportion of large secretory vesicles and bigger mean vesicle size
(Fig. 6C, D) compared to vesicles seen in Mist1−/−mice.

Lysosomes Accumulate and Engulf Secretory Vesicles in the Absence of MIST1
To address this possibility that the granular aberrations could be due to increased
destruction, we assayed for lysosomal distribution using the well-established LAMP1 membrane
marker. We found that in WT mice, lysosomes were sparse in mature zymogenic cells, and
those present were mostly basal, localized away from the apically maturing secretory vesicles
(Fig. 2A-D). In Mist1−/− ZCs, however, we saw a dramatic increase in LAMP1 lysosomes.
Again, most of these lysosomes were seen basal to the nucleus. But the basal compartment was
greatly expanded by accumulations of large lysosomes, labeled with LAMP1, LAMP2, or
Cathepsin D (Fig. 2A-D), while the nucleus was displaced to nearly the apical plasma
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membrane. Thus, in addition to secretory vesicular aberrations, Mist1−/− ZCs also display an
alteration in their lysosomes.
We next investigated whether accumulation of lysosomes was responsible for the smaller
secretory vesicles. Using transmission electron microscopy we surveyed multiple Mist1−/− ZCs
and consistently found engulfed secretory vesicles characterized by electron density in various
stages of degradation inside lysosomal structures, whereas neither degrading secretory vesicles
nor increased lysosomes were seen in WT ZCs (Fig. 3A, B). Based on these results, we used
confocal immunofluorescence microscopy to look for enhanced secretory vesicle-lysosome
overlap in Mist1−/− ZCs. Consistent with our tEM findings, Mist1−/− ZCs displayed many
regions, especially basal to the nucleus, where PGC containing vesicles resided within LAMP1
marked lysosomes (Fig. 3C, D). When quantified, almost 30% of all secretory vesicles in
Mist1−/− ZCs displayed LAMP1 overlap (Fig. 6E). WT mice showed small dispersed lysosomal
staining with no colocalization with PGC secretory vesicles (Fig 3D, 6E).

Lysosome Accumulation occurs immediately upon MIST1 loss
To test if lysosome accumulation was directly concomitant with MIST1 loss, first we
took advantage of Mist1−/− mice in which the Mist1 null allele has a LacZ cassette knock-in (Pin
et al., 2001), thereby allowing us to track when and where MIST1 would normally be expressed
by charting expression of the Mist1 promoter (Fig. 4A).

Importantly, during normal

differentiation, ZCs terminally differentiate towards the base of each gastric unit from a nonMIST1 expressing mucous neck cell precursor. In the Mist1−/− animals the basic elements of
this terminal differentiation step occur despite absence of MIST1 expression (Bredemeyer et al.,
2009; Ramsey et al., 2007).
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Our data show that upon emergence of these MIST deficient ZCs from their mucous
secreting precursors, they accumulated lysosomes, and they did so as early as the Mist1 promoter
became active (Fig. 4A). Furthermore, aberrant lysosomes persisted for the lifetime of the cell,
because ZCs from the earliest to most mature at the very base of the gastric unit showed the same
lysosomal phenotype (Fig. 2A-D, 3C, 4A).
In parallel experiments, we assayed the effects of conditionally knocking out MIST1 on
the two vesicle compartments using the Mist1BT/BT mouse model. Briefly, these mice have
knocked in an N-terminal BT tagged, C-terminal 6XHis-Myc tagged Mist1 and two loxP sites
introduced via homologous recombination into the endogenous Mist1 locus. Upon crossing to
Mist1CreERT mice (Shi et al., 2009), Mist1BT/Cre mice were generated in which the remaining allele
of Mist1 is susceptible to tamoxifen induced cre recombinase excision to generate induced
functional nulls. The Mist1BT/BT mouse served as a control in which both transgenic alleles of
myc-tagged MIST1 are expressed (Fig. S1A, 4B, C). One week after tamoxifen induced Mist1
deletion in the Mist1BT/Cre mice, we saw a mosaic pattern of secretory vesicle and lysosome
changes in cells losing MIST1 (Fig. S1B, 4B, C). Units that retained MIST1 expression, as
marked by myc staining, also preserved robust secretory vesicle apical distribution and scarce
basal scattered lysosomal as per WT and Mist1BT/BT mice (Fig. S1B, 4B, C). However, at two
weeks after Mist1 deletion, all gastric units exhibited MIST1 loss, scant apical secretory vesicles,
and accumulation of lysosomes (Fig. S1C, 4B, C). When quantified, average secretory vesicle
size decreased and overlap of those vesicles with lysosomes increased to over 90% (Fig. 4C).
These data show that the process of stomach lysosomal accumulation in Mist1−/− exocrine cells
is not a gradual, additive, or indirect effect that occurs as the cells age. But rather, it is a rapid
defect that ensues directly concomitant to failed induction of MIST1 expression.
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Other Acinar Tissues also exhibit Lysosome Accumulation upon MIST1 loss
Because MIST1 is expressed and functions analogously in all exocrine secretory tissues
(Lemercier et al., 1997; Pin et al., 2000), we investigate if this aberrant lysosomal accumulation
occurred in these other tissues. To this end, we surveyed LAMP1 staining in formalin fixed
paraffin embedded pancreatic sections using immunofluorescence microscopy. Consistent with
gastric zymogenic cells, pancreatic acinar cells also display an increase in lysosomes and
associated secretory vesicle disorganization (Fig. 5A). Upon closer examination, we observed
increased lysosomal structures in the Mist1−/− mice by high-magnification, single cell confocal
microscopy (Fig. 5B). By western blot we confirmed that in pancreatic acinar cells, Mist1−/−
mice showed dramatic increase in lysosomal markers, LAMP1 and CTSD (Fig. 5C). CTSD has
a distinctive pattern of degradation on western blot, which was increased in the absence of
MIST1 indicating increased global lysosomal activity. Finally, we found using the Mist1BT/Cre
mice that conditional knockout of MIST1, as in the stomach, induced rapid lysosomal
accumulation in the pancreas (Fig. 5D). Of note, the pattern of MIST1 loss (mosaic loss at one
week and complete acinar cell loss at two weeks post tamoxifen induced cre recombinase
excision) paralleled the results we found in the stomach. Thus, loss of MIST1 causes the same
increase in lysosomes in multiple exocrine secretory tissues, suggesting a shared mechanism of
MIST1 mediated lysosomal suppression.

Disruption of Lysosome Degradative Capacity Rescues Mist1-/- Secretory Vesicle Destruction
If MIST1 functions to suppress lysosomes in acinar secretory tissues to protect maturing
secretory vesicles, then if we disrupted lysosomal function in these cells we reasoned we should

206

see rescue of secretory vesicles from degradation (but not initial lysosome targeting), that would
manifest as 1) an increase in vesicle size and 2) an increase in undegraded secretory vesicles
inside lysosomes. Importantly, the degradative effects exist in concert with the secretory vesicle
formation defects previously reported in the absence of MIST1 (Capoccia et al., 2013; Direnzo et
al., 2012; Johnson et al., 2004; Pin et al., 2001; Ramsey et al., 2007), so we did not anticipate
complete restoration to WT levels of secretory vesicle appearance. We decided to investigate
mice with reduced lysosomal function due to genetic ablation of the α/β catalytic subunits of
GlcNAc-1-phosphotransferase (Gelfman et al., 2007). This enzyme is involved in the addition of
mannose 6-phosphate moieties to lysosomal acid hydrolases, and in its absence, mice exhibit
reduced lysosomal function (Boonen et al., 2011; Vogel et al., 2009). Intriguingly, these Gnptab/-

mice exhibit accumulation of undegraded vesicles at baseline, most predominantly in the

exocrine secretory cells (Boonen et al., 2011; Vogel et al., 2009).
Histologic examination showed that the basal zymogenic cell regions of Mist1-/-Gnptab-/gastric units exhibited an increase in eosin staining compared to WT or Mist1-/- (Fig. 6A),
suggesting increased intracellular vesicular membranes. Western blot examination of whole
stomach secretory vesicle components and markers of lysosomal function revealed that Mist1-/Gnptab-/- mice partially restored WT levels of secretory components (Fig. 6B). Accumulation of
LC3 (indicative of autolysosomes) and aberrant cathepsin D processing was observed consistent
with reported findings of lysosome and autolysosome abnormalities in Gnptab-/- mice. Partial
restoration to WT levels of secretory proteins in Mist1-/-Gnptab-/- mice would be expected as
MIST1 also coordinates secretory vesicle formation and maturation (Capoccia et al., 2013;
Direnzo et al., 2012; Johnson et al., 2004; Pin et al., 2001; Ramsey et al., 2007).
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To tease out the effects of lysosomal inhibition on secretory vesicles, we used confocal
microscopy to examine multiple mice of each genotype (WT, Mist1−/−, Gnptab−/−, and
Mist1−/−Gnptab−/−) for PGC granules and LAMP1 lysosomes (Fig. 6C). Subsequently, we
analyzed each genotype for vesicle number, secretory vesicle area size, and engulfment by
LAMP1 marked membranes (Fig. 6C-E). For WT mice, as expected, we saw that the majority
(>58%) of secretory vesicles were large (1 µm or greater) with mean vesicle size of 1.17 µm, and
essentially no lysosomal interaction (< 1% of vesicles) (Fig. 6C-E). In Mist1−/− mice, in line
with our reported findings, we saw a shift of vesicle distribution to smaller sizes (>52% of
vesicles were 0.1-0.3 µm) with mean vesicle size dropping to 0.34 µm and an increase in
lysosome overlap (28% of vesicles) (Fig. 6C-E). Scaled up lysosomal attack on secretory
vesicles was more apparent for the larger secretory vesicles such that only 20% of secretory
vesicles smaller than 0.7 µm were engulfed by lysosomes, whereas 75% of secretory vesicles
larger than 0.7 µm were targeted to lysosomes (Fig. 6C-E). Interestingly, Gnptab−/− mice alone
exhibited a subtle shift towards smaller secretory vesicles and reduction in mean vesicle size
(0.87 µm). Interactions with lysosomes increased to 15% compared to WT hinting at a possible
baseline interdependent relationship of secretory vesicles and lysosomes (Fig. 6C-E).

The

lysosomal interactions in Gnptab−/− mice occurred with all sizes of secretory vesicles uniformly.
Finally, Mist1−/−Gnptab−/− mice displayed an upwards shift in vesicle size distribution (all
binned vesicle sizes above 0.3 µm showed proportional increase in number compared to
Mist1−/−) and increased mean vesicle size (0.44 µm) compared to Mist1−/− mice (Fig. 6C, D). A
dramatic increase in secretory vesicle-lysosome interaction also occurred in these mice with 59%
of secretory vesicles positioned inside lysosomes (Fig. 6E). In addition, the preferential overlap
of larger secretory vesicles with lysosomes seen in Mist1−/− mice was abrogated in
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Mist1−/−Gnptab−/− mice (55% of vesicles smaller than 0.7 µm and 76% of vesicles larger than
0.7 µm were lysosome assocaited). These data suggest that in Mist1−/− all vesicles are targeted
to lysosomes and degraded, especially larger vesicles. But small vesicles are more rapidly and
efficiently degraded because of their size. Upon inhibition of lysosomal function, this entire
process is slowed, and emergence of these smaller group of vesicles is apparent as evidenced by
increased lysosomal overlap and a size distribution shift for the small vesicles in the
Mist1−/−Gnptab−/− mice. These results were corroborated by staining for other markers of
secretory vesicles (gastric intrinsic factor) and lysosomes (cathepsin D) (Fig. S2A, S3A), and
examination of another exocrine secretory tissue (Fig. S2B, S3B). Taken together, our data show
that MIST1 functions to suppress lysosomal accumulation and resulting degradative function in
maturing exocrine cells.

Loss of MIST1 resulted in immediate and active degradation of

secretory vesicles. These vesicles are restored upon inhibition of lysosome function in the
Mist1−/−Gnptab−/− mice revealing the extent of Mist1−/− vesicle destruction.

Discussion
The idea that specific cellular organelles and/or subcellular pathways might be under
direct transcriptional control is not a novel concept (Nunnari and Walter, 1996); however only
recently have clear examples been elucidated (Mills and Taghert, 2012). In fact, new advances
have revealed elegant examples of this concept as applied to lysosomes. The basic helix-loophelix (bHLH)-Zip transcription factor, TFEB, was demonstrated to control the expression of a
network of lysosomal genes that augments lysosomal number and degradative function
(Sardiello et al., 2009). Elegantly, the same group showed that levels of TFEB, and thus
degradative capacity, are directly regulated by extracellular nutrient signaling pathways
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(Settembre et al., 2012). GATA1, an important hematopoietic transcription factor, has been
shown to induce several lysosomal genes and the degradative function of maturing erythroblasts
(Kang et al., 2012). In addition, the caudal-type homeo box transcription factor, CDX2, with
known roles in gut maturation (Verzi et al., 2011), induces lysosomal genes and trafficking
proteins to establish proper cell polarity (Gao and Kaestner, 2010). These examples highlight
that all mature cells might need to strictly regulate autodegradative function. Regulation of
intracellular degradative pathways may be especially crucial during times of development when
cells engage in dramatic reorganizations of cellular architecture, and, conversely, it may be
critical for mature, long-lived cells to have mechanisms to suppress autodegradation.
For example, as exocrine secretory cells assemble into high-output secretory machines, it
would be expected that they would need to strictly regulate cellular degradative processes. The
transcription factor, MIST1, is a critical mediator of multiple, mostly exocrine, long-lived
secretory cell function (Capoccia et al., 2011; Lemercier et al., 1997; Pin et al., 2000). In all
tissues, those cells retain the ability to terminally differentiate even when MIST1 is lost.
However, MIST1-deficient cells exhibit a dramatic disorganization in secretory vesicle
homeostasis, with markedly smaller secretory granules and decreased response to stimulated
exocytosis. The secretory apparatus-regulating, scaling factor function of MIST1 is highly
conserved evolutionarily. Loss of function experiments in Zebrafish (Guo et al., 2007) and gain
of function studies with the Drosophila ortholog of MIST1, DIMMED (Hamanaka et al., 2010;
Hewes et al., 2003; Park et al., 2011; Park et al., 2008), confirm MIST1/DIMM is sufficient and
required to establish pro-secretory cell function across evolution. We and others have assumed
that MIST1/DIMM would establish/maintain stores of secretory granules by regulating levels of
targets directly involved in granule formation or trafficking (Capoccia et al., 2013; Johnson et al.,
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2004; Rukstalis et al., 2003; Tian et al., 2010). Understandably, accumulation of degradative
vesicles in the pancreas and seminal vesicles of MIST1-deficient mice was previously attributed
as secondary to aberrant regulation of secretion (Pin et al., 2008; Pin et al., 2001).
Thus, our results here are unexpected and are the first to suggest that a key, if not the
salient, way that MIST1 maintains secretory granules is by suppressing their destruction. That
mechanism of MIST1 would explain at least two previous observations. Clearly, it suggests that
the induction of degradation in Mist1−/− acinar cells (Pin et al., 2008; Pin et al., 2001) might be
directly due to aberrant lysosomal trafficking, rather than a secondary phenomenon. Also, it
would explain why transitional cells in Mist1−/− mice that are just beginning to emerge from
neck cell progenitors with Mist1 promoter expression show abundant, if not increased, stores of
normal-sized granules, in Mist1−/− mice relative to wildtype (Bredemeyer et al., 2009; Huh et al.,
2010; Ramsey et al., 2007).

It is possible that MIST1 is not required solely for granule

formation, but rather functions in concert to also suppress the normal cellular autodegradative
attack on long-lived vesicles needed for mature granule maintenance (Fig. 7).
Whatever the teleological reason, there is clearly aberrant interaction between the
secretory and the degradative compartments in Mist1−/− mice.

There are several possible

explanations why this occurs, based on our in vitro finding that RAB26 repositions lysosomes
centrally. Interestingly, centralization of the degradative machinery has been recently found to
augment secretory function and facilitate efficiency of secretion (Narita et al., 2011). Lack of
MIST1 and thus, RAB26, as a centralizing force, will by default move lysosomes further to the
cell periphery, where their proximity with mature secretory vesicles would increase, resulting in
direct degradation of the secretory granules by the process deemed crinophagy (Klionsky et al.,
2007; Marsh et al., 2007) or possibly by a microautophagic like process (Mijaljica et al., 2011;
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Santambrogio and Cuervo, 2011).

Similarly, MIST1, through RAB26, may inhibit direct

autophagosome targeting of zymogenic granules for ultimate autolysosome degradation, recently
termed zymophagy (Grasso et al., 2011) by separating the macroautophagy and lysosomal
machinery. Alternatively, lysosomal machinery may normally associate with secretory vesicles,
and RAB26 may be required for sorting lysosomal components from maturing secretory vesicles.
Multiple reports have shown that mechanistic defects or alterations in the normal maturation
process or trafficking of various vesicles or membrane-associated proteins will result in aberrant
interaction of contents across vesicular compartments that are normally spatiotemporally
separate (Arvan and Castle, 1998; Blott and Griffiths, 2002; Boonen et al., 2011; Hunziker and
Geuze, 1996; Kogel and Gerdes, 2010; Meister et al., 2010; Morvan and Tooze, 2008; Saftig and
Klumperman, 2009).
Furthermore, our work with RAB26 has also implicated its role in mitochondrial
reorganization. These effects are also seen in vivo. In the absence of MIST1, both mitochondrial
organization and mitochondria mediated calcium signaling were effected resulting in secretory
defects (Luo et al., 2005). Because calcium signaling is intimately tied to the secretory pathway
(Rizzuto et al., 2012), the effects of MIST1 on secretory vesicles may be even more complex
then suppression of lysosome degradation. The ultimate function of MIST1 may be to enhance
some compartments (secretory pathway), shrink and sequester other parts (degradative
lysosomes), and re-organize ancillary components to facilitate and maintain physiological
operation (mitochondria mediating calcium flux).
It is unlikely that RAB26 is the sole direct target to facilitate the MIST1 mediated
lysosomal effects. Other direct MIST1 targets may play complementary roles in these same
pathways. In fact, studies have found that the MIST1 target SPCA2 mediates calcium signaling
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(Garside et al., 2010), and work from our lab has shown the MIST1 target MIB1 coordinates
digestive enzyme cargo accumulation in secretory vesicles – but not their size – via its effects on
endolysosomal trafficking (Capoccia et al., 2013). Additional, yet uncharacterized direct MIST1
targets may also be important.

From our previous studies, we identified targets with potential

roles in vesicle maturation and trafficking, including ACP2 (a regulator of lysosome function),
CCPG1 (promotes CDC42 activation by regulating DBS), ARRDC3 (membrane protein with
known roles in cell proliferation), and FIGN (AAA protein involved in membrane fusion and
endosome sorting) (Tian et al., 2010). Clearly, MIST1 induces expression of multiple factors to
effect various vesicle, cytoskeletal, and organelle compartments through direct and indirect
interactions, all in order to facilitate and maintain the dynamic and highly organized secretion
apparatus.
In a differentiated exocrine cell, aside from protecting maturing secretory vesicles, what
other purpose does MIST1 mediated suppression of lysosomal function and localization serve?
Perhaps, MIST1 functions in mature cells to suppress the innate cellular defense mechanism that
cells mount against intracellular pathogens that hijack vesicles for latent infection (Levine et al.,
2011).

In gastric epithelial cells, Helicobacter pylori, the pathogen linked to gastritis and

stomach cancer development has been postulated to persist within autophagic vesicles via its
VacA toxin (Raju et al., 2012; Terebiznik et al., 2009; Terebiznik et al., 2006); likely this occurs
through subversion of lysosome fusion. In the exocrine pancreas, acute pancreatitis involves
damaging auto activation of secretory enzymes (Gaiser et al., 2011). Lysosomal enzymes have
been shown to activate zymogen constituents of secretory granules (Halangk et al., 2000; Saluja
et al., 1997).

Interestingly, loss of MIST1 and thus the lysosome suppression, results in

increased susceptibility to pancreatitis (Alahari et al., 2011; Kowalik et al., 2007; Zhu et al.,
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2004). Those examples demonstrate that precise control of lysosomal function should be critical
for all acinar cells. The mechanism described here will likely be a component of a larger
network of MIST1 regulated structural and organizational genes that influence additional aspects
of acinar cell secretory function.

Materials and Methods
Mice
All experiments involving animals were performed according to protocols approved by the
Washington University School of Medicine Animal Studies Committee. Germ line Mist1−/− mice
(Pin et al., 2001) were maintained in a specific-pathogen-free barrier facility. Control mice were
the littermates of Mist1−/− mice resulting from heterozygote-by-heterozygote crosses. Mist1BT/BT
mice (a kind gift from Dr. Stephen Konieczny) were generated via inserting an N-terminal BT
tagged, C-terminal 6XHis-Myc tagged Mist1 and two loxP sites into the endogenous Mist1 locus.
Mist1CreERT mice were generated as previously described (Shi et al., 2009). Mist1BT/Cre mice were
generated by het crossing of Mist1BT/Cre mice generated from breeding Mist1BT/BT mice with
Mist1CreERT mice; mice at 8 weeks of age were given 5 consecutive daily intraperitoneal
injections of tamoxifen (1 mg/20 g BW; Sigma-Aldrich). Littermate Mist1BT/BT mice served as
the controls in these experiments. Gnptab−/− mice (a kind gift from Dr. Stuart Kornfeld) were
generated as described (Gelfman et al., 2007). Mist1−/−Gnptab−/− were generated from crossing
Mist1+/−Gnptab+/− mice.

Other genotypes (Mist1+/+Gnptab+/+, Mist1−/−Gnptab+/+, and

Mist1+/+Gnptab−/−) served as littermate controls.

Mist1+/+Gnptab+/+ and Mist1−/−Gnptab+/+

were phenotypically the same as WT and Mist1−/− mice, respectively.
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Immunofluorescence / Imaging
Stomachs were prepared and stained as described previously (Ramsey et al., 2007). Briefly,
stomachs were inflated with freshly prepared methacarn fixative and suspended in fixative for 15
to 30 min at room temperature or 10% formalin fixative for 12 hrs at 4C, followed by multiple
rinses in 70% ethyl alcohol (EtOH), arrangement in 2% agar in a tissue cassette, and routine
paraffin processing. Pancreases were dissecting and suspended in 10% formalin fixative for 12
hrs at 4C, followed by multiple rinses in 70% ethyl alcohol (EtOH), arrangement in 2% agar in a
tissue cassette, and routine paraffin processing.

Sections (5 µm) were deparaffinized and

rehydrated, and antigen retrieval was performed by boiling in Trilogy (Cell Marque, Hot Springs,
AR) or 50 mM Tris-HCl, pH 9.0. Slides were blocked in 1% bovine serum albumin (BSA) and
0.3% Triton X-100 in phosphate-buffered saline (PBS) and then incubated in primary antibodies
followed by secondary antibodies (see below). Slides were incubated for 5 min in 1 µg/ml
bisbenzimide (Invitrogen, Carlsbad, CA) prior to mounting in Cytoseal XYL (Rishard-Allan
Scientific, Kalamazoo, MI).
Fluorescence microscopy and imaging were performed using a Zeiss Axiovert 200
microscope 20X (Plan-Apochromat, 0.8 NA), 40X (Plan-Neofluar 0.85 NA) and 63X objectives
(Plan-Apochromat, 1.4 NA) with Axiocam MRM camera and AxioVision software. Additional,
confocal microscopy and imaging were performed using a Zeiss LSM510 META microscope
with 40X (EC Plan-Neofluar, 0.75 NA) and 63X (Plan-Apochromat, 1.4 NA) objectives using
LSM510 software.

Contrast (maximal, minimal, and midtone) adjustment and fluorescent

channel overlay and pseudocoloring were performed with Photoshop (Adobe Systems, San Jose,
CA). All adjustments were performed on the entire image equally. Cartoon cell traces and
illustrations were produced using Illustrator (Adobe Systems, San Jose, CA).
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The primary antibodies used for mouse tissue immunostaining: rat anti-LAMP1 (1:250,
clone 1D4B, developed by J. Thomas August and obtained from the Developmental Studies
Hybridoma Bank under the auspices of the NICHD maintained by The University of Iowa),
mouse anti-β-Gal (1:500, Promega, Madison, WI), sheep anti-PGC (1:1000, Abcam, Cambridge,
MA), mouse anti-c-Myc (1:200, clone 9E 10, developed by J. Michael Bishop and obtained from
the Developmental Studies Hybridoma Bank under the auspices of the NICHD maintained by
The University of Iowa), rabbit anti-amylase (1:100, Calbiochem, CA), rabbit (1:10,000) and
goat (1:2000) anti-human gastric intrinsic factor (gifts of Dr. David Alpers, Washington
University), rat anti-LAMP2 (1:40), rabbit anti-CTSD (1:200), and rabbit anti-CI-M6PR (1:500)
(gifts of Dr. Stuart Kornfeld, Washington University). Secondary antibodies used were Alexa
Fluor 488-, 594-, and 647-conjugated donkey anti-goat, anti-rabbit, anti-sheep, and anti-mouse
antibodies (1:500; Invitrogen).
For immunohistochemical analyses, stomach sections were deparaffinized as stated above
and subsequently immersed in 3% H2O2 to quench endogenous peroxidase activity. Antigen
retrieval was performed as above. Avidin and biotin were applied consecutively to prevent
endogenous biotin related background staining. Sections were incubated with 1:250 mouse antiLAMP1 (clone 1D4B) overnight followed by incubation for one hour with biotinylated goat antimouse Abs (Santa Cruz). After rinsing (0.1% Tween-20), tissue sections were incubated with
horseradish peroxidase-conjugated streptavidin (Dako) for 20 minutes at room temperature.
Slides were washed (0.1% Tween-20), and the chromogen was developed for 5 minutes with
liquid 3,30-diaminobenzidine (DiNonA, Seoul, Korea) before counterstaining with Meyer’s
hematoxylin. After dehydration sections were mounted as described.
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Immunofluorescence Quantification
Secretory vesicle quantification was performed on immunostained stomachs for PGC and
LAMP1 as prepared above. Images were analyzed in ImageJ as follows. PGC secretory vesicles
were traced using circle tool and tracked using ROI manager. After all vesicles were traced,
individual areas were measured using the Analyze area measurement tool. Using ROI manager,
traced secretory vesicles were overlayed onto LAMP1 stained images and vesicle/LAMP1
overlap was noted for each of the traced vesicles. Three WT, Mist1−/−, Gnptab−/−, and five
Mist1−/−Gnptab−/− mice were analyzed.

Western Blot Analysis
Tissue was flash frozen in liquid nitrogen and homogenized in RIPA buffer using a PowerGen
700 (Fischer Scientific, Pittsburg, PA). Proteins were then separated on NuPAGE Bis-Tris gels
(Invitrogen), transferred to Immobilon polyvinylidene difluoride (Millipore, Bedford, MA) or
Amersham Hybond ECL nitrocellulose (GE Healthcare, Buckinghamshire, United Kingdom)
membranes, and detected by Immobilon chemiluminescence (Millipore, Billerica, MA). Primary
antibodies used were mouse anti-LAMP1 (1:1000, clone H4A3, developed by J. Thomas August
and James E. K. Hildreth and obtained from the Developmental Studies Hybridoma Bank under
the auspices of the NICHD maintained by The University of Iowa), rabbit anti-CTSD (1:2000,
gift of Dr. Stuart Kornfeld, Washington University), sheep anti-Pepsinogen C (1:3000, Abcam),
mouse anti-LC3 (1:1000, Cosmo Bio, Carlsbad, CA), and rabbit anti-Tubulin (1:2000, Cell
Signaling Technology, Beverly, MA).

Secondary antibodies were horseradish peroxidase–

conjugated donkey anti-rabbit, anti-rat and anti-mouse (Santa Cruz Biotechnology, Santa Cruz,
CA).
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PGC and GIF Western blot intensity were quantified using ImageJ and normalized to
actin control band intensities.

Transmission Electron Microscopy
For transmission electron microscopy (TEM) studies, stomachs were fixed, sectioned, stained,
and imaged as described previously (Ramsey et al., 2007).

Graphing and Statistics
All graphs and statistics were determined with GraphPad Prism and then visualized using Adobe
Illustrator. Statistical analysis was, in the case of simple control-versus-experimental condition
comparison, by Student’s t test. Otherwise, significances were determined by a one-way analysis
of variance (ANOVA) test with Dunnett’s multiple-comparison correction.
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Figure Legends

Figure 1. MIST1 is required for large secretory granule homeostasis. A. H&E micrographs
of representative gastric units (outlined in black) from WT and Mist1−/− mice with transmission
electron micrographs highlighting the basal zymogenic cell zones. Immunofluorescence staining
of WT and Mist1−/− gastric units with zymogenic cell secretory markers: B. pepsinogen C (PGC,
red) and C. gastric intrinsic factor (GIF, purple). Representative units are outlined in black and
parietal cells which do not express ZC secretory markers are shown in yellow. Western blots for
PGC and GIF levels between WT and Mist1−/− stomachs from triplicate experiments are shown
below with quantification of signal normalized to actin. (“*” – p <0.05, “**” – p <0.01, twotailed Student’s t-test). Scale bars = 20 µm unless indicated.

Figure 2.
MIST1.

Gastric zymogenic cells show accumulation of lysosomes in the absence of
A.

Fluorescence microscopy of an outlined WT gastric unit showing only light,

perinuclear LAMP1-positivity (green) in ZCs (stained red for PGC and purple for GIF
expression) compared to the bright diffuse LAMP1 staining ZCs from a Mist1−/− gland. Yellow
tracing demarcates parietal cells which do not express MIST1 and do not change in LAMP1
staining between WT and Mist1−/− gastric glands, thus serving as internal controls for relative
immunofluorescence intensity. B. Immunohistochemistry for LAMP1 in WT and Mist1−/−
gastric glands. Two representative units highlighted in black and parietal cell staining control
outlined in yellow. Epiflourescence staining of WT and Mist1−/− gastric glands for additional
lysosomal markers: C. cathepsin D (CTSD, green) and D. LAMP2 (green) co-stained with GIF
(red). Glands are demarcated in white with parietal cells shown in yellow. Scale bars = 20 µm.
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Figure 3. Mist1−/− ZCs display degraded secretory vesicles inside accumulating lysosomes.
A.

Transmission electron micrograph of WT ZCs with large apical secretory vesicles and

basally located nuclei. B. tEM of Mist1−/− ZCs with a reduction in large apical vesicles and an
increase in degrading secretory granules. Panels represent higher magnification of boxed regions
containing vesicles (arrows) in various states of degradation (later stages “*”). C. Confocal
sections of WT and Mist1−/− basal gastric units (outlined) stained for LAMP1 (green) and PGC
(red). D. Higher magnified region of Mist1−/− ZCs through multiple serial optical sections. “*”
indicates LAMP1 labeled lysosomal structures with various stages of degraded PGC entrapped.
Scale bars = 20 µm unless indicated.

Figure 4. Lysosomes accumulate rapidly in the absence of MIST1. A. In Mist1−/− mice,
which have a LacZ cassette inserted into the endogenous Mist1 locus, the transitional cells where
MIST1 should be expressed can be identified by nuclear β-galactosidase expression (red). Left
inset – Higher magnification of the boxed region with nuclei in blue. Note that staining for
LAMP1 (green) is absent in mucus precursor neck cells (NC, “*” marks their nuclei), becomes
stronger in the earliest transitional cells that begin to express the Mist1 promoter (arrows) and
continues to be strong in all mature ZC cells trying to express Mist1 (arrowheads). B. Confocal
images of Mist1BT/BT and Mist1BT/Cre mice (see Materials and Methods) treated with tamoxifen
after one or two weeks stained for LAMP1 (green) and PGC (red). Units are highlighted. C.
Quantification of confocal immunofluorescent microscopy gastric units shown in B.

PGC

secretory vesicles were counted and areas measured, and percentage of vesicles with LAMP1
overlap was determined. Mean vesicle size is indicated in red. Scale bars = 20 µm.
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Figure 5. Mist1−/− pancreatic acinar cells have lysosomal accumulations. A. Fluorescence
microscopy of WT and Mist1−/− mice stained for amylase (red) and LAMP1 (green). Acini are
outlined in white. B. Confocal image of a single Mist1−/− pancreatic acinar cell showing the
large vesicular nature of the lysosomes (“*” in lumen of individual vesicles, “N” – nucleus). C.
Western blot analysis of two wildtype and two Mist1−/− mice showing protein levels of LAMP1,
cathepsin D, and tubulin. D. Immunofluorescence of Mist1BT/BT and Mist1BT/Cre mice treated with
tamoxifen after one or two weeks stained for LAMP1 (green) and c-Myc (purple). Acini are
outlined in white. Scale bars = 20 µm.

Figure 6. Inhibition of lysosome degradation partially rescues Mist1−/− secretory vesicles.
A.

H&E histology panel of WT, Mist1−/−, Gnptab−/−, and Mist1−/−Gnptab−/− gastric units

(labeled in black, parietal cells outlined in yellow). B. Western blots of multiple mice for each
of the indicated genotypes (WT, Mist1−/−, Gnptab−/−, and Mist1−/−Gnptab−/−) probed for PGC,
LC3, cathepsin D, and tubulin. C. Confocal immunofluorescence images of WT, Mist1−/−,
Gnptab−/−, and Mist1−/−Gnptab−/− mouse stomachs stained for LAMP1 (green) and PGC (red).
Gastric units highlighted in white.

For each genotype, multiple mice were stained, PGC

containing secretory vesicles were counted and sizes measured, and PGC LAMP1 vesicle
overlap was quantified (see Materials and Methods).

Binned percentage of total secretory

vesicles (red bars) for each binned size (from 0.1 to 1.0 and greater µm) is graphed below. For
each red bar, proportion of those secretory vesicles engulfed by LAMP1 lysosomes is shown to
the right (green bars). D. Graphed PGC vesicle areas and numbers for multiple WT, Mist1−/−,
Gnptab−/−, and Mist1−/−Gnptab−/−immunostained murine stomachs (Averaged vesicle size for
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multiple mice for each genotype shown in red).

E. Percentage of PGC vesicles enclosed in

LAMP1 lysosomes for multiple WT, Mist1−/−, Gnptab−/−, and Mist1−/−Gnptab−/− immunostained
murine stomachs. Scale bars = 20 µm.

Figure 7. MIST1 induces direct targets to reorganize subcellular architecture. All WT ZCs
(left) initiate and maintain expression of MIST1. Subsequent expression of Rab26 and Rab3D
along with other yet unidentified MIST1 transcriptional targets (labeled “A” and “B”) is also
induced. RAB26 functions to maintain lysosomes in a basal perinuclear distribution and RAB3D
serves to mature secretory vesicles. This ensures proper segregation of the destructive basal
lysosomes from the maturing apical secretory vesicles.

In the absence of MIST1 (right), and

thus no direct target induction, ZCs have lysosomes that are no longer maintained basally
coupled with a secretory vesicle formation defect. Together, this manifests as more aberrant
lysosomal-secretory vesicle interactions and overall smaller, more disorganized secretory
vesicles in the Mist1−/− ZCs.
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Supplemental Figure Legends

Supplemental Figure 1. Conditional deletion of Mist1 results in lysosomal accumulation.
Immunofluorescence of a conditional Mist1 knockout model (See Materials and Methods)
stained for LAMP1 (green), PGC (red), and c-Myc (purple). A. Mist1BT/BT represents the control
condition, in two copies of an N-terminal BT tagged, C-terminal 6XHis-Myc tagged Mist1 and
two loxP sites were introduced via homologous recombination into the endogenous Mist1 locus.
Mist1BT/Cre mice were generated by crossing Mist1BT/BT with Mist1CreERT mice, the Mist1 loci in
excised by 5 consecutive intraperitoneal injections of tamoxifen

(1 mg/20 g BW; Sigma-

Aldrich), and phenotypes were examined at B. one and C. two weeks. Units expressing Mist1
detectable by c-Myc staining (purple) are outlined in white (present in all Mist1BT/BT stoamchs;
mosaic pattern of deletion in one week post tamoxifen injected Mist1BT/Cre mice) and parietal
cells are outlined in yellow. Scale bars = 20 µm.

Supplemental Figure 2. Inhibition of lysosome degradation partially rescues secretory
vesicles in Mist1−/− gastric ZCs and pancreatic acinar cells. A. Immunofluorescence images
of WT, Mist1−/−, Gnptab−/−, and Mist1−/−Gnptab−/− mouse stomachs stained for LAMP1 (green)
and PGC (red). Gastric units are outlined in white. B. Immunofluorescence images of WT,
Mist1−/−, Gnptab−/−, and Mist1−/−Gnptab−/− murine pancreases stained for amylase (red) and
LAMP1 (green). Acini are outlined in white. Scale bars = 20 µm.

Supplemental Figure 3. Other markers show partial rescue of secretory vesicles in Mist1−/−
gastric ZCs and pancreatic acinar cells. A. Immunofluorescence images of WT, Mist1−/−,
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Gnptab−/−, and Mist1−/−Gnptab−/− mouse stomachs stained for cathepsin D (green), LAMP1
(red), and GIF (purple). Gastric units are outlined in white. B. Immunofluorescence images of
WT, Mist1−/−, Gnptab−/−, and Mist1−/−Gnptab−/− murine pancreases stained for cathepsin D
(green) and LAMP1 (red). Acini are outlined in white. Scale bars = 20 µm.
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CHAPTER 6: Conclusions and Future Directions
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As a whole, this work has focused on the role of MIST1 and its direct transcriptional
target RAB26 in zymogenic chief cells of the stomach. Chief cells are an ideal system to study
transcriptional regulation of subcellular organization because 1) they are organized spatiotemporally within the stomach, 2) they have a well-structured secretory architecture, and 3)
establishment of their secretory function occurs rapidly from a relatively long-lived
developmental precursor. Using complementary in vivo mouse genetic approaches and in vitro
cell culture techniques, I have uncovered a MIST1 regulatory network that is crucial for
establishment and maintenance of secretory cell architecture in all exocrine tissues.

MIST1 Induces a Gene Network for Integrated Control of Secretion
In Chapter 2, I show that MIST1 directly induces the expression of 16 genes and that it
directly binds highly-conserved first intronic CATATG E-boxes in 6 of those genes. Focusing
on two targets, RAB3D and RAB26, I show that they are expressed in gastric ZCs in the corpus
of mouse stomach in a MIST1-dependent manner. To address the function of these two small
protein GTPases, I developed a MIST1 dependent secretory vesicle formation system, in which
gastric epithelial cells stably expressing MIST1 produce large ZC-like secretory granules upon
transfection with RFP-tagged pepsinogen C (PGC). In contrast, control cell lines expressing
GFP lacked the ability to form large granules when given the same secretory load. Using this
system, I confirm that expression levels of RAB26 and RAB3D were also specifically induced in
the MIST1 overexpressing cell lines. Finally, I show that formation of the large granules in these
cells is dependent on MIST1-induced Rab activity. Granule formation is abrogated by disrupting
Rab prenylation and overexpression of dominant negative RAB26 mutant. These data show that
MIST1 activates a network of genes including RAB26 and RAB3D, to enact mature secretory
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cell architecture, organize vesicle trafficking, and maintain production of large secretory
granules.

Future Directions
From the list of direct MIST1 targets, we only have yet explored the functions of two of
those genes.

I chose these two genes, RAB3D and RAB26, because they stood out as

representing a possible mechanism by which MIST1, could regulate formation of exocrine
secretory granules in differentiating cells. Because these targets were generated from two gastric
cell lines, I wanted to confirm their in vivo relationship with MIST1 expression. To this end, I
performed laser capture microdissection (LCM) to isolate zymogenic cells (ZCs) and precursor
neck cells (NCs) from nine WT and nine Mist1−/− mice (Capoccia et al., 2013). A pooled sample
of RNA from four mice for each group (WT NC, WT ZC, KO NC, and KO ZC) was sent for
gene expression profiling with Affymetrix Mouse Gene 1.0ST arrays. Upon analyses, I found
MIST1 dependent expression patterns, in which expression was preferentially restricted to WT
ZCs, for 8 of the 16 genes (Fig. 1A).
Among these in vivo MIST1 targets were two genes, CCPG1 and SERPINI1, for which
we had previously shown direct MIST1 binding by chromatin immunoprecipitation and that they
were induced in cell culture by MIST1 overexpression (Tian et al., 2010). In collaboration with
Dr. Xiaolin Tian, I confirmed these Genechip results using in situ hybridization to show specific
expression of both CCPG1 and SERPINI in zymogenic cells from wildtype mice only (Fig. 1B).
Further support for these two targets includes immunofluorescence microscopy indicating
protein expression patterns that match our gene expression and in situ hybridization results (Fig.
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1C). These data indicate that CCPG1 and SERPINI1 are direct MIST1 targets that are expressed
in mature zymogenic cells.
The published functions of both these genes warrant further study of their roles in
zymogenic cell biology. In the only study of its function, CCPG1 was found to bind and regulate
the activity of the RhoA and CDC42 guanine nucleotide exchange factor (Kostenko et al., 2006).
Rho GTPases are key regulators of the actin cytoskeleton (Hall, 1998), and may reveal a yet
unstudied function of MIST1.

The morphology of Mist1−/− zymogenic cells includes a

disorganized and contracted apical cytoplasmic region resulting in luminal expansion
(Bredemeyer et al., 2009; Tian et al., 2010). CCPG1 may represent a mechanism by which
MIST1 controls the cytoskeletal rearrangements necessary to expand the apical cytoplasm.
SERPINI1 or NEUROSERPIN functions as a secreted serine proteinase inhibitor and
regulator of cell adhesion whose role is has been extensively studied in the nervous system
(Kinghorn et al., 2006; Lee et al., 2008; Osterwalder et al., 1998). Mutations in SERPINI1
affecting conformational stability results in a familial form of dementia (Davis et al., 2002; Davis
et al., 1999). These studies suggest the possibility of novel roles of MIST1 in the brain.
Unpublished work from our group and other studies (Luo et al., 2005) have shown MIST1
expression in the brain where it retains its ability to regulate secretory function. In addition, our
collaborator, Dr. Paul Taghert, has comprehensively studied the role of DIMM, the Drosophila
ortholog of MIST1, in the fly brain (Hamanaka et al., 2010; Hewes et al., 2003; Park et al., 2011;
Park et al., 2008a; Park and Taghert, 2009; Park et al., 2008b). On top of its well established
neuronal function, SERPINI1 has recently been implicated to have tumor suppressive effects in
gastric cancer (Yamanaka et al., 2012). Clearly, these data suggest that SERPINI1 may have an
important physiological role in MIST1 expressing tissues including the stomach.
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Additional work should examine CCPG1 and SERPINI1 using the tools that we have
already developed. The roles of these two proteins should be examined in secretory vesicle
formation using the MIST1-stably expressing PGC-RFP system.

Overexpression and

knockdown experiments should reveal novel secretion effects. In addition, other subcellular
compartments should be examined including lysosomes and mitochondria. We can also apply
our AR42J differentiation system to these two MIST1 targets by using these polarized cells to
mimic in vivo development. This system will further confirm and reveal structural effects (e.g.,
actin cytoskeletal and cell-cell junctional defects) that might be induced by overexpression or
knockdown of these two targets. These functional experiments will augment our preliminary
data (Fig. 1) to assign functional roles to these two proteins; adding two more genes to our
network of MIST1 regulated genes. Ultimately, a murine model for CCPG1 deficiency should
be engineered, and the gastric phenotype for the SERPINI1 knockout mice (Gelderblom et al.,
2013) needs to examined to see if any component of the Mist1−/− phenotype is recapitulated.
An additional intriguing target that has been confirmed in our gastric cells and our in vivo
studies is Lysosomal Acid Phosphotase (ACP2).

This enzyme is involved in lysosome

homeostasis with a role in dephosphorylation of M6P containing acid hydrolyases (Makrypidi et
al., 2012). Deficiency in mice leads to formation of lysosomal accumulations (characterized by
enhanced LAMP1 and cathepsin D immunostaining) in many tissues (Mannan et al., 2004; Saftig
et al., 1997).
Finally, the in vivo Genechip data might prove to more informative than our in vitro
genechip results, specifically by providing us with a more physiologically relevant list of MIST1
targets (Capoccia et al., 2013). More work needs to be done with this data to analyze, refine, and
add to our current list of MIST1 regulated genes.
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RAB26 Functions to Reorganize Lysosomes and Prune Mitochondria
In Chapter 3, I present work showing that RAB26 expression in tissues and cells depends
on MIST1 induction. In contrast to previous studies, I show direct association of RAB26 not
with secretory vesicles but with lysosomes.

By immunofluorescent microscopy, both

endogenous and EGFP-tagged RAB26 localize to a LAMP1 and cathepsin D positive lysosome
compartment. These data were confirmed by immunoelectron microscopy, gradient density cell
fractionation, and live imaging of vesicle dynamics. Furthermore, forced expression of RAB26,
but not the GTP cycling null point mutants (T77N, Q123L), specifically repositions lysosomes
from the cell periphery to a perinuclear central region. As a consequence of this RAB26
mediated lysosomal reorganization, I demonstrate by electron microscopy, immunofluorescence
microscopy, and immunoblotting that mitochondria are concomitantly pruned and reorganized
into distinct cellular neighborhoods. Taken together, our data establish a role for RAB26 as a
novel lysosome-associated Rab whose expression is transcriptionally induced by MIST1
specifically in a subset of highly secretory tissues to reorganize the cellular distribution of
lysosomes and, indirectly, mitochondria.

Future Directions
Many unanswered and interesting questions remain from this work involving RAB26 and
the mechanistic details required for it to effect lysosome positioning, degradative function, and
mitochondrial organization. Further characterization of Rab mechanistic function has usually
meant assaying for additional Rab effectors. Preliminarily, I have observed that EGFP-RAB26
in transfected HGC-27 cells is trafficked along microtubules in a nocodazole-dependent manner
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(Fig. 2A). This is consistent with the known mechanism of Rab mediated lysosome movement.
It has been shown that RAB7, RAB34, and RAB36 all function to reposition lysosomes upon
overexpression (Bucci et al., 2000; Chen et al., 2010; Wang and Hong, 2002). Interestingly, all
three of these Rab proteins interact with the same effector, RILP (RAB7 interacting lysosomal
protein) (Cantalupo et al., 2001; Colucci et al., 2005; Jordens et al., 2001; Wang and Hong,
2005). In fact, RILP has been well established in its ability to recruit the microtubule motor
protein, dynein, and induce trafficking of lysosomes towards the minus ends of microtubules
adjacent to the microtubule organizing center near the center of the cell. (Cantalupo et al., 2001;
Jordens et al., 2001). Thus, RILP is an intriguing Rab effector that might also regulate RAB26
mediated lysosome movement. In addition to this specific protein, other RAB26 effectors can be
assayed in unbiased screens including well-established yeast two-hybrid (Fukuda et al., 2008) or
mass spectroscopy (Seals et al., 2000) assays for protein-protein interactions. These screens will
be augmented by using the point mutants (T77N and Q123L) or non-hydrolyzable GTP analogs
(GTPγS or Gpp(NH)p) to elucidate nucleotide binding dependent effector interactions.
In addition to further RAB26 biochemical analyses, I propose to study the effects of
“scaling up” RAB26 on the degradative process of autophagy. Briefly, this pathway involves the
sequestration of proteins and organelles in a double membrane autophagosome for degradation
upon fusion with lysosomes (Klionsky and Emr, 2000). RAB7, a protein with homologous
function and localization as RAB26, has been found to be critical in the final fusion of
autophagosomes with lysosomes (Jager et al., 2004). I posit that RAB26 mediated repositioning
of lysosomes might affect the degradative capacity of the cell through a similar mechanism. In
fact, I have found that overexpression of RAB26 in HGC-27 cells causes a similar aggregation of
autophagosome markers (LC3 and p62) (Fig. 2B, C). These aggregations of LC3 marked
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vesicles remained upon induction of the pathway by rapamycin treatment (Fig. 2B) or serum
starvation. Immunofluorescence staining for p62 (a marker for autophagocytic flux) in these
rapamycin treated cells revealed less p62 in the EGFP-RAB26 overexpressing cells, suggesting
that autophagocytic degradation is induced in these cells (Fig. 2B). I confirmed this finding
using a mCherry-EGFP-LC3 plasmid in which fluor intensity indicates progression along this
degradative pathway. Specifically, both EGFP and mCherry mark the autophagosome, but upon
lysosome fusion, EGFP is degraded, and more stable mCherry remains. Co-transfection of this
plasmid with untagged-RAB26 (marked by increased RAB26 immunostaining) revealed that
cells overexpressing RAB26 clustered autophagosomes (red and green) along with lysosomes
(red) (Fig. 2C). These preliminary data suggest a role of RAB26 in regulating autophagy.
Additional studies would need to address if RAB26 overexpressing increases
autophagosome formation, trafficking, or fusion with lysosomes. Specifically, we can use well
established assays to measure levels of each of these steps (Klionsky et al., 2008a). It would also
be interesting to address if RAB26 has the ability to function as a complement to RAB7 by
knocking down RAB7 and assaying for rescue of degradative capacity upon restoration with
RAB26. Based on our previous findings with lysosomal function (Chapter 3), it would be
unlikely that reducing cellular levels of RAB26 would influence autophagy, but this would be
another avenue needing further study. Involvement in any of the steps in autophagy would be an
important finding, and would mean that autophagy as a process may be scaled up in secretory
cells in response to MIST1 induction.
How RAB26 prunes and reorganizes mitochondria is also an area that merits further
study. Two separate pathways have been found to mediate the actual delivery of mitochondria to
lysosomes (Ashrafi and Schwarz, 2013). Mitophagy is a subset of autophagy that involves
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formation of isolation membranes around damaged mitochondria before subsequent delivery to,
fusion with, and degradation in lysosomes (Youle and Narendra, 2011). Cells may also use an
autophagy independent route that involves direct vesicular transport of damaged mitochondria to
lysosomes (Soubannier et al., 2012).

Both pathways of lysosome mediated mitochondrial

degradation can be induced pharmacologically (Jin and Youle, 2012; Soubannier et al., 2012).
Mitophagy can be induced by addition of the mitochondrial membrane uncoupler carbonyl
cyanide m-chlorophenylhydrazone (CCCP) in cells that express the ubiquitin ligase, Parkin,
which functions to mark damaged mitochondria for degradation (Narendra et al., 2008). Using
HGC-27 cells, which do not express much endogenous Parkin, I show that mitophagy is induced
upon CCCP treatment and mCherry-Parkin transfection (Fig. 2D). This process is characterized
by Parkin and LC3 (an autophagosome marker) recruitment to mitochondria and co-localization.
Upon addition of RAB26, I find that these Parkin positive structures (damaged mitochondria)
become marked with RAB26 and LAMP1 vesicles (Fig. 2E). Recruitment of lysosomes to these
damaged Parkin bound mitochondria was not affected by transfection of RAB26 point mutants
(Fig. 2E).
Conveniently, the autophagy-independent mitochondria degradation pathway is also
inducible chemically (Soubannier et al., 2012). Glucose oxidase can stimulate direct vesicular
interactions between lysosomes and the TOM20 mitochondrial membrane marker. Interestingly,
this is the same mitochondrial marker that I used to monitor RAB26 induced mitochondrial
reorganization (Chapter 3). In sum, I have provided preliminary data indicating that RAB26 is
recruited to damaged mitochondrial through both autophagy (i.e., mitophagy) dependent and
independent processes.
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Using the tools that I have developed, specifically live cell imaging, it would be
interesting to visualize the timing and capacity of RAB26 recruitment to mitochondria upon
pharmacologic damage. At baseline, overexpressing RAB26 is already accelerating the pruning
of mitochondria, it would also be important to quantify the effects of RAB26 overexpression in
the setting of mitochondrial damage. Are damaged mitochondria more efficiently degraded upon
RAB26 transfection? Using confocal live imaging, I can measure the decrease in mitochondrial
area as a function of time after addition of drug. I can then compare the effects on timing and
reduction of mitochondrial area upon overexpressing RAB26 or the point mutants.
In addition, the contribution by both pathways can be teased out pharmacologically using
drugs which can block autophagosome-lysosome fusion (bafilomycin A1,(Klionsky et al.,
2008b)) or inhibit lysosome proteolysis (leupeptin, (Haspel et al., 2011). I would look for
abrogation of RAB26 mediated baseline mitochondrial pruning (shown in Chapter 3) or
prevention of any additional RAB26 mediated effects upon damaging mitochondria by the
methods previously discussed.

If treatment with bafilomycin does not inhibit baseline or

pharmacologic damage induced RAB26 mediated mitochondrial degradation, then this process
would be autophagy independent (i.e., RAB26 shuttles damaged mitochondria directly to
lysosomes without an autophagosome intermediate). Treatment with leupeptin should delay
mitochondrial degradation no matter the pathway they take to reach the lysosomes. In summary,
all proposed experiments would further elucidate the sufficiency and necessity of RAB26 in
lysosome mediated mitochondria degradation, and the exact vesicular trafficking pathways that
are involved.
The relationship between RAB26 and secretory vesicles remains to be fully investigated.
My initial characterization of RAB26 showed that the T77N point mutant inhibited formation of
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large PGC-RFP secretory vesicles in MIST1 overexpressing cells (Tian et al., 2010). I assume
based on subsequent studies that this effect is an indirect one. In these cells, as in chief cells in
vivo, lysosomes must be moved and organized away from the secretory vesicles. MIST1induced RAB26 mediated perinuclear lysosomal movement would shuttle lysosomes away from
developing secretory vesicles.

To prove this, I would use live imaging in this PGC-RFP

expressing secretory vesicle system to monitor lysosome-secretory vesicle interactions upon
transfection of RAB26 or any of its point mutants. Specifically, I would monitor for increased
lysosome-secretory vesicle interaction upon T77N or even Q123L overexpression. In addition,
the AR42J differentiation system would be an independent method to test the effects of RAB26
on secretion. These cells would be induced with dexamethasone treatment to induce expression
of MIST1 and RAB26, increase amylase secretory vesicles, and cluster their lysosomes. Using
siRNA knockdown or point mutant transfection, I would again assay by microscopy for
increased lysosome-secretory vesicle interaction. This system would also be amenable to assays
for secretion by measurement of amylase in the media upon RAB26 overexpression or
knockdown either by siRNA or functionally through transfection with point mutants. The effects
of RAB26 on secretory vesicle maturation may be indirectly related to its ability to position
lysosomes.
Ultimately, a murine model of RAB26 deficiency and RAB26 overexpression should be
engineered. The former should recapitulate the lysosomal phenotype of Mist1−/− mice, and the
latter should rescue the lysosomal phenotype in the setting of MIST1 loss. Discouragingly,
murine Rab knockout models have been difficult to interpret. For example, when RAB3D,
another MIST1 target with well-established roles in secretory vesicle docking was overexpressed
in Mist1−/− mice, secretory vesicle disorganization was not rescued (Johnson et al., 2004). When
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exocrine tissues were examined in RAB3D deficient mice, no secretion defect was found (Riedel
et al., 2002).

As a result, results from in vivo genetic models of RAB26 deficiency or

overexpression should be carefully interpreted, because redundancy among Rabs might mask
loss of function effects.

MIST1 Suppresses Lysosome Mediated Degradation in Mature Exocrine Cells
In Chapter 4, I demonstrate that MIST1 regulates the exocrine secretory apparatus by
suppression of the degradative lysosomal machinery. Specifically, I show that, in addition to the
reduction in secretory vesicle size and general granule disorganization seen in Mist1−/− mice,
there is a dramatic increase in functional lysosomes. Normally in these exocrine secretory
tissues, lysosomes are small, diffuse, and organized away from larger maturing secretory
vesicles. But upon MIST1 loss, this degradative compartment expands apically engulfing and
degrading many of the forming vesicles. In collaboration with Greg Sibbel, I assayed the timing
of this lysosome accumulation using an inducible mouse model of MIST1 loss. We found that
lysosomes accumulate rapidly upon loss of MIST1 in all exocrine tissues.

I confirm the

functionality of these increasing lysosomes and the severity of secretory vesicle degradation by
crossing Gnptab−/− mice with Mist1−/− mice. Because these Gnptab−/− mice exhibit impaired
acid hydrolase trafficking and reduced lysosomal capacity, we were able to partially rescue the
secretory destruction in Mist1−/− mice as measured by increased vesicle size and undegraded
secretory vesicle content inside lysosomes. In other words, we were able to rescue subsequent
destruction of the vesicles once inside lysosomes but did not effect on the aberrant targeting of
vesicles to lysosomes.

These data demonstrate the effects of MIST1 on other vesicular

compartments and hint at the role of RAB26 in exocrine cells to effectively move and organize
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lysosomes.

In cells that lack MIST1, and have nominal levels of RAB26, lysosomes are

ineffectively trafficked away from secretory vesicles causing promiscuous interactions between
the two compartments.

Future Directions
These proposed experiments would shed light as to the exact pathway secretory vesicles
take to reach lysosomes in the absence of MIST1 in vivo. Previous work from our lab has shown
that in the absence of MIST1, as precursor mucous secreting neck cells differentiate into
zymogenic chief cells, there is a transient increase of secretory vesicles (Ramsey et al., 2007).
These “transition cells” express both precursor neck cell and mature zymogenic cell markers,
and, in wildtype mice, would be increasing expression of MIST1 and its gene targets. Because
MIST1 is not expressed, lysosomal degradation is not suppressed, and subsequent secretory
vesicles show fewer secretory vesicles by immunofluorescence microscopy compared to these
Mist1−/− “transition cells”. Interestingly, I have found that in WT mice, most mature secretory
vesicles are marked with markers of autophagosomes (Fig. 3A). However, in contrast, in the
absence of MIST1, only these “transition cells” with their transient increase in secretory vesicles
exhibit the same staining for LC3 and p62 autophagosome markers (Fig. 3A, B).

Once

lysosomes are increased in Mist1−/− mice, these markers along with secretory vesicle proteins are
all decreased as visualized by immunostaining (Fig. 3B). Therefore, this data suggest that at
baseline mature secretory vesicles are tagged and poised to be degraded by lysosomes. It is only
MIST1 suppression of the degradative compartment that prevents this process. So, when MIST1
is lost, these vesicles that are formed and tagged at the transition (arrowheads, Fig. 3B) become
readily degraded as shown in Chapter 4.
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Why would mature zymogenic cells maintain their secretory vesicles in a state of highalert, ready to be immediately destroyed? I suggest that the answer lies in the evolutionary
relationship between pathogen and host. Helicobacter pylori is the main constituent of the
gastric microbiome (Fox and Sheh, 2013). Recent studies have revealed that people with defects
in the degradative pathway increases susceptibility to H. pylori infection (Raju et al., 2012). In
fact, intracellular survival has been found to be an important part of the pathogenesis of this
bacterium (Deen et al., 2013; Terebiznik et al., 2009).

H. pylori intracellular survival is

dependent on entry into these autophagosomes and prevention of subsequent lysosome fusion by
vacuolating toxin binding and sequestration of RAB7 (Terebiznik et al., 2006). As a whole,
these studies indicate that the careful balance between formation of secretory vesicles and their
degradation to prevent H. pylori infection is an important task for mature secretory cells in the
stomach.
To test the involvement of autophagy in the degradation of secretory vesicles in Mist1−/−
mice, I propose to use a mouse model in which autophagy can be conditionally downregulated.
Using the well characterized Atg7flox/flox mice, in which the autophagy essential Atg7 gene is
deleted under the control of Cre recombinase (Komatsu et al., 2005), I propose to turn off
autophagy in exocrine cells and in all cells using Mist1CreERT2 and CAGGCreERTM, respectively.
Preliminary results show that Atg7 is deleted by message and protein levels in the stomach by
induction with CAGGCreERTM (Fig. 3C). Interesting in these whole mouse inducible ATG7
knockouts, by immunofluorescence microscopy, we see aggregation of undegraded LC3 and p62
(consistent with previous reports (Riley et al., 2010)) preferentially in the exocrine secretory
cells of the stomach (Fig. 3D, E) and the pancreas (Fig. 3F). Crossing these MIST1 expressing
cell specific and whole mouse ATG7 knockouts to Mist1−/− mice and then assaying for the
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effects on secretory vesicle degradation through established assays (Chapter 4) will reveal the
effects and necessity of autophagy in lysosome mediated secretory vesicle destruction. If in the
absence of MIST1 and the ATG7, secretory granules are rescued from degradation, specifically
no longer targeted to lysosomes, this would prove that autophagy is indeed the intermediate
pathway by which secretory vesicles are targeted to lysosomes.

Further exploration of

autophagy in MIST1 regulated secretory vesicle maintenance will have critical importance for
our cell biological and microbiological understanding of zymogenic chief cells.

Loss of MIST1 Induces Lysosome Mediated Downscaling During Gastric Metaplasia
In Chapter 1, I highlighted the zymogenic cell lineage and its involvement in many of the
critical diseases that affect the stomach. Specifically, these post mitotic mature secretory cells
have been shown to possess the ability in response to tissue damage to dedifferentiate, become
metaplastic (Goldenring et al., 2011; Nam et al., 2010), and regain stem cell-like properties
(Stange et al., 2013).

Thus, understanding the process by which these cells initiate this

dedifferentiation program may be critical to furthering our knowledge of gastric carcinogenesis.

Future Directions
MIST1 and the maintenance of secretory architecture may be a key factor in preventing
these cells from this metaplastic transformation. In fact, this may be a theme for all exocrine
tissues including the pancreas. Specifically, loss of MIST1 has been found to directly render
gastric chief and pancreatic acinar cells susceptible to injury, metaplasia, and carcinogenesis
(Alahari et al., 2011; Kowalik et al., 2007; Lennerz et al., 2010; Nam et al., 2010; Nozaki et al.,
2008; Shi et al., 2013; Shi et al., 2009). Studies using a pharmacologic (high dose tamoxifen)
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inducible model of gastric atrophy and metaplasia show that MIST1 is one of the first factors that
is lost as mature zymogenic cells respond to injury (Huh et al., 2012). Additional studies in the
pancreas using an inducible MIST1 knockout model revealed that within hours of MIST1 loss,
mature pancreatic acinar cells began to remodel their granules, cytoskeleton, and cellular
junctions (Direnzo et al., 2012).
In the stomach, I have found that concomitant with early MIST1 loss upon high dose
tamoxifen induced injury, LAMP1 stained lysosomes significantly increased. This increase in
lysosomes is accompanied by loss of mature PGC secretory vesicles and re-expression of
mucous neck cell markers (GSII) (Fig. 4A). By higher magnification confocal microscopy, I
observed increasing lysosome and secretory vesicle interactions until 24 hours post tamoxifen
injury (Fig. 4B). These degradation events were restricted to mature native PGC secretory
vesicles and excluded newly formed metaplastic GSII-marked mucous vesicles. After 24 hours,
the majority of zymogenic cells had turned over all their PGC vesicles, replaced with GSII
vesicles. These data show that MIST1 loss and LAMP1 mediated lysosomal attack on secretory
vesicles occur as early events during gastric tissue injury response, prior to and independent from
synthesis of neck cell mucous granules.
These animal data are supported by observations made in human gastric biopsy samples
containing regions of normal stomach adjacent to metaplastic areas. In the normal areas, large
PGC secretory vesicles are preserved apically and lysosomes are small and diffusely distributed
basally, consistent with our mouse model (Fig. 4D). However, in these areas of metaplasia
characterized, as in our murine model, by metaplastic re-expression of precursor markers (GSII)
and associated decrease in mature PGC vesicles, we find aberrant lysosome-secretory vesicle
interactions (Fig. 4E). These lysosome mediated degradation events only occur for the PGC
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vesicle population; the newly forming metaplastic mucous granules are excluded from this
destruction.
Based on these findings, this process of lysosome mediated vesicle attack during injury
response warrants further characterization.

First, other injury models of murine gastric

metaplasia (elicited by Helicobacter species (Nomura et al., 2004), other pharmacologic agents
(Goldenring et al., 2000), or genetically (Li et al., 1996; Nomura et al., 2005)) should be
examined to confirm this lysosome mediated attack on secretory vesicles is a universal feature of
early gastric metaplasia. Next, as with the increase in lysosomes seen in our Mist1−/− mice, the
role of autophagy should be investigated by looking for co-localization of autophagy markers
with secretory vesicles in these early time points after injury induction.
All findings should be related to pancreatic metaplasia models (Habbe et al., 2008; Shi et
al., 2013) to establish lysosome downscaling of mature secretory cell architecture as a common
first step during injury response in MIST1 expressing tissues. Encouragingly, in the exocrine
pancreas, acute pancreatitis (an injury state preceeding metaplasia and carcinogenesis (Hezel et
al., 2006)) often involves damaging auto activation of secretory enzymes (Gaiser et al., 2011).
Studies have shown that this process involves fusion of lysosomes and activation of secretory
zymogens by lysosomal hydrolases (Halangk et al., 2000; Saluja et al., 1997).
After these experiments that characterize the process, I propose a series of functional
experiments to address the requirement of MIST1 and upregulation of degradation in the
metaplastic response of zymogenic chief cells. The former will be addressed by using an
inducible model of MIST1 overexpression (Direnzo et al., 2012). Pharmacologic provocation of
gastric metaplasia will be studied in the setting of continued MIST1 overexpression through Cre
recombinase excision of a Lox-STOP-Lox cassette allowing constitutive CAG promoter driven
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expression of MIST1. These experiments will assay the requirement of MIST1 loss during
gastric metaplasia.

In other words, if loss of MIST1 is needed for the metaplastic

dedifferentiation of zymogenic cells, then these constitutive MIST1 expressing mice will retain
morphologically normal chief cells upon gastric injury.
In addition, the mechanistic requirement for lysosomal degradation of secretory vesicles
will also be addressed. Metaplasia will be induced in mice defective in lysosomal hydrolases,
the Gnptab−/− mice, and ability of mature zymogenic cells to degrade mature PGC vesicles and
form mucous precursor granules will be tracked. Complementary experiments exploring the role
of autophagy in this process are also possible using ATG7fl/fl mice as described or additional
well-established genetic models of autophagy inhibition (Hara et al., 2006; Ichimura and
Komatsu, 2011).
Ultimately, the role RAB26 in this process should also be addressed. As previously
mentioned, a murine model of RAB26 overexpression must first be constructed. With this tool
in hand, metaplasia can be induced in gastric zymogenic cells overexpressing RAB26 and the
lysosomal degradation of secretory vesicles can be examined. If RAB26 is the critical MIST1
target whose maintained expression is needed to suppress lysosome-secretory vesicle
interactions, then these mice should exhibit increased PGC vesicles and resiliency against
metaplasia.

In summary, these proposed experiments will explore the physiologic role of

MIST1, RAB26, and degradative cell architectural reorganization.

Final Remarks
The goal of this thesis was to determine the direct transcriptional targets of the exocrine
cell specific transcription factor, MIST1. From this process, I found and focused on a specific
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MIST1 target, RAB26, and elucidated its novel role in lysosome movement and mitochondrial
reorganization. These findings led me to uncover the function of MIST1 in suppression of
lysosome mediated degradation of mature secretory vesicles in exocrine cells. As a whole, this
work demonstrates the importance of basic transcriptional factor controlled gene networks in the
establishment of cellular form and function. I hope these findings will elucidate a physiologic
correlate in and uncover a previously unrecognized feature of gastric pathologies.
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Figure Legends

Figure 1. The expression of CCPG1 and SERPINI1 is MIST1 dependent. A. Microarray
analysis from isolated populations of gastric ZCs and their precursor neck cells from wild-type
and Mist1−/− mice. MIST1 expression is shown atop as a positive control validation of the
microarray data. Expression of previously identified MIST1 targets from gastric cell lines are
indicated and separated into groups exhibiting a MIST1 dependent pattern or a MIST1
independent pattern.

Two of these MIST1 dependent targets, CCPG1 and SERPINI1 are

highlighted in red. Gene expression for microarray analyses are shown with relative expression
scale (-3.0 to 3.0) with red=high, blue=low expression. B. In situ hybridization of mouse fundic
gastric gland sections showing antisense CCPG1 and SERPINI1 signal confined to the ZCs at the
base of the glands in wild-type mice, and lack of staining in Mist1−/− mice.

C.

Immunofluorescence microscopy of wild-type and Mist1−/− mice stained for CCPG1 and
SERPINI1 protein expression (green). Lysosomes (LAMP1, red) and secretory vesicles (GIF,
purple) are also shown. Insets contain high magnification confocal images of CCPG1 and
SERPINI vesicle staining in basal zymogenic cells. Gastric units are outlined in white and scale
bars = 20 µm.

Figure 2.

RAB26 traffics along microtubules and co-localizes with autophagy and

mitophagy markers. A. Live confocal timelapse microscopy of EGFP-RAB26 vesicles after
treatment with 10 µg/mL of nocodazole. Three panels indicate images taken at one minute
intervals with arrowheads indicating the static nature of previously motile RAB26 vesicles post
treatment. B. Epifluorescence of HGC-27 cells transfected with EGFP-RAB26 (green) and
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stained for LC3 (red) and p62 (purple) after 6 hour treatment with 10 µm rapamycin to induce
autophagy. C. Immunofluorescence staining of HGC-27 cells co-transfected with mCherryEGFP-LC3B (red and green) and RAB26 without GFP tag (pcDNA3.1-RAB26) stained with
anti-RAB26 (purple).

D. mCherry-Parkin (red) transfected HGC-27 cells stained for LC3

(green) upon 1 hour treatment with carbonyl cyanide m-chlorophenylhydrazone (+CCCP). E.
Fluorescence microscopy of CCCP treated EGFP-RAB26, EGFP-RAB26T77N, EGFPRAB26Q123L, and EGFP HGC-27 cells (green) co-transfected with mCherry-Parkin (red)
stained for LAMP1 (purple). Scale bars = 20 µm.

Figure 3. Autophagocytic vesicles mark secretory vesicles and accumulate upon deletion of
Atg7. A. Fluorescence microscopy of outlined WT and Mist1−/− gastric units showing LC3
(green) and p62 (red) staining in ZCs (stained purple for PGC expression).

Arrowheads

indicated higher expression levels of LC3, p62, and PGC in the transitional cells of Mist1−/−
gastric units. Parietal cells are shown in yellow. B. Immunofluorescence staining of a Mist1−/−
gastric unit showing LAMP1 (green), LC3 (red), and GIF (purple) staining.

Arrowheads

indicated higher expression levels of LC3 and GIF in the Mist1−/− transitional cells before
expansion of the LAMP1 lysosome compartment. C. Western blot and PCR analysis of the
knockdown of ATG7 protein and mRNA for CAGGCreERTM+ATG7fl/fl (+) and CAGGCreERTMATGfl/fl (-) mice after tamoxifen induction. D. Immunofluorescence microscopy of gastric units
from CAGGCreERTM-ATG7fl/fl (-) and CAGGCreERTM+ATG7fl/fl (+) mice 2 weeks after tamoxifen
induction stained for LC3 (green), p62 (red), and GIF (purple). E. Inset shows confocal image
of GIF (purple) stained basal zymogenic cells of CAGGCreERTM+ATG7fl/fl tamoxifen induced
mice with arrows highlighting LC3 (green) and p62 (red) aggregations. F. Immunofluorescence
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and confocal microscopy of pancreatic acini from CAGGCreERTM-ATG7fl/fl (-) and
CAGGCreERTM+ATG7fl/fl (+) mice 2 weeks after tamoxifen induction stained for LC3 (green) and
p62 (red). Arrows show LC3 (green) and p62 (red) aggregations. Gastric units and pancreatic
acini are outlined in white and scale bars = 20 µm.

Figure 4. Lysosome mediated secretory vesicle destruction is an early event during gastric
metaplasia. A. Gastric units from untreated (control) mice and mice 12 and 24 hours post
tamoxifen induced metaplasia showing immunofluorescence staining of LAMP1 (green), GIF
(red), and the mucous neck cell marker (GSII, purple). Gastric units are outlined in white.
Higher magnification confocal microscopy of basal zymogenic cells B. 12 hours and C. 24 hours
post tamoxifen treatment stained for LAMP1 (green), GIF (red), and GSII (purple). Arrows
indicate

GIF

stained

secretory

vesicles

inside

LAMP1

labeled

lysosomes.

D.

Immunofluorescence imaging of human gastric cancer biopsy samples immunostained for
LAMP1 (green), PGC (red), and GSII (purple). Normal and adjacent metaplastic regions are
outlined. E. Confocal sections (basal to apical) of a metaplastic zymogenic cell stained for
LAMP (green), PGC (red), and GSII (purple). GSII vesicular regions devoid of LAMP1 overlap
indicated (‘*’).
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